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Chapter 1  •
Chronic obstructive pulmonary disease 
 Chronic obstructive pulmonary disease (COPD) is one of the most important 
causes of morbidity and mortality worldwide.  In 2008, COPD was already the fourth 
leading cause of death in the world, but the number of patients is still rising and the World 
Health Organization (WHO) predicts that COPD will become the third most common cause 
of mortality in 2030 (1).  COPD is a systemic disease characterised by a progressive airflow 
limitation which is not fully reversible.  Patients with COPD usually present with cough, 
sputum production, dyspnoea and impaired exercise tolerance.  It is associated with a 
chronic and abnormal inflammatory response of the lung, primarily caused by exposure 
to cigarette smoke and/or other risk factors such as biomass cooking and occupational 
exposure to dust and chemical reagents (2-5).  The diagnosis is traditionally confirmed by 
an airflow limitation defined as a decreased ratio of forced expiratory volume in 1 second 
(FEV1) over forced vital capacity (FVC), and a reduction of the FEV1 on spirometry that is 
not fully reversible by inhaling a bronchodilator (6).
Alpha1-antitrypsin deficiency as a risk factor of COPD
 Alpha1-antitrypsin deficiency is the most widely recognised genetic disorder 
causing COPD.  It was first described in 1963 by Carl-Bertil Laurell and his fellow investigator 
Sten Erikkson, who discovered two emphysematous patients missing a normal α1-band 
on plasma protein electrophoresis (7).  After this initial finding, over 100 variants of α1-
antitrypsin have been reported and the characterisation of different genetic variants and 
their prevalence has been an important challenge.  The different genetic mutations were 
classified by the proteinase inhibitor (Pi) nomenclature according to their electrophoretic 
mobility compared to the normal M variant (PiMM) and it became apparent that the 
majority of mutations in the SERPINA1 gene, leading to α1-antitrypsin deficiency, were 
due to single amino acid substitutions (8).  The most frequent and severe mutation in 
Northwest Europe and North America is the Z mutation (E342K), which originated 
in Scandinavia, and compromises over 95% of all α1-antitrypsin deficiency cases (8). 
Approximately 4% of the affected individuals are heterozygous (PiMZ) for this variant, 
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while roughly 1 in 1700 Northern Europeans are PiZZ homozygotes, which is as common as 
cystic fibrosis-associated CFTR mutation.  Although the PiZZ homozygotes  are extremely 
prone to develop disease (9), there is a high variability in clinical presentation.  About 
10% of the new-borns exhibit prolonged jaundice and juvenile cirrhosis, of which the 
majority clinically recover.  In contrast, only 2-3% develop severe hepatitis and cirrhosis of 
the liver during childhood or adulthood requiring liver transplantation (10-12).  In most 
homozygotes who smoke tobacco, the mutation is accompanied by a rapidly developing 
and progressive early-onset lung emphysema.  Although the increased risk of developing 
COPD in PiMZ individuals remains controversial (13, 14), a meta-analysis revealed an odds-
ratio of 2.31 (95% confidence interval 1.60-3.35; (15)).  Historically, it has been suggested 
that severe lung and liver disease rarely coexists in the same patient (16, 17).  However, 
Dawwas et al. (18) recently demonstrated that 63.2% of PiZZ individuals with clinical lung 
disease had a history or clinical findings of liver disease, and 17.5% had evidence of severe 
fibrosis or cirrhosis as confirmed by ultrasound or liver biopsy.  The management of the 
lung condition of this deficiency with intravenous augmentation therapy of α1-antitrypsin 
is at present not fully accepted to be effective, and disease progression is ultimately a 
major reason for lung transplantation (19).     
Pathogenesis
 Alpha1-antitrypsin deficiency is a so-called conformational disease, which develops 
as a result of a mutation that alters protein conformation, leading to protein misfolding, 
aggregation and depositions within cells or tissues.  Besides α1-antitrypsin deficiency, 
other members of this group of disorders include other serine protease inhibitor (serpin) 
mutants (serpinopathies), Alzheimer’s and Parkinson’s disease, prion encephalopathies 
and amyloidosis (20).  Alpha1-antitrypsin, a member of the serpin superfamily, is the major 
serpin active within the lung, but is mainly synthesised by hepatocytes (21).  In addition, 
small amounts are made by peripheral blood monocytes, alveolar macrophages and lung 
epithelial cells (22-24).  One of the most important inhibitory functions of α1-antitrypsin is 
its irreversible inactivation of neutrophil elastase, thereby protecting lung tissue against 
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the destructive effects of neutrophil elastase released by degranulating neutrophils 
during inflammation.  More recently, the anti-inflammatory properties of α1-antitrypsin 
have become apparent, including the inhibition of TNFα gene expression (25), inhibition 
of a disintegrin and metalloprotease (ADAM)17 activity in neutrophils and endothelial 
cells (26, 27), and the regulation of CD14 expression and cytokine release in monocytes 
(28, 29). 
 The native structure of α1-antitrypsin is composed of three β-sheets (A-C), nine 
α-helices (A-I) and an exposed mobile reactive centre loop (Figure 1A; (30, 31)).  Upon 
docking with neutrophil elastase, the enzyme cleaves the P1-P1’ peptide bond of the 
reactive centre loop, which can subsequently be inserted as an additional central strand 
(strand 5) into the β-sheet A (32).  This results in stabilisation of the α1-antitrypsin, 
inactivation of the active site of the elastase and subsequent clearance of the serpin-
enzyme complex from the circulation by various cell types, including hepatocytes (32). 
Although Z α1-antitrypsin is transcribed and translated at the same rate as normal M 
α1-antitrypsin, the mutation affects post-translational folding of the Z α1-antitrypsin 
polypeptide chain inside the endoplasmic reticulum (ER).  This has been hypothesised to 
generate an unstable intermediate state, termed M*, in which β-sheet A is more exposed, 
allowing it to accept the reactive centre loop of another Z α1-antitrypsin molecule to form 
a dimer (Figure 1B; (33-35)).  Subsequent extension would then form longer chains of loop-
sheet polymers (36).  Other possible molecular mechanisms of polymerisation described 
are the β-hairpin linkage model (37) and the more recently suggested triple-strand 
linkage model or C-terminal swap (38) (Figure 1C-D).  While polymers do not only lack any 
inhibitory activity, their formation leads to accumulation within the ER of hepatocytes and 
subsequent degradation by the proteasome, resulting in a plasma deficiency (33).  
 Thus, the current concept is that the accumulation of intracellular polymers of 
α1-antitrypsin causes liver pathology through toxic gain-of-function, while early-onset 
emphysema is due, in large part, to loss-of-function resulting from a protease-antiprotease 
imbalance (39).  However, after the discovery of polymers in broncho-alveolar lavage fluid 
and pulmonary tissue up to ten years following liver transplantation (40), it has been 
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proposed that these polymers can be produced locally within the lung.  As these polymers 
are chemotactic for neutrophils in vivo and in vitro, such local formation might contribute 
to sustained inflammation in subjects with α1-antitrypsin deficiency (41). 
ER stress
 Within the ER, proteins destined for secretion and insertion into the cell-membrane 
are folded to their tertiary structure and undergo post-translational modifications, such 
as disulphide bond formations and glycosylation.  The organelle’s quality control system 
allows only properly folded proteins to exit the ER and traffic to their site of action (42). 
Delayed folding can be caused by mutant proteins, rapid surges in demand for protein 
secretion and metabolic disturbances such as hypoxia.  The imbalance between protein 
load and the ER’s capacity to handle newly synthesised proteins is termed “ER stress” 
(43-45).  Moreover, toxins such as tunicamycin, an irreversible inhibitor of N-linked 
glycosylation, and thapsigargin, a sarcoendoplasmic reticulum calcium ATPase (SERCA)-
pump inhibitor, lead to protein misfolding and thus chemically-induced ER stress.  Since 
misfolded ER client proteins are prone to aggregation, they pose a cytotoxic risk to the 
cell.  Accordingly, early in evolution eukaryotes developed an Unfolded Protein Response 
(UPR) to deal with this threat (44). 
The UPR
 The UPR is activated by three distinct stress sensors: inositol-requiring 
enzyme 1 (IRE1), protein kinase R-like endoplasmic reticulum kinase (PERK), and 
activating transcription factor 6 (ATF6).  In the resting state, each sensor is inactive.  One 
theory states that inactivity is maintained through the binding of a chaperone called 
glucose-regulated protein 78 (GRP78, also known as BiP) (46, 47).  With the accumulation 
of unfolded or misfolded proteins inside the ER lumen, GRP78 dissociates from its kinase 
to bind these proteins.  This sequestration of GRP78 is the central trigger for each kinase 
to become activated, thereby initiating distinct downstream pathways (Figure 2).  More 
recently, it has been suggested that PERK and IRE1 may interact directly with misfolded 
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proteins (48, 49).
 Early during ER stress, the dimerisation and subsequent trans-autophosphorylation 
of PERK strongly activates this kinase (50, 51).  It then phosphorylates eukaryotic 
translation initiation factor 2 on its alpha subunit (eIF2α) causing global inhibition of 
protein synthesis, and thereby reducing the load of newly synthesised proteins entering 
the ER (50).  In addition, eIF2α phosphorylation promotes a gene expression programme 
known as the integrated stress response (ISR (52); see Chapter 2).  This is mediated by 
the translation of specific mRNAs, notably activating transcription factor 4 (ATF4) (53). 
ATF4 triggers a signalling cascade leading to the induction of the transcription factor C/
EBP homologous protein (CHOP), which in turn induces growth arrest and DNA damage-
inducible protein 34 (GADD34, also known as PPP1R15A) (54).  In complex with protein 
phosphatase 1 (PP1), GADD34 dephosphorylates eIF2α thus completing a negative 
feedback loop and enabling the recovery of general protein synthesis (55).  Another target 
gene of CHOP encodes ERO1α, an ER oxidase that in conjunction with Protein Disulphide 
Isomerase (PDI) catalyses the generation of disulphide bonds in ER client proteins (54).   
 In parallel, the dissociation of GRP78 releases ATF6 to be transported from the ER 
to the Golgi via the specific coat protein complex II (COPII) vesicles (56, 57).  Here, site 1 and 
site 2 proteases (S1P and S2P, respectively) cleave ATF6, liberating a cytosolic N-terminal 
Figure 1.  Folding of α1-antitrypsin and its misfolding in α1-antitrypsin deficiency. 
A.  The reactive centre loop (red) of native α1-antitrypsin binds to neutrophil elastase (dark grey). 
This allows the conformational change leading to an additional strand into β-sheet A (blue) and the 
inactivation of neutrophil elastase.  B-D.  Three proposed models for Z α1-antitrypsin polymerisation.  All 
mechanisms involve an unstable intermediate.  In the single-strand linkage model (B), the reactive centre 
loop of one α1-antitrypsin molecule is inserted in between strands 3 and 5A of another molecule.  The 
β-hairpin linkage model (C) proposes that both the reactive centre loop and strand 5A translocate into 
another α1-antitrypsin molecule.  The newest model is the tirple-strand linkage model (D).  The reactive 
centre loop self inserts and strands 1C, 5 and 6B translocate between the molecules.  Reproduced with 
permission from B. Gooptu and D.A. Lomas (104).
<<<
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Figure 2.  The unfolded protein response (UPR).  
Three endoplasmic reticulum (ER) signal transducers sense the protein-folding state inside the ER.  When 
unfolded or misfolded proteins accumulate in the ER lumen, PERK, ATF6 and IRE1 become activated 
through a loss of binding to GRP78 (also called BiP) and/or directly by interacting with the misfolded 
proteins.  PERK activation leads to the phosphorylation of eIF2α and subsequent global translational 
attenuation.  Controversially, it activates a pathway involving ATF4 and its downstream targets CHOP 
and GADD34, of which the latter is able to dephosphorylate eIF2α.  The endoribonuclease activity of 
IRE1 results in the splicing of XBP1 mRNA and reduces mRNA stability (a process called RIDD), thereby 
contributing to the inhibition of global mRNA translation.  Activation of ATF6 results in its translocation 
to the Golgi and its cleavage to allow translocation into the nucleus and activation of UPR target genes. 
Reproduced with permission from J.E. Chambers, University of Cambridge (105).
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fragment (ATF6c) that travels to the nucleus and binds ER stress response elements (ERSE) 
to initiate translation of UPR target genes, including many chaperons (58), to enhance 
protein folding (59). 
 Like PERK, IRE1 is activated via dimerisation and trans-autophosphorylation 
(60-62).  Unlike PERK, however, this triggers the RNAase domain of IRE1 to initiate the 
unconventional splicing of the mRNA encoding X-box binding protein-1 (XBP1) (63).  Spliced 
XBP1 mRNA encodes an active transcription factor that, together with ATF6c, induces 
expression of UPR target genes, such as the chaperones GRP78 and GRP94 (63).  In addition, 
spliced XBP1 induces components involved in the ER-associated degradation (ERAD) 
pathway (see below; (64)).  Moreover, phosphorylated IRE1 facilitates the degradation of 
mRNAs encoding proteins destined to enter the ER, thus further diminishing the influx of 
new proteins into the ER; a process called Regulated IRE1-Dependent Decay (RIDD, (65)). 
Finally, activated IRE1α may recruit TRAF2, which, via activation of cJUN NH2-terminal 
kinase (JNK), can lead to enhanced cytokine release and eventually cell death (66).  
ERAD and apoptosis
 When the UPR fails to restore protein homeostasis by reducing the influx of 
newly synthesised proteins into the ER and increasing the protein folding capacity, a third 
mechanism is evoked: the ERAD.  This degradation pathway targets terminally unfolded or 
misfolded proteins for proteasomal degradation, relieving the ER of its burden (67).
 Whereas induction of the UPR during acute ER stress is a necessity for cell survival, 
chronic ER stress and prolonged activation of the UPR is associated with increased cell 
death (54, 68-70).  As mentioned above, IRE1 activation can trigger apoptosis via the TRAF2-
JNK pathway.  Urano et al. (66) showed that TRAF2 binds to IRE1α leading to the activation 
of JNK.  Accordingly, Ire1α-/- fibroblasts are impaired in JNK signalling in response to ER 
stress.  Because sustained JNK activity has been associated with apoptosis, this pathway 
may contribute to IRE1α-mediated cell death (71-73).  Other possible links between IRE1 
and ER stress-induced apoptosis may involve increased RIDD activity of essential proteins 
(74), and the interaction of IRE1 with pro-apoptotic proteins such as Bak and Bax (75).  
18
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 Furthermore, prolonged high level of GADD34 expression have been shown 
to induce cell death, perhaps by promoting on-going protein secretion via the 
dephosphorylation of eIF2α, thereby overloading an already stressed ER (54).  Of note, 
CHOP has often been reported as pro-apoptotic.  However, this is misleading as CHOP 
does not directly induce cell-death target genes, but instead appears to promote 
apoptosis indirectly via its target genes, especially GADD34 and ERO1α, which increase 
protein synthesis and oxidation within the ER (54). 
ER overload response (EOR)
 Besides the activation of the well-characterised UPR, ER stress also induces 
the activation of the poorly understood ER overload response (EOR), also known as the 
ordered protein response (76).  This response was initially observed in cells transfected 
with an expression vector for immunoglobulin µ chain, which are unable to exit the ER, 
leading to the activation of nuclear factor-kappa B (NF-κB) (77).  Furthermore, several 
ER stress inducers selectively caused the induction of NF-κB or the activation of the 
UPR, suggesting that the activation of NF-κB required a distinct signal.  Although NF-
κB activation can follow inhibition of IκB translation by PERK (78), a UPR-independent 
signal for NF-κB activation appears to be the accumulation of ordered proteins causing 
distension of the ER (79).  This accumulation leads to the efflux of Ca2+, which, together 
with the production of reactive oxygen species (ROS), is an essential messenger signal for 
NF-κB activation (76).   
19
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ER stress and inflammation in α1-antitrypsin deficiency
 For many years, the protease-antiprotease imbalance in the lungs was thought 
to be the main explanation for early-onset emphysema in patients with Z α1-antitrypsin 
deficiency.  However, over the years, α1-antitrypsin appeared to possess additional roles 
besides its antiprotease activity, which might be altered due to the Z mutation.  Although 
the Z mutation causes a conformational change and an accumulation of α1-antitrypsin 
polymers in the ER of hepatocytes, to date these polymers have not been convincingly 
shown to activate the UPR directly (80, 81).  However, recently it has been recognised that 
the intracellular polymerisation of Z α1-antitrypsin may prime cells to ER stress if exposed 
to a second insult (82, 83).  For instance, Chinese hamster ovary (CHO) cells overexpressing 
Z α1-antitrypsin show impaired protein mobility within the ER due to distension of the ER 
by polymer accumulation (84).  Importantly, this accumulation does not elicit activation 
of an ATF6-luciferase reporter or trigger the splicing of XBP1 mRNA.  However, when these 
cells encounter a “second hit”, such as the chemical ER stress inducer tunicamycin or a 
more physiological glucose starvation, they show an exaggerated activation of the ATF6-
luciferase reporter together with increased XBP1 splicing (84).  It has been suggested that 
Z α1-antitrypsin expression in human embryonic kidney cells leads to the cleavage of 
caspase-4 and -7, resembling thapsigargin-induced apoptosis (85), but this appears to 
be cell-type specific since 16HBE cells expressing Z α1-antitrypsin show reduced levels 
of apoptosis and decreased caspase-3 activity, similar to M α1-antitrypsin expressing 
16HBE cells (81).  The enhanced sensitivity of Z α1-antitrypsin expressing cells to ER stress 
may contribute to lung disease through the induction of inflammation and cell death in 
pulmonary epithelial cells and macrophages following exposure to a secondary trigger, 
but to date there is limited evidence for this hypothesis within the lung.
 The constitutive activation of NF-κB in lung epithelial cells expressing Z α1-
antitrypsin has been thought to reflect protein polymer formation leading to increased 
cytokine release and inflammation (83, 86, 87). Carroll and colleagues previously showed 
increased IκBα degradation and increased cytokine production together with intracellular 
accumulation of α1-antitrypsin in ZZ monocytes (80).  It is worth noting, however, that 
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the conformation of the retained α1-antitrypsin protein remained unclear and so the 
mechanism for the hyperinflammatory phenotype of Z α1-antitrypsin cells remains 
unknown.
NF-κB
 The transcription factor NF-κB regulates many genes involved in inflammation 
and cell death, and therefore plays a key role in inflammation and immunity (88).  It is 
the main regulator of numerous cytokines and chemokines such as interleukin (IL)-8 
(89).  NF-κB is a cytosolic protein consisting of the p50/p52 and p65 (or ReIA) subunits 
and is inactive when in complex with inhibitor kappa-B alpha (IκBα; (90, 91)).  The 
phosphorylation of this IκBα, which results in its degradation by the proteasome, reveals 
the nuclear localisation site of NF-κB (92, 93).  Subsequently,  NF-κB translocates into the 
nucleus, where it is able to bind to specific DNA sequences and regulate transcription (89, 
94).  A key regulatory step in the translocation of this transcription factor is activation of a 
high molecular weight IkappaB kinase (IKK) complex, which phosphorylates IκBα (95, 96). 
The IKK complex consists of three subunits, of which IKKα and IKKβ are catalytically active 
and IKKγ serves as a regulatory unit (97).  Numerous pathways lead to the activation of 
NF-κB, with most exogenous stimuli acting via the classical IKK-IκB pathway.  Examples 
important for innate immunity include cytokine receptors, such as tumor necrosis factor 
(TNF) receptor, and Toll-like receptors, the main class of pattern-recognition receptors 
(Figure 3).  However, it is now generally acknowledged that NF-κB can also be activated 
via mitogen-activated protein kinase (MAPK) signalling cascades (98, 99). 
MAP kinases
 The MAPKs are a conserved group of serine/threonine kinases that mediate a 
wide range of cellular responses, including cell growth, differentiation, cell survival and 
the immune response (reviewed in (100)).  There are six distinct groups of MAPK, but the 
most extensively studied MAPKs are the extracellular signal-regulated kinases 1 and 2 
(ERK1/2), the p38 MAPK and the c-Jun NH2-terminal kinases (JNK). 
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 ERK1/2 was the first MAPK discovered and its upstream kinases and signalling 
cascades have been widely studied.  Upon stimulation, Ras activates c-Raf, which will 
lead to phosphorylation of the mitogen-activated protein/extracellular signal-regulated 
kinase kinases (MEK) which, in turn, phosphorylate ERK1/2.  The initiation of this pathway 
generally starts via the activation of tyrosine kinases receptors on the cell membrane. 
In the lung, the tyrosine kinase receptor epidermal growth factor (EGF) receptor (EGFR) 
plays an important role in epithelial cell proliferation, cytokine induction, and cell survival 
by activating ERK1/2 (101).  EGF and EGF-like growth factors, of which heparin binding-
EGF (HB-EGF), amphiregulin (AREG) and transforming growth factor alpha (TGFα) are 
the most important, are membrane-bound growth factors, which, upon cleavage by 
metalloproteases, as ADAMs, trigger EGFR signalling (102, 103).  
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Figure 3.  Activation of the NF-κB pathway. 
A variety of triggers, such as cytokines and Toll-like receptor (TLR) ligands, bind to their receptor, resulting 
in the activation of the IκB kinase (IKK) complex.  IKK phosphorylates the inhibitor of NF-κB (IκBα), thereby 
releasing IκBα from NF-κB and exposing the nuclear localisation site of NF-κB.  IκBα is degraded by the 
proteasome and the activated NF-κB is then translocated into the nucleus where it activates its target 
genes.
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Outline / aim of the thesis
 Altered physiological stress responses, including ER stress, may contribute to the 
development of lung diseases.  The aberrant folding of Z α1-antitrypsin and its accumulation 
within the ER has led some to suggest that α1-antitrypsin deficiency might represent an 
ER stress-induced disease.  However, as discussed above, there is much controversy about 
the extent to which Z α1-antitrypsin triggers the UPR.  The studies described in this thesis 
focus on the induction of ER stress in bronchial epithelial cells and (monocyte-derived) 
macrophages and its contribution to inflammation in lung disease, with a specific focus 
on Z α1-antitrypsin deficiency.
 ER stress, leading to the unfolded protein response (UPR), is a complex cellular 
process.  As discussed in this introduction, activation of the PERK-arm of the UPR leads to 
phosphorylation of eIF2α and subsequent global translational repression.  In addition to 
PERK, three other kinases can also initiate translational attenuation via the phosphorylation 
of eIF2α and its downstream targets.  These pathways are collectively called the integrated 
stress response (ISR).  This thesis starts in Chapter 2 with a review on the importance of the 
ISR in lung diseases.  
 Another important UPR-arm, leading to the induction of ER chaperones to allow 
refolding, is the IRE1-pathway.  In Chapter 3, we validated a new technique that allows 
rapid and reliable detection of one of the key features of this arm, namely the splicing of 
XBP1 mRNA.  
 Bacteria and especially viruses, which have been more extensively studied 
than other microbes, can induce splicing of XBP1 mRNA, phosphorylation of eIF2α and 
induction of GADD34, with a lack of CHOP induction.  Recently, it has been proposed that 
this microbe-induced specific stress response induced by microbes, which mimics an ER 
stress response and an ER stress independent activation of the ISR, should be termed 
the “microbial stress response (MSR)”.  However, the precise description is not yet clearly 
defined and we therefore investigate the ER stress response and ISR induced by secreted 
virulence factors of Pseudomonas aeruginosa in Chapter 4.
 Z α1-antitrypsin is a misfolded protein that polymerises and subsequently 
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accumulates in the ER.  However, overexpression of the protein does not initiate the ER 
stress response, but rather primes the cell for a “second hit”.  Instead, this accumulation 
leads to an enhanced NF-κB response.  In Chapter 5, we investigated what is causing 
the increased inflammatory (NF-κB) signalling in primary bronchial epithelial cells with 
an endogenous expression of Z α1-antitrypsin.  We explored the possibility of polymer 
formation as an underlying mechanism and investigated whether endogenous Z α1-
antitrypsin primes primary bronchial epithelial cells for a second hit, and thereby causing 
this augmented response.
 Previous studies have shown that macrophages are also able to produce 
α1-antitrypsin.  Since macrophages constitute a heterogeneous population, we first 
investigated in Chapter 6 whether there is a difference in α1-antitrypsin production 
between the two main macrophage subtypes of healthy donors that can be generated in 
vitro.  Subsequently, in Chapter 7, we assessed the α1-antitrypsin production by monocyte-
derived macrophages of Z α1-antitrypsin patients and the cellular consequences of its 
expression.  Finally, a summary and general discussion of these studies are presented in 
Chapter 8. 
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Abstract
 Lungs are repeatedly exposed to inhaled toxic insults, such as smoke, diesel 
exhaust and microbes, which elicit cellular stress responses.  The phosphorylation of 
eIF2α by one of four stress-sensing kinases triggers a pathway called the integrated 
stress response (ISR) that helps protect cellular reserves of nutrients and prevents 
that accumulation of toxic proteins.  In this review, we will discuss how activation 
of the ISR has been shown to play an important role in pulmonary pathology and 
how its study may help in the development of novel therapies for diverse conditions 
from hypoxia to cancer. 
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Introduction
 Because of its direct contact with the outside world, the lung is continuously 
challenged by inhaled insults, including smoke, diesel exhaust and a multitude of micro-
bes, all of which trigger various cellular stress pathways.  Recent studies have underlined 
the critical role played by one of these stress pathways, which involves phosphorylating 
the alpha subunit of eukaryotic translation initiation factor 2 (eIF2α).  This single molecular 
event serves to integrate signalling from multiple stress-sensors and so has been termed 
the “integrated stress response” (ISR) (Figure 1).  In this review, we will discuss the ISR with 
particular regard to its evolving role in pulmonary medicine and we highlight how this 
knowledge is enabling the development of novel therapies.
The integrated stress response (ISR) 
 Activation of the ISR occurs when one of four homologous stress-sensing kinases 
is triggered.  This family comprises General Control Nonrepressible-2 (GCN2), Heme-Reg-
ulated Inhibitor (HRI), Protein Kinase R (PKR) and PKR-like Endoplasmic Reticulum Kinase 
(PERK) (1).  GCN2 evolved first and allows all eukaryotes, including yeast, to respond to 
amino acid starvation.  As multicellular animals developed, this kinase gave rise to a family 
of proteins that could respond to other stresses.  HRI was identified as a kinase responsive 
to iron-deficiency; however, over time, it has been shown to respond also to other stress-
ful stimuli including damaging oxidation.  PKR responds to the appearance of double-
stranded RNA within the cell, which occurs most commonly during viral infections; and 
finally, PERK senses the efficiency of protein folding within the endoplasmic reticulum 
(ER), thus enabling cells to trigger the ISR during ER stress.  This pathway induced by PERK 
activation is also one of the three arms of the unfolded protein response (UPR) to ER stress, 
which has been reviewed elsewhere (2). 
 When eIF2α is phosphorylated, protein synthesis is blocked, which serves a num-
ber of cytoprotective roles.  During ER stress, it lowers the rate at which new proteins en-
ter the ER thereby off-loading its overburdened chaperones; in conditions of amino acid 
starvation or iron limitation, it reduces the rate at which these nutrients are consumed 
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to make new proteins; and during viral infection, blocking protein synthesis can impede 
viral replication.  Furthermore, the phosphorylation of eIF2α paradoxically promotes the 
translation of a subset of mRNAs, most notably that encoding activating transcription 
factor 4 (ATF4).  Indeed, most canonical ISR target genes are transactivated by this tran-
scription factor and act to adapt the cell to these stresses.  For example, up-regulation of 
numerous transporters increases the rate of amino acid import, thus overcoming nutrient 
limitation, while also providing the substrates needed for the synthesis of the antioxidant 
glutathione (Figure 1).  In addition, ATF4 induces expression of another transcription fac-
tor, C/EBP homologous protein (CHOP), which cooperates with ATF4 to induce the eIF2α 
phosphatase growth arrest and DNA damage-inducible protein 34 (GADD34; also known 
as PPP1R15A) (3). GADD34 completes a negative feedback loop and allows protein syn-
thesis to recover by dephosphorylating eIF2α (4).   
 It is often claimed that CHOP is a pro-death transcription factor, but this is inac-
curate.  In some situations, the expression of CHOP promotes cell survival (5); however, 
in conditions of very prolonged stress, for example in models of chronic disease, the loss 
of CHOP is clearly protective.  This protective effect of CHOP deletion reflects the toxic 
consequence of recovering protein synthesis (via GADD34) if the original stress has not 
adequately been ameliorated by the ISR.  In addition, another target of CHOP is the ER 
oxidase ERO1α, which is up-regulated during the ISR to promote oxidative protein folding, 
but can itself contribute to cellular oxidative stress (Figure 1).  Finally, CHOP contributes to 
the induction of pro-inflammatory genes, such as interleukin (IL)-8 (6).
 
Activation of the ISR in lung pathology
Inhaled toxins
 Of the pulmonary insults recognised to trigger the ISR, perhaps the best known 
is oxidative stress, frequently caused by exposure to cigarette smoke.  In vitro studies have 
shown that cigarette smoke extract induces apoptosis in a CHOP-dependent manner and 
this can be antagonised by antioxidants (7, 8).  ER stress appears to be a major mediator of 
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Figure 1. The integrated stress response (ISR) in the lung.  
Phosphorylation of eIF2α by the stress-sensing kinases GCN2, PKR, PERK or HRI, leads to activation of the 
ISR by a wide range of insults including amino acid starvation, viral infection, protein misfolding and iron 
deficiency.  This attenuates global protein synthesis via the inhibition of eIF2B, which normally functions 
to maintain the translation initiation factor eIF2 in its active GTP-bound state.  Simultaneously, limiting 
levels of active (GTP-bound) eIF2 lead to the translation of the transcription factor ATF4.  Targets of ATF4 
include amino acid transporter and synthesases, which serve a cytoprotective role.  Via induction of 
the transcription factor CHOP and the eIF2α phosphatase GADD34, ATF4 also promotes the recovery of 
protein synthesis and oxidative protein folding (through induction of the oxidase ERO1α).  During severe 
or prolonged stress, the recovery of protein translation and protein oxidation can contribute to the failure 
of homeostasis and ultimately to cell death.  COPD, chronic obstructive pulmonary disease.
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the response to cigarette smoke extract because inhibition of the kinase PERK can block 
this induction of CHOP (7).  Consistent with this, heightened levels of ER stress have been 
observed within the lungs of current smokers (9) and patients with COPD (10).  It has 
recently been demonstrated that exposure even to the smoke of a single cigarette can 
impair oxidative protein folding in lungs of mice, probably through impaired function of 
the ER enzyme Protein Disulphide Isomerase (PDI) (11).  
 Recently, an airway gene expression signature associated with COPD was de-
scribed and included 98 genes, many of which are targets of ATF4 (12).  When ATF4 is 
overexpressed in epithelial cells in vitro, this COPD gene signature is recapitulated.  The 
observation that many of the COPD-associated changes in gene expression in bronchi-
al biopsies can be reversed by inhaled corticosteroid therapy suggests that treatments 
might be targeted to this mechanism in future (12).  
 When mice are exposed to inhaled environmental particulate pollution, they also 
show evidence of ISR activation due to ER stress (13), as do cultured human cells treated 
with diesel exhaust particles (14).  Since the effects of particulate matter can be antago-
nised by antioxidants, these too most likely reflect oxidative stress impairing the function 
of the ER (13).  In fact, the toxicity of particulates may be mediated by the ISR, since CHOP 
deficient cells are protected from particulate-induced apoptosis. 
 It would be wrong to suggest that the ISR is purely toxic during pulmonary oxida-
tive stress or that PERK is the sole kinase involved.  For example, when mice are exposed 
to hyperoxia (95% O2), phosphorylation of eIF2α does not involve ER-stress (5).  Instead, 
PKR is activated by unknown mechanisms to induce ATF4 and CHOP.  In this instance, 
CHOP is protective since Chop-/- mice reared in 95% O2 develop more severe lung injury, 
and even modest hyperoxia (80% O2) causes higher mortality in CHOP deficient animals 
(5).  The mechanism for this protection is unclear but CHOP appears to prevent increased 
epithelial permeability.  But the complex role of CHOP in hyperoxic lung injury requires 
more study because in newborn mice with hyperoxia-induced bronchopulmonary dys-
plasia CHOP appears to mediate pathological apoptosis (15).
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Intrinsic defects
 Point mutations of secreted proteins can cause ER stress and activate PERK. 
Surfactant protein C (SFTPC), which is normally secreted by type II pneumocytes, is mu-
tated in some rare cases of familial interstitial lung disease (16).  A splice-site mutation 
(c.460+1A>G) that causes deletion of SFTPC exon4 results in protein misfolding and famil-
ial interstitial pneumonia.  The Sftpc null mouse has a non-lethal phenotype suggesting 
that the disease-associated mutations in man may be caused by toxic gain-of-function. 
Accordingly, when the Δexon4 mutant is expressed in cells it causes ER stress and phos-
phorylation of eIF2α (17).  It remains to be tested, however, whether CHOP or GADD34 
genotype can alter the toxicity of the SFTPC mutants.  Although currently only a correla-
tion, it is intriguing that elevated levels of ATF4 and CHOP protein have been detected in 
lung homogenates and in type II cells from patients with idiopathic pulmonary fibrosis 
compared with controls (18).  It is therefore tempting to speculate that ISR activation may 
be a final common pathway in many cases of interstitial lung disease.
 Mutations of the SERPINA1 gene, which encodes α1-antitrypsin, can lead to its ac-
cumulation within the ER, but surprisingly most of these mutants fail to trigger the UPR, 
although they do enhance the cell’s susceptibility to ER stress (19).  The most common of 
these, the so-called Z allele, results from a missense mutation (E342K) that destabilises 
the protein such that most is degraded while some polymerises within the ER resulting 
in serum deficiency and early onset emphysema in most homozygous individuals.  Ap-
proximately 10% of homozygotes also develop clinically significant liver disease but the 
mechanism for this is not entirely clear.  The increased sensitivity of hepatocytes to ER 
stress and therefore activation of the ISR by PERK may be involved, since mice made to 
express the Z variant are far more susceptible to developing hepatic fibrosis following bile 
duct ligation, which causes ER stress, than are animals expressing wild type α1-antitrypsin 
(20).  In this model, Z expressing mice show an exaggerated ISR as evidenced by signifi-
cantly higher induction of CHOP (20) and it is known that CHOP expression is essential 
for cholestasis-induced hepatic fibrosis (21).  However, these effects are critically depend-
ent on the level of Z α1-antitrypsin expressed by a cell.  Primary bronchial epithelial cells, 
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which secrete detectable levels of Z α1-antitrypsin, fail to achieve concentrations of the 
mutant protein within their ER to allow protein polymerisation (22).  As a result, in contrast 
to hepatocytes, airway epithelial cells show no augmentation of CHOP or GADD34 expres-
sion upon a second hit of mild ER stress (22).  Each tissue should therefore be considered 
individually, since monocytes, another α1-antitrypsin-expressing cell, have been reported 
to display enhanced expression of ATF4 when purified from Z homozygous individuals 
(23).  Whether these cells, unlike hepatocytes, experience constitutive activation of the ISR 
in Z individuals is not clear.  But it is plausible that isolation of the cells may be sufficiently 
stressful to trigger the ISR, which in itself represents an interesting question for future 
research.
Infection 
 The lung is exposed daily to large numbers of inhaled infectious micro-organ-
isms. These represent the third class of stimuli causing activation of the ISR.  The canonical 
stimulus for the eIF2α kinase PKR is dsRNA, which reduces the rate of protein translation 
and so impedes viral replication (as reviewed in (24)).  Because of the need to recover 
translation in order to synthesise inflammatory cytokines, there is also a requirement for 
GADD34 induction and translational recovery as demonstrated by the increased suscep-
tibility of GADD34 deficient cells and mice to viral infection (25).  But there is redundancy 
within the system: for example the coronavirus IBV (infectious bronchitis virus) can acti-
vate both PKR and PERK, leading to expression of ATF4 and CHOP (26).  Surprisingly, both 
kinases appear to mediate the cytotoxicity of this infection via CHOP-dependent apop-
tosis.  Curiously, although PKR serves an antiviral role in most instances, in IBV infection, 
eIF2α phosphorylation contributes to enhance viral replication.  
 Activation of Toll-like receptors (TLRs), specifically TLR3 by dsRNA and TLR4 by 
lipopolysaccharide (LPS), can also trigger phosphorylation of eIF2α (24).  The mechanism 
for this is not entirely clear, but may plausibly reflects increased ER activity due to the 
need to secrete cytokines and antimicrobial peptides upon TLR activation.  Interestingly, 
the ISR shows specific modulation by TLR signalling that goes beyond simple activation. 
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In macrophages, when phosphorylation of eIF2α is induced by other stimuli, for example 
ER stress, activation of TLR4 by LPS blocks induction of ATF4, CHOP and GADD34 (27).  It is 
now becoming clear how this can be explained.  Normally, when eIF2α is phosphorylated 
it binds to and inhibits eIF2B, an enzyme responsible for maintaining eIF2α in its active 
GTP-bound state.  Indeed, binding of phospo-eIF2α to eIF2B is responsible both for the 
inhibition of translation seen during the ISR and for the up-regulation of ATF4 and CHOP. 
However, activated TLR4 stimulates eIF2B thus overcoming the effects of eIF2α phospho-
rylation (28).  It has been proposed that this mechanism may enable cells selectively to 
inhibit the ISR during chronic ER stress caused by infection and thus avoid the toxic effects 
of inducing CHOP and its target GADD34.  
 But the phosphorylation of eIF2α and subsequent activation of the ISR can have 
negative consequences during chronic infection and so may represent a therapeutic tar-
get.  In cystic fibrosis, most causative mutations of CFTR do not cause robust ER stress 
directly because these mutations lie within its cytosolic portion (29, 30).  But loss of CFTR 
function leads to the generation of thickened airway mucus with reduced clearance, 
which is prone to chronic colonisation by bacteria such as Pseudomonas aeruginosa.  This 
induces local ER stress and can be recapitulated in normal airway epithelia by application 
of CF mucus directly (30), and explains why primary CF epithelia recover from ER stress 
if allowed to grow in vitro in the absence of colonised mucus (29).  It has been noted, 
however, that the ER stress seen in models of CF in response to P. aeruginosa is deficient 
in PERK-eIF2α signalling (31).  This may contribute to the chronic inflammation seen in CF, 
since pharmacological induction of eIF2α phosphorylation with the drug salubrinal was 
found to lessen the inflammatory response of CF cells.  The mechanism by which ER stress 
fails to activate the ISR in this context has not been studied in detail, but may involve the 
novel TLR-eIF2B pathway introduced above.
 Where on-going translation is essential for efficient immune responses, for ex-
ample in PKR-activated dendritic cells, a modified ISR is activated in which robust induc-
tion of GADD34 prevents significant translational attenuation (32).  This and other ob-
servations, including those of the TLR-eIF2B pathway, have given rise to the concept of a 
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specific “microbial stress response”, which shares many features of the canonical ISR, but 
with modifications such as less robust induction of CHOP (reviewed in (24)).  However, 
the induction of components of the ISR, including CHOP, can differ substantially between 
models, perhaps because of cell type or the stimuli used, and thus many ‘flavours’ of the 
ISR may exist.  For example, when dendritic cells are challenged either with ER stress or 
TLR agonists, efficient induction of CHOP is required for secretion of interleukin (IL-) 23 
(33), which appears to contrast with the response elicited by PKR activation.  It should also 
be noted that viruses and bacteria have evolved numerous mechanisms to escape the an-
timicrobial effects of the ISR.  For example, respiratory syncytial virus (RSV) can sequester 
activated PKR and prevent phosphorylation of eIF2α (34). 
Nutrient stress 
 Being the oldest in evolutionary terms, GCN2 is ubiquitous in eukaryotes.  In 
terms of pulmonary pathology, it has been studied most in the context of tumour biology 
as it functions to match amino acid supplies with demand, which can be a limiting factor 
in cancer growth.  The induction of ATF4 during nutrient stress promotes the induction of 
many amino acid transporters and synthetic enzymes in tumour cells, such as asparagine 
synthetase (35).  As a result, inhibition of the GCN2-ATF4 pathway can reduce prolifera-
tion and cell survival (35).  This accounts for the up-regulation of GCN2 (both activated 
and total) in lung cancer samples compared to healthy controls or the surrounding non-
tumorous cells (35).  
 In addition to limiting the levels of nutrients, such as amino acids required for 
macromolecule biosynthesis, nutrient deprivation also profoundly affects the metabolism 
of a tumour.  A consequence of this is a heightened level of ER stress that is seen in many 
hypoxic tumours (36, 37).  It is therefore unsurprising that ER stress and the UPR have 
been implicated in the pathophysiology of solid tumours including human lung cancer 
(8). Evidence of ER stress is associated with more aggressive tumours and resistance to 
chemotherapy (36).  As the mediator of eIF2α phosphorylation during ER stress, PERK has 
proved necessary for the growth of larger solid tumours (37) and contributes to resistance 
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to therapy (36).  It ensures that protein synthesis remains at a level consistent with the 
supply of nutrients and energy, and through ISR-mediated activation of autophagy it also 
promotes the recycling of nutrients from old and damaged organelles (38).  Under such 
conditions, the recovery of translation mediated by CHOP and GADD34 would be expect-
ed to be toxic.  Indeed, loss of GADD34 in tumours may prevent apoptosis and promote 
cell survival in hypoxic conditions (39).  Accordingly, GADD34 expression correlates with 
the degree of differentiation of malignant mesothelioma, with lower levels of expression 
being seen in the more aggressive sarcomatoid subtype (40).  It is therefore tempting to 
speculate that GADD34 may be a tumour suppressor in ER stressed environments, but this 
has yet to be tested formally.  
Mechanical stress
 Finally, the pulmonary epithelium is not a static culture of cells as it is frequently 
treated in the laboratory.  Instead, it is a rhythmically flexing and stretching structure.  The 
forces placed upon it profoundly alter its biology, as the challenges of invasive ventilation 
in acute lung injury have shown.  Marked mechanical stress has been shown to induce 
apoptosis in a PERK dependent manner (41).  Surprisingly, other limbs of the UPR do not 
appear to be activated, even during prolonged mechanical stress.  Moreover, the mecha-
nism of apoptosis is independent of CHOP-GADD34.  This is likely to be a fruitful area for 
research and there will be much to learn from other areas of biology, for example the bone 
where cyclical loading, rather than static loads, have been show to modulate protein syn-
thesis via activation of PKR (42). 
Therapeutic options
 It is clear that the ISR plays a crucial role in many aspects of pulmonary patho-
physiology and the basic science of ISR signalling is sufficiently well understood that it 
could plausibly be manipulated for therapeutic gain.  In many cases, the transient activa-
tion of the ISR plays a cytoprotective role.  For that reason, agents that promote phos-
phorylation of eIF2α have been shown to be protective.  The small molecule salubrinal 
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was identified as a compound that prevented the dephosphorylation of eIF2α during ER 
stress and during infection with herpes simplex virus (HSV) (43).  Although it has been 
claimed to inhibit the eIF2α phosphatases directly, convincing evidence for this is lacking. 
Nevertheless, it can increase cellular levels of phosphorylated eIF2α with cytoprotective 
results.  Amelioration by this drug of inflammatory signalling in Pseudomonas-exposed 
CF cells has already been mentioned (31), but salubrinal has also been shown to be pro-
tective in the monocrotaline model of pulmonary hypertension (44) and the toxicity of 
cigarette smoke extract (45).  More recently, the drug guanabenz, used previously as an 
anti-hypertensive, has been found to inhibit GADD34 thus increasing phosphorylation of 
eIF2α and promoting cell survival during chronic ER stress (46).  The hypotensive effects 
of this drug, which are unrelated to its effects on the ISR, limit its use in animals, but it is 
likely that future GADD34 inhibitors will be useful in situations where activation of the ISR 
would be beneficial.
 In contrast, blockade of the cytoprotective effects of the ISR will be useful in 
chemotherapy.  Potent small molecules have been developed, such as GSK2656157, that 
show high selectivity for PERK, which is especially important in malignancy, and in animal 
models have proved effective at inhibiting tumour growth through alterations in amino 
acid metabolism and angiogenesis (47). 
 
Conclusion and future directions 
 The progress from understanding the basic biology of the ISR to its role in pulmo-
nary pathology has been dramatic and rapid.  The breadth of noxious stimuli to which it 
responds may hamper efforts to identify which stress or stresses were the original insult in 
some diseases; however, the very fact that multiple kinases converge on a single substrate 
to regulate translation during disease offers many advantages for research and treatment. 
If selectivity is required, identification of the upstream kinase should offer this, while mo-
dulation of the downstream phosphatase(s) can generate a more broad effect.  But many 
unknowns remain, which will make the ISR an exciting and fruitful area for respiratory 
research for many years to come.
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Abstract  
 Endoplasmic reticulum (ER) stress is increasingly recognised as an 
important mechanism in a wide range of diseases including cystic fibrosis, α1-
antitrypsin deficiency, Parkinson’s and Alzheimer’s disease.  Therefore, there is an 
increased need for reliable and quantitative markers for detection of ER stress in 
human tissues and cells.  Accumulation of unfolded or misfolded proteins in the 
endoplasmic reticulum can cause ER stress, which leads to the activation of the 
unfolded protein response (UPR).  UPR signaling involves splicing of X-box binding 
protein-1 (XBP1) mRNA, which is frequently used as a marker for ER stress.  In most 
studies, the splicing of the XBP1 mRNA is visualised by gel electrophoresis which 
is laborious and difficult to quantify.  In the present study we have developed and 
validated a quantitative RT-PCR method to detect the spliced form of XBP1 mRNA. 
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Introduction
 Endoplasmic reticulum (ER) stress induced by protein misfolding is an important 
mechanism in cellular stress in a variety of diseases.  When protein folding in the ER is 
compromised, the unfolded proteins accumulate in the ER which leads to ER stress.  ER 
stress triggers the unfolded protein response (UPR), a transcriptional induction pathway 
which is aimed at restoring normal ER functioning (1). 
 The UPR is mediated by three ER stress receptors: protein kinase RNA-like ER kinase 
(PERK), inositol-requiring protein-1 (IRE1) and activating transcription factor-6 (ATF6).  In 
the absence of ER stress, all three ER stress receptors are maintained in an inactive state 
through their association with the ER chaperone protein GRP78 (BiP).  ER stress results in the 
dissociation of BiP from the three receptors, which subsequently leads to their activation 
(2).  Dissociation of BiP from PERK leads to autophoshorylation and thereby activation of 
PERK and subsequent phosphorylation of translation initiation factor eIF2α, resulting in 
an inhibition of mRNA translation, and eventually in the translation of the transcription 
factor ATF4.  Dissociation of BiP from ATF6 leads to translocation of ATF6 to the Golgi 
complex where it is cleaved by proteases into an active transcription factor.   Active ATF6 
moves to the nucleus and induces expression of genes with an ER stress response element 
(ERSE) in their promoter such as the ER chaperone BiP and the transcription factors C/EBP 
homologous protein (CHOP) and X-box binding protein-1 (XBP1).  Dissociation of BiP from 
IRE1 leads to the activation of IRE1 which cleaves a 26-nucleotide intron from the XBP1 
mRNA.  The spliced XBP1 mRNA encodes a stable, active transcription factor that binds 
to the UPRE or ERSE sequence of many UPR target genes, leading to transcription of ER-
chaperone proteins (2, 3). 
 The UPR can be induced experimentally by chemicals like thapsigargin and 
tunicamycin.  Thapsigargin blocks the ER calcium ATPase pump, leading to depletion of ER 
calcium stores and tunicamycin blocks N-linked glycosylation of proteins.  Both chemicals 
lead to high levels of stressors which are expected to rapidly activate all three components 
of the UPR (4). 
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 An increasing number of studies have reported the involvement of ER stress in 
a variety of diseases, including cystic fibrosis, α1-antitrypsin deficiency, Parkinsons’ and 
Alzheimers’ disease.  Therefore there is a growing demand for quantifiable markers to 
measure ER stress.  The splicing of XBP1 mRNA is considered to be an important marker for 
ER stress, however the quantification is difficult because the splicing is mainly visualised 
by gel electrophoresis after conventional RT-PCR.  We have now developed a simple and 
quantitative method to measure spliced human XBP1 by using quantitative real-time RT-















Figure 1.  Location of the forward XBP1spl primer on the spliced and unspliced XBP1 mRNA.
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Results and discussion
 Several publications described methods for monitoring ER stress and the UPR, 
and spliced XBP1 mRNA is generally considered to be a relevant marker for ER stress. 
However, the semi-quantitative conventional RT-PCR method is currently used to assess 
the splicing of the XBP1 mRNA.  Only Hirota et al. (5) developed a quantitative real-time 
RT-PCR method for measuring spliced XBP1, but this method does involve an additional 
step with a restriction enzyme during the PCR reaction, which we consider to be more 
laborious and more complex.  Both Samali et al. (6) and Zhao et al. (7) recently reviewed 
methods for monitoring ER stress, and recommended the analysis of spliced XBP1 by 
conventional RT-PCR for detection of ER stress. 
 In our study we have designed primers that span the 26bp intron of the XBP1 
mRNA, in order to amplify only the spliced XBP1 mRNA.  Because of the similarities 
between the sequence of the XBP1 mRNA just before this intron and the last part of the 
intron itself, only a very few options were possible to design a specific forward primer 
for the spliced XBP1 mRNA (Figure 1).  We tested the specificity of the XBP1spl primers by 
sequencing.  The PCR product of the thapsigargin treated, as well as the DMSO treated 
cells, both matched the spliced XBP1 mRNA and no unspliced XBP1 mRNA was detected 
with the new primers. These results also indicate that in DMSO treated cells there is a low 
level of spliced XBP1 mRNA present. 
 Next, we compared the semi-quantitative conventional RT-PCR method with 
the newly developed quantitative real-time RT-PCR method by conducting a time course 
experiment with thapsigargin and DMSO on primary bronchial epithelial cells.  In both 
methods the spliced XBP1 mRNA was mostly expressed after 6 hours, and its levels were 
found to be comparable between the two methods (Figure 2).  Next, we used the XBP1spl 
primers to perform a quantitative RT-PCR in a dose-response experiment on primary 
bronchial epithelial cells, using various concentrations of thapsigargin as well as two 
concentrations of tunicamycin.  In addition, CHOP and BiP mRNA were analysed and 
correlated with levels of spliced XBP1 mRNA (Figure 3A and 3B).  We found a significant 
and high correlation between CHOP and spliced XBP1 mRNA (r=0.962, p<0.001) as well 
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as between BiP and spliced XBP1 mRNA (r=0.884, p<0.001).  Since both CHOP and BiP 
genes contain an ERSE region which is recognised by the XBP1 protein, a good correlation 
between the spliced XBP1 and the more downstream ER stress markers CHOP and BiP was 
anticipated.
 To evaluate whether the new XBP1spl primers could also be used in other cell 
lines, experiments were performed in two different epithelial cell lines, HK-2 (a proximal 
tubule epithelial cell line from normal adult human kidney) and A549 (a human lung 
carcinoma cell line with type II alveolar epithelial cell characteristics).  We repeated the 
dose-response experiments on these cell lines and compared the results with those 
Figure 2.  Effect of thapsigargin exposure for various time periods on spliced XBP1 expression in 
primary bronchial epithelial cells.  
The spliced XBP1 mRNA was mostly expressed after 6 hours of stimulation with 50 nM thapsigargin, as 
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previously obtained with the primary bronchial epithelial cells (Figure 4).  We found a 
dose-dependent increase of spliced XBP1 mRNA in both cell lines, similar to the results 
found in primary bronchial epithelial cells. 
 
Figure 3.  Effect of thapsigargin and tunicamycin on markers of ER stress in primary bronchial 
epithelial cells.   
Primary bronchial epithelial cells were exposed to various concentrations of thapsigargin or tunicamycin 
for 6 hours, and next total RNA was isolated for quantitative RT-PCR-based detection of spliced XBP1, 
CHOP and BiP mRNA.  The results showed a dose-dependent increase in spliced XBP1 mRNA after exposure 
to both stimuli (A), that showed a significant correlation with levels of CHOP and BiP mRNA (B).  Data 
are mean ± SEM using cells from 3 different donors (A), and data points represent the result of a single 
experiment (B).
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 In conclusion, the novel quantitative real-time RT-PCR method described in this 
report is a reliable quantitative method to measure spliced human XBP1 mRNA as a marker 
for ER stress. 
Figure 4.  Effect of thapsigargin and tunicamycin on spliced XBP1 mRNA in different cell lines.  
Primary bronchial epithelial cells, HK-2 and A549 cells were exposed to various concentrations of 
thapsigargin or tunicamycin, and next total RNA was isolated for quantitative real-time RT-PCR-based 
detection of spliced XBP1 mRNA. The results showed a dose-dependent increase in spliced XBP1 mRNA 
after exposure to both stimuli for all cell lines.  Data are mean ± SEM using cells from 3 different donors 
(primary bronchial epithelial cells) or 3 separate experiments (HK-2, A549).  Spliced XBP1 mRNA data for 
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Materials and methods
Cell culture and stimulation
 Primary bronchial epithelial cells were isolated from resected lung tissue obtained 
from patients undergoing surgery for lung cancer as described previously (8).  Briefly, the 
cells were cultured in a 1:1 mixture of DMEM (Invitrogen, Carlbad, CA, USA) and BEGM 
(Clonetics, San Diego, CA, USA) , supplemented with 0.4% w/v BPE, 0.5 ng/ml EGF, 5 μg/
ml insulin, 0.1 ng/ml retinoic acid, 10 μg/ml transferrin, 1 μM hydrocortisone, 6.5 ng/ml 
T3,  0.5 μg/ml epinephrine (all from Clonetics), 1.5 μg/ml BSA (Sigma-Aldrich, St Louis, MO, 
USA), 1mM Hepes (Invitrogen), 100 U/ml penicillin and 100 μg/ml streptomycin (Cambrex, 
East Rutherford, NJ, USA).
 Immortalised human renal PTEC (HK-2, kindly provided by M. Ryan, University 
College Dublin, Dublin, Ireland) were grown in serum-free DMEM/HAM-F12 (Bio-
Whittaker, Walkersville, MD) supplemented with 100 U/ml penicillin, 100 µg/ml 
streptomycin (Invitrogen, Breda, The Netherlands), insulin (5 µg/ml), transferrin (5 µg/ml), 
selenium (5 ng/ml), triiodothyronine (40 ng/ml), epidermal growth factor (10 ng/ml), and 
hydrocortisone (36 ng/ml, all purchased from Sigma).
 Cells from the A549 human lung carcinoma cell line were obtained from the 
American Type Culture Collection (ATCC, Manassas, VA).  The cells were routinely cultured 
in RPMI 1640 medium (Gibco, Grand Island, NY), supplemented with 2 mM L-glutamine, 
100 U/ml penicillin, 100 μg/ml streptomycin (Cambrex, East Rutherford, NJ, USA)  and 10 
% (v/v) heat-inactivated FCS (Gibco) at 37°C in a 5 % CO2-humidified atmosphere.
 ER stress was induced in cells by exposure to thapsigargin or tunicamycin (both 
Sigma).  After reaching near-confluence, primary bronchial epithelial cells were exposed 
to thapsigargin (50 nM) for various time periods.  For the dose-response experiment , 
primary bronchial epithelial cells from 3 different donors were stimulated with various 
concentrations of thapsigargin or tunicamycin for 6 hours.  Dimethyl sulfoxide (DMSO; 
Merck, Darmstadt, Germany) served as a solvent control for both thapsigargin and 
tunicamycin.  The dose-response experiments were repeated on HK-2 cells and A549 cells 
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with 2 hours stimulation instead of 6 hours.  This shorter duration of exposure in HK-2 and 
A549 cells was based on pilot experiments using these cell lines. 
Total RNA isolation and reverse-transcription
 After stimulation, the cells were washed twice with PBS and total mRNA was 
isolated using the RNeasy mini kit (Qiagen, Valencia CA, USA).  DNase I amplification grade 
(Invitrogen) was used to remove genomic DNA.  Total RNA concentration and purity were 
measured on a NanoDrop spectrophotometer (NanoDrop technologies, Wilmington 
USA).  Next, cDNA synthesis was performed with M-MLV Reverse Transcriptase (Promega, 
Madison WI, USA).
Semi-quantitative RT-PCR
 To amplify the spliced and unspliced XBP1 mRNA, XBP1 primers were used as 
described previously (3).  PCR products were electrophoresed on 2.5% agarose gel. GAPDH 
(forward 5’ GGATGATGTTCTGGAGAGCC 3’, reverse 5’ CATCACCATCTTCCAGGAGC 3’) was 
used as a loading control.  The size difference between the spliced and the unspliced XBP1 
is 26 nucleotides.
Quantitative real-time RT-PCR
 Primers were designed to span the 26 base pair intron that is removed by IRE1 
to obtain the spliced XBP1 mRNA (XBP1spl; forward 5’ TGCTGAGTCCGCAGCAGGTG 3’ and 
reverse 5’ GCTGGCAGGCTCTGGGGAAG 3’).  Also specific primers for CHOP mRNA (forward 
5’ GCACCTCCCAGAGCCCTCACTCTCC 3’ and reverse 5’ GTCTACTCCAAGCCTTCCCCCTGCG 
3’) and BiP mRNA (5) were used.  Quantitative real time RT-PCR was carried out at 95°C for 
an initial 3 minutes followed by 40 cycles of denaturation at 95°C for 10 seconds, annealing 
at 62°C for 15 seconds and extension at 72°C for 30 seconds using IQ SYBRGreen supermix 
(Bio-Rad, Hercules, CA, USA).  Each assay was run on a Bio-Rad CFX Real-time PCR system 
in triplicates and arbitrary mRNA concentrations were calculated by the Bio-Rad software, 
using the relative standard curve method.  Stable housekeeping genes were selected 
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using the Genorm software (9).  Relative mRNA concentrations of ATP5B and RPL13A 
(GeNorm, Primerdesign, Southampton, UK) were used as reference genes to calculate 
the normalised expression of the spliced XBP1 mRNA.  The identity of the PCR products 
obtained with the XBP1spl primers was verified by DNA sequencing. 
Statistical analysis
 The results of the dose-response experiment were expressed as mean ± SEM. 
The correlation coefficient was determined by the use of Pearson’s correlation statistics. 
The correlation coefficient was considered significant at p-values < 0.05.
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Abstract 
 Pseudomonas aeruginosa infection can be disastrous in chronic lung diseases 
such as cystic fibrosis and chronic obstructive pulmonary disease (COPD).  Its toxic 
effects are largely mediated by secreted virulence factors including pyocyanin, 
elastase and alkaline protease (AprA).  Efficient functioning of the endoplasmic 
reticulum (ER) is crucial for cell survival and appropriate immune responses, while 
an excess of unfolded proteins within the ER leads to “ER stress” and activation of 
the “unfolded protein response” (UPR).  Bacterial infection and Toll-like receptor 
(TLR) activation trigger the UPR most likely due to the increased demand for protein 
folding of inflammatory mediators.  In this study, we show that cell-free conditioned 
medium of the PAO1 strain of P. aeruginosa, containing secreted virulence factors, 
induces ER stress in primary bronchial epithelial cells as evidenced by splicing of 
XBP1 mRNA, and induction of CHOP, GRP78 and GADD34 expression.  Most aspects 
of the ER stress response were dependent on TAK1 and p38 MAPK, except for the 
induction of GADD34 mRNA.  Using various mutant strains and purified virulence 
factors, we identified pyocyanin and AprA as inducers of ER stress.  However, the 
induction of GADD34 was mediated by an ER stress-independent integrated stress 
response (ISR) mediated by the iron-sensing eIF2α kinase HRI.  This increased 
GADD34 expression protected against Pseudomonas-induced, iron-sensitive cell 
cytotoxicity.  In summary, the virulence factors from P. aeruginosa induce ER stress 
in airway epithelial cells, and also trigger the ISR via activation of the iron-sensing 
kinase HRI, to improve cell survival of the host.
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Introduction
 The Gram-negative bacterium P. aeruginosa is an opportunistic pathogen that 
increases morbidity and mortality in chronic lung diseases, such as cystic fibrosis (CF) and 
chronic obstructive pulmonary disease (COPD; GOLD stages III-IV) (1-3).  P. aeruginosa 
often causes chronic infection due to its ease of developing antibiotic resistance and its 
ability to form biofilms in these patients.  Furthermore, its survival in the host in the early 
stages of infection is supported by the secretion of toxins and virulence factors, including 
pyocyanin and its proteases elastase and alkaline protease (AprA) (reviewed in (4, 5)). 
Interestingly, their production appears to be lower in the later stages of infection (6, 7). 
Therefore, the specific role of these virulence factors in chronic infections is incompletely 
understood.  Pyocyanin is a redox-active toxin that causes cellular senescence (8), 
ciliary dyskinesia (9), increased expression of interleukin (IL)-8 (10) and disruption of 
calcium homeostasis (11) in human lung epithelial cells.  Pyocyanin inactivates α1-
antitrypsin, contributing to the protease-antiprotease imbalance found in CF lungs (12), 
while  P. aeruginosa elastase additionally cleaves many proteins of the extra-cellular 
matrix including collagen, fibrinogen and elastin, and cleaves opsonin receptors, thus 
contributing to the invasion of bacteria into the lung parenchyma (13).  AprA is thought 
to modulate the host response and prevent bacterial clearance by degrading proteins of 
the host immune system, including TNFα and complement factors (14-16).
 P. aeruginosa requires iron both for its respiration and for biofilm formation 
(17,18).  Competition with the host is fierce and so P. aeruginosa has evolved specific 
strategies to obtain iron (19).  It produces redox-active phenazine compounds to turn 
insoluble Fe3+ to the more soluble Fe2+, siderophores to scavenge iron and receptors for the 
uptake of iron-siderophore complexes, proteases to degrade host iron-binding proteins, 
and bacteriocins to eliminate competitors (reviewed in (19)).  Moreover, iron availability 
regulates the production of virulence factors such as pyocyanin, AprA and exotoxin A 
(20) .
 The endoplasmic reticulum (ER) functions to fold secretory and membrane 
proteins and its quality control systems ensure that only properly folded proteins exit 
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the organelle.  Accumulation of incompletely folded proteins can impair ER homeostasis 
and induces “ER stress”, which activates intracellular signal transduction pathways 
collectively called the “unfolded protein response” (UPR; Figure 1).  This response restores 
ER homeostasis by reducing the influx of new proteins into the lumen of the ER and 
by enhancing the organelle’s capacity to fold proteins; however, if the stress cannot be 
resolved then apoptotic cell death pathways are invoked (reviewed by Marciniak and Ron 
(21)).
 Three distinct sensors detect ER stress: protein kinase RNA (PKR)-like ER kinase 
(PERK), inositol-requiring enzyme-1 (IRE1) and activating transcription factor-6 (ATF6) 
(21).  Early during ER stress, the kinase PERK phosphorylates eukaryotic translation 
initiation factor 2 on its alpha subunit (eIF2α) causing the inhibition of protein synthesis 
and thus preventing the load on the ER from increasing further (22-24).  In addition, this 
promotes the translation of specific mRNAs, for example that encoding the transcription 
factor ATF4 (25).  One important target of ATF4 is the transcription factor called C/EBP 
homologous protein (CHOP), and both individually can trans-activate the GADD34 gene 
(26).  GADD34 is a phosphatase that selectively dephosphorylates eIF2α, completing a 
negative feedback loop and enabling the translation of other targets of the UPR (27).  In 
parallel, IRE1 initiates the unconventional splicing of the mRNA encoding X-box binding 
protein-1 (XBP-1) (28).  Spliced XBP-1 mRNA encodes an active transcription factor that, in 
concert with ATF6, induces expression of UPR genes, such as the chaperones GRP78 (also 
known as BiP) and GRP94 (28-30).
 The phosphorylation of eIF2α is a point at which the responses to several forms 
of stress are integrated (31, 32).  During ER stress, PERK phosphorylates eIF2α, but eIF2α 
can also be phosphorylated by PKR responding to double-stranded RNA during viral 
infection (33, 34), by GCN2 during amino acid starvation (25, 35, 36), and by HRI during iron 
deficiency (reviewed in (31)).  For this reason, the events initiated by eIF2α phosphorylation 
have been termed the “integrated stress response” (ISR; Figure 1 and (37)).
 Abnormal function of the ER has been implicated in the pathogenesis of many 
diseases, including diabetes mellitus, atherosclerosis, Alzheimer’s disease and cancer (21, 
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38).  Remarkably, the ER also plays an important role during immune responses to infection 
and malignancy.  For example, during bacterial infection, Toll-like receptor (TLR) activation 
triggers splicing of XBP1 mRNA, possibly in response to the increased biosynthesis of 
secreted inflammatory mediators, increasing the capacity for protein secretion and thus 
contributing to an augmented inflammatory response (39-41).  In addition, induction of 
GADD34 is required for cytokine expression during viral infection; however, in contrast to 
ER stress, pathogen-induced induction of GADD34 appears to be independent of CHOP 
(42, 43).  Nevertheless, sustained activation of the UPR can impair the immune response 
by triggering cell death (26, 44).
 Previously, it has been shown that infection of airway epithelia or Caenorhabditis 
elegans with P. aeruginosa can elicit an UPR (40, 45, 46).  In worms, activation of the IRE1-
XBP-1 branch of the UPR was dependent on p38 MAPK-signalling (40), but it is unknown 
if this signalling response is conserved in humans.  Moreover, it is unclear whether living 
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bacteria are required for the induction of ER stress or if unidentified secreted factors are 
sufficient.  
 In the present study, we set out to test the hypothesis that virulence factors 
secreted by P. aeruginosa trigger the UPR in human cells via the p38 MAPK pathway. 
We found that p38 MAPK signalling was required for the response of human epithelial 
cultures to bacterial conditioned medium and that the secreted factors pyocyanin and 
AprA contribute to the induction of ER stress.  Furthermore, we showed that induction 
of the ISR target GADD34 is mediated by the iron-regulated kinase HRI and this induction 
protects the host against the toxic effects of P. aeruginosa. 
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Results
Conditioned medium of P. aeruginosa strain PAO1 (CM-PAO1) causes ER stress in primary 
bronchial epithelial cells
 Infection with live P. aeruginosa has previously been shown to induce the UPR 
in mouse macrophages and human immortalized bronchial epithelial cells (41, 46).  To 
identify whether P. aeruginosa could induce the UPR in primary bronchial epithelial cells 
and whether living bacteria were necessary for this, we stimulated primary bronchial 
epithelial cells with filter-sterilised conditioned medium (CM) from P. aeruginosa strain 
PAO1 (CM-PAO1), containing secreted virulence factors without living bacteria.  Treatment 
with CM-PAO1 induced ER stress in a time- and dose-dependent manner, as evidenced by 
a 9.9-fold increase of splicing of XBP1 mRNA (p<0.001), a 12.8-fold increase of CHOP mRNA 
(p=0.02) and a 16.2-fold increase of GADD34 mRNA (p<0.05) after 8-12 hours (Figure 2A 
and 2B).  This was accompanied by an increase in phosphorylation of eIF2α and protein 
expression of GADD34 and GRP78 protein (Figure 2C).  This increase in phosphorylated 
eIF2α was accompanied by a decrease in global protein translation as assessed by 
puromycin incorporation into nascent proteins (Figure 2D) (47).  In line with previous 
reports (48-50), CM-PAO1 gradually impaired epithelial integrity until the monolayer 
was completely disrupted after 24 hours.  Although the epithelial layer was disrupted 
by CM-PAO1 (as reported by trans-epithelial resistance; Figure S1A), the cell membranes 
themselves remain intact as reported by exclusion of trypan blue stain (Figure S1B).  
Induction of ER stress in human bronchial epithelial cells by P. aeruginosa is dependent on 
p38 MAPK 
 Infection of C. elegans with P. aeruginosa has been reported to cause splicing 
of XBP1 mRNA in a p38 MAPK-dependent manner (40).  To exclude the effects of donor 
variation and complex nutrient/growth factor requirement of primary cells, we therefore 
tested whether exposure of 16HBE cells, a SV-40 transformed bronchial epithelial cell line, 
to P. aeruginosa conditioned medium would trigger phosphorylation of p38 MAPK and 
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activate the UPR.  We observed that CM-PAO1 caused prolonged phosphorylation of p38 
MAPK in 16HBE cells up to 6 hours (Figure 3A).  We reasoned that the activation of p38 
MAPK after 15 minutes might represent the activation of TLR signalling, since stimulation 
of HEK-TLR2 or HEK-TLR4 cells (51) with CM-PAO1 demonstrated robust TLR2 and TLR4 
activation (data not shown).  The sustained activation was similar to that observed in C. 
elegans infected with Pseudomonas (40) (Figure 3A), which suggests the importance of 
p38 MAPK in the induction of the UPR.  To examine if p38 MAPK signalling was required 
for the ER stress response, we pre-treated 16HBE cells with an inhibitor of p38 MAPK 
(SB203580) or an inhibitor of TAK1 (5Z-7-oxozeanol, also known as LL-Z1640-2), a kinase 
upstream of p38 MAPK.  We then exposed cells to CM-PAO1, and observed that both 
compounds markedly reduced activation of p38 by CM-PAO1 (Figure 3B).  In addition, 
both compounds reduced secretion of IL-8 in response to CM-PAO1 treatment (Figure 
3C).  Of note, these compounds strongly inhibited splicing of XBP1 mRNA and abrogated 
the induction of CHOP and GRP78 mRNA (Figure 3D).  However, the induction of GADD34 
was insensitive to the inhibitors (Figure 3D) suggesting the involvement of an additional 
pathway independent of CHOP.
Pyocyanin is able to induce ER stress 
 To prepare P. aeruginosa conditioned medium, cultures were grown for 5 days 
(see Experimental procedures and (48)) to a high optical density at which quorum-sensing 
is activated in this strain, thus triggering the production of a variety of virulence factors 
among which the cytotoxic exoproduct pyocyanin.  When pyocyanin levels in P. aeruginosa 
conditioned medium were measured, values up to 5.5 µg/ml (26 µM) were detected 
(Figure 4A), which were similar to values observed in sputum of CF patients colonised 
with P. aeruginosa (52).  We therefore tested whether purified pyocyanin could induce ER 
stress in 16HBE cells.  Treatment with purified pyocyanin caused dose-dependent splicing 
of XBP1 mRNA, induction of CHOP and GRP78 mRNAs and expression of GRP78 and GRP94 
protein (Figure 4B-C), maximal at 10 µM (2.1 µg/ml).  In contrast, GADD34 mRNA continued 
to rise up to a maximum at ≥ 30 µM (6.3 µg/ml) pyocyanin (Figure 4B).  Once again, this 
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Figure 2. P. aeruginosa secreted virulence factors induce ER stress in primary bronchial epithelial 
cells.  
A. Time-dependent induction of ER stress in primary bronchial epithelial cells, as assessed by spliced 
XBP1, CHOP and GADD34 mRNA after treatment with CM-PAO1 (n=5; mean ± SEM).  B. Dose-response of 
spliced XBP1, CHOP and GADD34 mRNA in primary bronchial epithelial cells treated with CM-PAO1 for 12 
hours (n=5; mean ± SEM).  C. Time-dependent phosphorylation of eIF2α and synthesis of GADD34 and 
GRP78 (visualised with anti-KDEL antibody).  Relative quantifications for each protein are shown within 
(representative of n=3).  D.  Time-dependent decrease of puromycin incorporation in nascent proteins. 
Total eIF2α and β-actin serve as loading controls.  * p<0.05, ** p<0.01, ***p<0.001 versus control (ctrl) 
two-way repeated-measurements ANOVA (Bonferroni post-hoc) or untreated (-) with a one-way repeated-
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suggested that induction of GADD34 in this system might not simply reflect activation 
by ER stress.  As expected, pyocyanin potently induced secretion of IL-8 by 16HBE cells 
(Figure 4D) (10).  
 Next, we wished to determine if pyocyanin was also an important mediator of 
the observed ER stress response by CM-PAO1.  To this end, P. aeruginosa bacterial cultures 
were supplemented with iron to suppress pyocyanin production together with other 
iron-regulated factors (Figure 4A).  The conditioned medium prepared in this manner 
was significantly less efficient at triggering the splicing of XBP1 mRNA and at increasing 
expression of GRP78 mRNA (Figure 4E).  Surprisingly, CHOP mRNA was not significantly 
affected (Figure 4E), whereas GADD34 mRNA induction was completely abrogated.  These 
experiments provided only indirect support for the involvement of pyocyanin, since iron 
supplementation also affects production of other P. aeruginosa virulence factors and 
may also affect host cells. Since pyocyanin is a redox active toxin, we tested the effect 
of co-administration of the anti-oxidants N-acetylcysteine (10 mM) and glutathione 
reduced ethyl-ester (10 mM) for 24 hours.  Both failed to ameliorate the ER stress response 
suggesting that pyocyanin caused ER dysfunction independent of causing oxidative 
Figure 3. Conditioned medium of P. aeruginosa induces ER stress via TAK1-p38 MAP kinase (MAPK). 
A. Time-dependent phosphorylation of p38 MAPK in 16HBE after treatment with CM-PAO1.  Total 
p38 MAPK and β-actin serve as loading controls.  Numbers display the relative quantifications for 
phosphorylated p38 MAPK to total p38 MAPK (representative of n=3).  B. Western blot of phosphorylated 
p38 MAPK from 16HBE after pre-treatment for 30 min with the TAK-1 inhibitor LL-Z1640-2 (LL) or p38 
MAPK inhibitor SB203580 (SB), followed by CM-PAO1 stimulation for 6 hours.  Total p38 MAPK and β-actin 
serve as loading controls.  Numbers display the relative quantifications for phosphorylated p38 MAPK 
to total p38 MAPK (representative of n=3).  C. IL-8 release of 16HBE cells treated as in B (n=3; mean ± 
SEM).  D. Normalised mRNA levels of spliced XBP1, CHOP, GADD34 and GRP78 in 16HBE cells, treated as B 
(n=3; mean ± SEM).  All values are normalised to the housekeeping genes RPL13A and ATP5B.  * p<0.05, 
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stress (53, 54) (data not shown).
 Taken together, these observations suggested that conditioned medium 
of P. aeruginosa caused ER stress via multiple virulence factors, including pyocyanin. 
Furthermore, the induction of GADD34 appeared to involve an additional pathway 
independent of CHOP. 
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Identifying other factors mediating ER stress
 Having found evidence for the involvement of multiple virulence mechanisms 
in the induction of ER stress, we next attempted to determine their identities.  The P. 
aeruginosa AB toxin exotoxin A is known to cause translational attenuation by catalysing 
the ADP-ribosylation of elongation factor 2 (EF2) (55).  We investigated whether purified 
exotoxin A could also induce ER stress, but detected no increase in spliced XBP1, CHOP, 
GADD34 or GRP78 mRNA nor the phosphorylation of eIF2α (Figure S2A-B).  Next, to explore 
more broadly the involvement of other potential virulence factors, we made use of strains 
of P. aeruginosa that lacked specific toxic products: PAN8, a lasB aprE double mutant, which 
is deficient in the production of elastase (56) and the secretion of AprA; PAN11, a xcpR 
lasB mutant, which is deficient in the production of elastase and the secretion of all other 
substrates of the type II protein secretion system but still produces AprA; and PAO25,  a 
leu arg double mutant derivative of PAO1 and the direct parental strain of both mutants 
(table S1).  CM-PAO25 did not differ from CM-PAO1 in the content of all toxins measured 
(Figure S3A-C).  In spite of the aprE mutation, still traces of AprA were detected in the 
culture supernatant of the PAN8 strain (Figure 5A), presumably due to cell lysis during the 
5 days growth period.  
Figure 4. Pyocyanin is able to cause ER stress.  
A. Quantitation of pyocyanin in CM-PAO1.  Iron (Fe3+) was supplemented in the culture medium of the 
bacteria to inhibit virulence factor secretion (n=3; mean ± SEM).  B. Normalised mRNA expression levels 
of spliced XBP1, CHOP, GADD34 and GRP78 after pyocyanin treatment (0-1-3-10-30 µM) (n=3; mean ± 
SEM).  All values are normalised to the housekeeping genes RPL13A and ATP5B.  C. Western blot of GRP78/
GRP94 and GAPDH (loading control) from 16HBE cell lysates treated as in B. (representative of n=3).  D. IL-8 
release of 16HBE cells treated as in B (n=3; mean ± SEM).   E. Spliced XBP1, CHOP, GADD34 and GRP78 mRNA 
levels in 16HBE cells exposed to CM-PAO1 derived after growth in the presence or absence of iron (Fe3+) 
(n=3; mean ± SEM).  All values are normalised to the housekeeping genes RPL13A and ATP5B.  * p<0.05, 
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 When 16HBE cells were incubated with CM-PAN8 (lacking elastase and AprA), 
induction of spliced XBP1 and GRP78 mRNA were completely abolished, and only minimal 
induction of CHOP mRNA remained (Figure 5B).  The CM-PAN11 (containing AprA, but no 
elastase or other substrates of the type 2 secretion system) caused measurable splicing of 
XBP1 mRNA and the induction of CHOP and GRP78 mRNA, albeit significantly less than the 
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stimulating 16HBE cells with purified elastase did not elicit an ER stress response within 
24 hours (data not shown).  On the other hand, incubation with 10 nM purified AprA 
induced the splicing of XBP1 mRNA, and up-regulated CHOP and GRP78 mRNA (Figure 
5C).  These experiments suggested that, in addition to pyocyanin, AprA also contributed 
to the induction of ER stress in 16HBE cells.
 Remarkably, once again the induction of GADD34 mRNA followed a distinct 
trend from the other markers of ER stress.  Particularly a lack of AprA (in CM-PAN8) was 
correlated with an increased expression of GADD34 (Figure 5B).  Likewise, purified AprA 
did not induce GADD34 mRNA (Figure 5C).  This suggested that an unrelated mechanism 
regulated GADD34 induction by CM-PAO1 and that this might be independent of ER stress.
GADD34 is regulated via the integrated stress response (ISR) independent of PERK
 To examine the involvement of ER stress-dependent and -independent responses 
to CM-PAO1, we next made use of the specific inhibitor of IRE1, 4µ8C, which blocks splicing 
of XBP1 mRNA during ER stress ((57) and Figure 6A).  Of note, this compound not only 
attenuated the ER stress response elicited by CM-PAO1, but, interestingly, also attenuated 
the secretion of IL-8 by 16HBE in response to CM-PAO1 (Figure S4A).  
 During ER stress, the kinase PERK phosphorylates eIF2α, thereby activating the 
ISR.  When Perk-/- mouse embryonic fibroblasts (MEFs) were exposed to CM-PAO1, the 
induction of Gadd34 mRNA was unaffected, while the response to the ER stress-inducing 
agent tunicamycin (Tm) was abrogated (Figure 6B).  However, phosphorylation of eIF2α 
was required for the induction of Gadd34 mRNA in response to CM-PAO1 as demonstrated 
by the failure of the conditioned medium to induce Gadd34 mRNA in fibroblasts 
homozygous for the eIF2αAA mutation, which renders them insensitive to all eIF2α 
kinases (Figure 6C).  Moreover, Atf4, a transcription factor translationally up-regulated 
upon phosphorylation of eIF2α, was essential for the induction Gadd34 mRNA by CM-
PAO1 (Figure 6D).  As we have shown previously (26), Chop was only partially required 
for tunicamycin (ER stress)-induced expression of Gadd34 mRNA (Figure S4B).  The same 
was observed for CM-PAO1, although it did not reach statistical significance (Figure S4B). 
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Figure 5. The P. aeruginosa secreted virulence factors alkaline protease (AprA) and pyocyanin 
mediate ER stress.  
A. Western blot analysis of conditioned medium (CM) of strains PAO25, PAN8 and PAN11 for AprA 
(representative of n=2; complete blot is showed in Figure S1B).  Equal volumes of the conditioned 
medium were loaded onto the gel.  AprA displays 200 nM purified AprA and serves as a positive control. 
B. Normalised expression levels of spliced XBP1, CHOP, GADD34 and GRP78 mRNA in 16HBE cells after 
stimulation with CM-PAO25, CM-PAN8 or CM-PAN11 (n=3; mean ± SEM).  All values are normalised to the 
housekeeping genes RPL13A and ATP5B.  C. Normalised expression values of spliced XBP1, CHOP, GADD34 
and GRP78 mRNA in 16HBE cells after stimulation with 10 nM purified AprA.  All values are normalised to 
the housekeeping genes RPL13A and ATP5B.  * p<0.05, ** p<0.01, ***p<0.001 versus untreated (-) with a 
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Interestingly, murine fibroblasts stimulated with CM-PAO1 failed to splice Xbp1 mRNA 
(Figure S4C), suggesting that activation of IRE1 by CM-PAO1 may be less important in this 
cell type than in human epithelial cells.  However, reassuringly, ISR-dependent signalling 
in response to P. aeruginosa toxins was preserved in these cells and, once again, expression 
of Chop mRNA was regulated via eIF2α and Atf4.  As had been observed for Gadd34, Chop 
induction was independent of PERK, suggesting that in MEFs treated with CM-PAO1, Chop 
was induced by a stimulus other than ER stress (Figure S4D-F). 
 We next examined which eIF2α kinase was responsible for activation of the 
ISR by CM-PAO1.  To this end, we made use of Pkr-/-, Gcn2-/- and Hri-/- MEFs (25,58,59) and 
Figure 6. GADD34 mRNA expression is regulated via the activation of the integrated stress response 
by P. aeruginosa. 
A. Spliced XBP1 mRNA in 16HBE cells after treatment with CM-PAO1 in the presence of 30 µM 4µ8C, a 
selective inhibitor of the ER stress responsive kinase IRE1α (n=3; mean ± SEM).  All values are normalised 
to the housekeeping genes RPL13A and ATP5B.  B-G. Gadd34 mRNA normalised expression in Perk-/-, eIF2α 
AA, Atf4-/-, Pkr-/-, Gcn2-/- and Hri-/- mouse embryonic fibroblasts (MEFs) exposed to CM-PAO1 for 8, 16 or 24 
hours or tunicamycin (Tm) for 6 hours as a positive control (n=3; mean ± SEM).  All values are normalised 
to the housekeeping genes Actb and Sdha.  H. GADD34 mRNA levels in HeLa cells upon exposure to CM-
PAO1 after knock-down of GCN2 or HRI with siRNA  (n=3; mean ± SEM).  All values are normalised to the 
housekeeping genes RPL13A and ATP5B.  I.  Normalised expression values of spliced XBP1, CHOP, GADD34 
and GRP78 mRNA in 16HBE cells after stimulation with 1-100 nM deferoxamine (DFO).  All values are 
normalised to the housekeeping genes RPL13A and ATP5B.  J. Gadd34 mRNA levels in wild-type MEFs 
after repletion of the cell culture medium with iron (Fe3+) when treated with CM-PAO1 (n=3; mean ± SEM). 
The first lane (- Fe3+, - CM-PAO1) reflects medium control cells, without adding or depleting iron from 
the cell culture medium.  All values are normalised to the housekeeping genes Actb and Sdha.  * p<0.05, 




Chapter 4  •
observed a significant deficit of CM-PAO1 induction of Chop and Gadd34 mRNA in Hri-/- 
cells, suggesting the involvement of the iron-sensing kinase HRI (Figure 6E-G, and Figure 
S4G-I).  Although we observed no significant effect on the induction of Gadd34 mRNA 
in Gcn2-/- cells (Figure 6F), it has been suggested previously that GCN2 is involved in the 
stress response induced by P. aeruginosa in gut epithelial cells (60).  We therefore went on 
to deplete either GCN2 or HRI in HeLa cells using two separate siRNA oligonucleotides for 
each gene and obtained similar results, supporting a role for HRI rather than GCN2 (Figure 
6H and Figure S4J).
 Since RPMI is an iron-poor medium, we reasoned that the CM-PAO1 would limit 
iron availability to epithelial cells (e.g. by siderophores; (61)), which might activate HRI 
through depletion of iron from the culture medium.  We therefore first evaluated the 
effect of iron depletion of the epithelial cell culture medium using deferoxamine (DFO). 
DFO treatment resulted in a marked increase in the expression of the ISR and UPR related 
genes CHOP and GADD34, whereas GRP78 and spliced XBP1 were not affected (Figure 6I). 
This is line with selective activation of the ISR by iron depletion.  We next confirmed the 
presence of the iron-chelating siderophore pyoverdine in the CM-PAO1 by the bright 
fluorescence of the medium upon exposure to UV light (data not shown).  To test the 
possible involvement of iron depletion in CM-PAO1-mediated Gadd34 induction, we 
supplemented the epithelial cell culture medium with iron, which indeed completely 
suppressed the induction of Gadd34 mRNA (Figure 6J, and Figure S4K).
 Taken together, these data demonstrate that CM-PAO1 induces splicing of 
XBP1 mRNA (ER stress) in human bronchial epithelial cells, while induction of GADD34 
predominantly reflects an iron-dependent ISR mediated by the eIF2α kinase HRI.
The role of Gadd34 induction in cell survival
 During chronic ER stress in cell and animal models of disease, the induction of 
GADD34 appears to mediate cellular toxicity (26, 44).  In contrast, during the acute stress 
of SERCA pump inhibition by thapsigargin, GADD34 has been shown to be protective (62). 
To test the role of ER stress-independent induction of GADD34 by exposure to CM-PAO1, 
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we made use of Gadd34ΔC/ΔC MEFs (62), which lack GADD34 phosphatase activity.   Cells 
expressing wild-type Gadd34 were more resistant to the cytotoxic effects of CM-PAO1 
compared with Gadd34ΔC/ΔC fibroblasts, as reported by the release of lactate dehydrogenase 
(LDH) (Figure 7A).  To confirm these findings, we repeated these experiments in HeLa cells 
Figure 7. Induction of GADD34 protects against P. aeruginosa mediated cell cytotoxicity. 
A. LDH release of Gadd34+/+ and Gadd34ΔC/ΔC MEFs after stimulation with CM-PAO1 for 16 and 24 hours 
(n=3; mean ± SEM).  B. MTT cell viability of HeLa cells conditionally expressing GADD34 (± dox) after 
treatment with CM-PAO1 (n=3; mean ± SEM).  C. LDH release (left) and cell viability assessed with a MTT 
assay (right) of wild-type MEFs treated with CM-PAO1 after repleting the cell culture medium with iron 
(Fe3+) (n=3; mean ± SEM).  * p<0.05, ** p<0.01, *** p<0.001 versus untreated (-) with a two-way repeated-
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expressing GADD34 from a tetracycline-responsive promoter.  The induction of GADD34 
protein with doxycycline significantly increased cell viability on exposure to CM-PAO1 
(Figure 7B).  When the cell culture medium of wild-type cells was supplemented with iron, 
the release of LDH was prevented (Figure 7C, left panel).  Iron supplementation was also 
observed to rescue the reduction of cell viability reported by MTT assay (Figure 7C, right 
panel).  Taken together, these data suggest that the toxicity of CM-PAO1 is sensitive to iron 
and that HRI-mediated induction of GADD34 is protective in this context.  Supplementation 
with iron relieves both the cytotoxicity and the requirement for induction of GADD34. 
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Discussion
 It is known that a normal response to ER stress is required for an efficient innate 
immune response to bacterial infection (40), but whether live bacteria are required for 
this has been unclear.  In this study, we have shown that secreted virulence factors of P. 
aeruginosa cause ER stress in primary bronchial epithelial cells and in different cell lines, 
and that this is mediated by TAK1 and phosphorylated p38 MAPK.  In addition, we have 
identified GADD34 induction via an ER-stress independent ISR.  We have demonstrated 
pyocyanin to be one of the factors eliciting these responses, while AprA contributes to the 
activation of the UPR.  In contrast, activation of the ISR with induction of GADD34 mRNA 
is a response to reduced iron availability and serves a cytoprotective role during exposure 
to conditioned medium of P. aeruginosa.
 In line with these observations, phosphorylation of p38 MAPK has previously 
been shown to be involved in the splicing of XBP1 upon infection with P. aeruginosa 
(40, 46), although the involvement of TAK1 upstream of p38 MAPK and its essential 
involvement in the activation of CHOP and GRP78 are novel findings.  Interestingly, 
GADD34, classically a downstream target of CHOP, was regulated independently of the 
TAK1-p38 MAPK pathway. The induction of GADD34 is only partially dependent on CHOP 
(Figure S2A and (26)), but it is absolutely reliant on phosphorylation of eIF2α and ATF4 
(26).  This is concordant with the recent description of a virus-induced “microbial stress 
response” mediated via the PKR/eIF2α/ATF4 pathway, which fails to induce CHOP, but 
potently induces GADD34 (42, 43).  
 In contrast to the response of human airway epithelial cells, P. aeruginosa 
conditioned medium failed to cause splicing of Xbp1 mRNA in murine fibroblasts, 
suggesting that ER stress may not be a conserved feature of the cellular response to 
this insult.  This is unsurprising, as induction of ER stress is known to be highly cell-type 
dependent (41).  In the absence of ER stress in the murine fibroblasts, the induction of 
Chop and Gadd34 suggests that activation of the ISR by the secreted virulence factors 
may be a more conserved response.  Of note, in human primary bronchial epithelial cells, 
the induction of CHOP seems primarily subordinate to an ER stress-induced ISR, rather 
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than the microbial stress response (Figure S7).  Consequently, induction of CHOP was 
dependent on the TAK1-p38 MAPK pathway in those cells (Figure 2D) and its induction 
was only partially inhibited when bacterial cultures were supplemented with iron (Figure 
3E), in contrast to MEFs where Chop induction was dependent on HRI (Figure S2I).
 Recent evidence suggests that bacterial components may function as triggers for 
the UPR.  Flagellin has been shown to induce an atypical ER stress response in CF bronchial 
epithelial cells during live infection (46), while N-(3-oxo-dodecanoyl) homoserine lactone 
(C12) has been observed to cause phosphorylation of eIF2α and activation of p38 MAPK 
(63).  We have now shown that at least two secreted virulence factors, pyocyanin and 
AprA, also contribute to this ER stress response to Pseudomonas.  More research has to be 
done to assess the involvement of (other) individual virulence factors.  
 High concentrations of pyocyanin also mediated an ER stress-independent, ISR-
dependent induction of cytoprotective GADD34 (Figure 3B).  We were able to identify 
a crucial role for iron availability and for the iron-sensing kinase HRI in this response. 
Interestingly, AprA was not involved in the induction of this response but rather appeared 
to dampen it, since considerably higher GADD34 expression was observed when 
conditioned medium of the aprE mutant PAN8 was used to stimulate the cells (Figure 4B). 
Among other possibilities, an explanation for this observation could be that AprA present 
in the conditioned medium of the wild-type strain partially degrades HRI, a possibility 
that warrants further investigations.  The discovery of this ER stress-independent ISR may 
plausibly offer novel potential therapeutic targets.
 It has been shown recently that spliced XBP1 is required for C12-mediated 
apoptosis (63).  Remarkably, exposure of cells to C12 does not itself trigger the splicing of 
XBP1 mRNA suggesting that basal levels of spliced XBP1 are both necessary and sufficient 
for this response.  Moreover, the transcriptional activity of spliced XBP1 does not appear 
to be required for this cell death, indicating that the spliced XBP1 protein may have 
additional, as yet unidentified, activities.  C12 appears able to trigger the ISR in an ER 
stress-independent matter, although the mechanism for this remains to be determined. 
It would be interesting to determine if C12 can activate HRI.
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 Chronic elevation of GADD34 in ER stress can mediate cellular toxicity (26), but 
GADD34 has shown to be protective during the acute stress of SERCA pump inhibition 
with thapsigargin, which depletes the ER of calcium (62).  As with thapsigargin, P. 
aeruginosa has been associated with altered ER calcium signalling (39, 45).  It is therefore 
of interest that expression of GADD34 reduced cell toxicity and increased cell survival 
upon iron deficiency caused by treatment with conditioned medium from P. aeruginosa. 
It has been shown that lungs of cystic fibrosis patients lack the ability to induce GADD34 
(46), which might plausibly lead to increased cytotoxicity or altered innate immunity due 
to Pseudomonas infection of the lungs of CF patients. 
 In summary, secreted virulence factors of the PAO1 strain of P. aeruginosa, 
including pyocyanin and AprA, are sufficient to elicit an ER stress response but the relative 
contribution of these virulence factors remains to be investigated. In contrast to these 
virulence factors, iron depletion causes an ER stress-independent ISR.  The induction 
of GADD34 via this response ameliorates the toxic effects of P. aeruginosa conditioned 
medium.
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Materials and Methods
 
Bacterial strains and preparation of conditioned medium of P. aeruginosa
 All strains used in this study are listed in Table S1.  CM was prepared as described 
previously with slight modifications (48).  Briefly, overnight bacterial cultures in Luria Broth 
were inoculated 1:50 into RPMI 1640 (Gibco, Life Technologies, Breda, the Netherlands) 
and incubated at 37°C shaking at 200 rpm.  After 5 days, the cultures were centrifuged 
and supernatants were filter-sterilised through 0.22 µm pore-size filter (Whatman, Dassel, 
Germany) to obtain CM.  Pyocyanin and AprA levels in CM were measured as described 
previously (64, 65).
Cell culture
 Primary bronchial epithelial cells were obtained from tumour-free resected 
lung tissue by enzymatic digestion as described previously (66).  16HBE cells (passage 
4-15; kindly provided by Dr. D.C. Gruenert, University of California, San Francisco, CA, 
USA) were cultured in MEM (Invitrogen) supplemented with 1 mM HEPES (Invitrogen), 
10% (v/v) heat-inactivated FCS (Bodinco, Alkmaar, the Netherlands), 2 mM L-glutamine, 
100 U/ml penicillin and 100 µg/ml streptomycin (all from BioWhittaker).  All MEFs were 
maintained as described previously (23, 26, 37, 67, 68).  HEK-TLR2 and HEK-TLR4 (51) were 
a kind gift from M. Yazdanbakhsh (Leiden University Medical Center, the Netherlands). 
HeLa cells were transfected for 6 hours with two different ON-TARGETplus Human EIF2AK1 
siRNA (GCACAAACUUCACGUUACU and GAUUAAGGGUGCAACUAAA) or EIF2AK4 siRNA 
(GGAAAUUGCUAGUUUGUCA and GACCAUCCCUAGUGACUUA) and knockdown was 
assessed 48 hours after transfection (Figure S5).
 GADD34-N1-eGFP (kind gift form S. Shenolikar, Duke-NUS Graduate Medical 
School Singapore, Singapore) was excised with BglII and NotI and ligated into pTRE2-hyg 
plasmid (Clontech Laboratories, Mountain View, CA, USA) digested with BamHI and NotI. 
HeLa Tet-On advanced cells (Clontech Laboratories) were transfected with the pTRE2-hyg_
GADD34-eGFP plasmid and selected with 600 µM hygromycin to generate a stable cell 
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line conditionally expressing GADD34-GFP (Figure S6).  Positive cell clones were visualised 
by GFP expression in response to 1 µg/ml of doxycycline.  Once identified, expanded 
and characterised, these clones were maintained in DMEM (Sigma) supplemented with 
10% FBS and antibiotics (100 U/ml penicillin G, 100 µg/ml streptomycin, 200 µg/ml G418 
and 200 µM hygromycin).  Expression of GADD34 was typically induced using 1 µg/ml 
doxycycline (Sigma) for 24 hours.
 Cells were exposed at 80-90% confluence for 24 hours (unless stated otherwise) 
to CM-PAO1 (1 in 5 dilution, unless stated otherwise), pyocyanin (1-30 µM), ammonium 
iron (III) citrate (100 µM; Fe3+), exotoxin A (1-10 ng/ml) and/or DFO (1-100 nM) as indicated 
(all from Sigma).  Puromycin (10 µg/ml; Sigma) was added 30 minutes before harvesting. 
Thapsigargin (100  nM; Sigma), TNFα and IL-1β (both 20 ng/ml; Peprotech, Rocky Hill, 
NJ) were used as positive controls.  The compounds SB203580 (10 nM; Sigma) and 5Z-7-
oxozeanol (also called LL-Z1640-2; 100 nM; TebuBio, Heerhugowaard, the Netherlands) 
were added 30 minutes before stimulation for the inhibition of p38 MAPK and TAK1, 
respectively.  The specific IRE1-inhibitor 4µ8C (30 µM) (57) was a kind gift from Prof. dr. D. 
Ron, University of Cambridge.  
Western Blot
 Cells were lysed in buffer H (10 mM HEPES, pH 7.9, 50 mM NaCl, 500 mM sucrose, 
0.1  mM  EDTA, 0.5% (v/v) Triton X-100, 1  mM  PMSF, 1X Complete™ protease inhibitor 
cocktail (Roche Applied Science, Mannheim, Germany)) supplemented with phosphatase 
inhibitors (10  mM  tetrasodium pyrophosphate, 17.5  mM β-glycerophosphate, and 
100 mM NaF (25, 27)) for detection by antibodies directed against phospho-eIF2α (Cell 
Signaling Technology, Danvers, MA, USA), eIF2α (gift from Prof. D. Ron), KDEL (Enzo Life 
Sciences), GADD34 (ProteinTech, Chicago, IL, USA), puromycin (Millipore, Billerica, MA, 
USA), β-actin and GAPDH (CellSignalling), or in sample buffer (0.2 M Tris-HCl pH 6.8, 16% 
(v/v) glycerol, 4% (w/v) SDS, 4% (v/v) 2-mercaptoethanol, 0.003% (w/v) bromophenol 
blue) for detection by antibodies directed against phospho-p38 MAPK and total p38 
MAPK (both CellSignalling).  The proteins in the samples were separated using a 10% 
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SDS-PAGE gel and transferred onto a nitrocellulose membrane. After blocking with 
PBS containing 0.05% Tween-20 (v/v) and 5% skimmed-milk (w/v), the membrane was 
incubated overnight with the primary antibody (1:1000) in TBS with 0.05% Tween-20 (v/v) 
and 5%  BSA (w/v) at 4°C.  Next, the membrane was incubated with HRP-labelled anti-
mouse or anti-rabbit antibody (Sigma) in blocking buffer for 1 hour and developed using 
ECL (ThermoScientific).  
Quantitative reverse-transcriptase polymerase chain reaction (qPCR)
 Total RNA was isolated using Qiagen RNeasy mini kit (Qiagen/Westburg, Leusden, 
the Netherlands).  Quantitative reverse-transcriptase polymerase chain reaction (qPCR) 
was performed as described previously (69) using the primer pairs as defined in Table 
S2.  Relative mRNA concentrations of RPL13A and ATP5B (GeNorm, PrimerDesign Ltd., 
Southampton, UK) were used as housekeeping genes for human genes and Actb (β-actin) 
and Sdha for mouse genes to calculate normalized expression.
ELISA
 IL-8 (Sanquin, Amsterdam, the Netherlands) were measured using commercially 
available ELISA kit according to manufacturer’s instructions.
Cytotoxicity assays
 LDH release was measured with a LDH-cytotoxicity colorimetric assay kit following 
manufacturer’s instructions (Biovision, Milpitas, CA, USA).  Thiazolyl blue tetrazolium 
bromide (MTT; Sigma) was dissolved in a 5 mg/ml stock concentration in sterile water and 
cells were incubated with a 1:10 dilution for 2 hours at 37°C.  Next, the water-insoluble 
formazan formed from MTT is viable cells was dissolved in isopropanol for 10 min before 
the absorbance was read at 570 nm wavelength.
Electric Cell-sensing Impedance Sensing
 Epithelial barrier function was measured using ECIS (Applied Biophysics, Troy, NY, 
93
•  P. aeruginosa induces the UPR and ISR
USA) as described previously (70).  Resistance was measured at 1000 Hz and cells were 
stimulated with CM-PAO1 when the resistance was stable.
Statistical analysis
 Results are expressed as mean ± SEM.  Data were analysed using one- or two-way 
analysis of variance (ANOVA) and corrected with the Bonferroni post-hoc test.  Differences 
with p-values < 0.05 were considered to be statistically significant.
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Table S1. Bacterial strains
Strain Characteristics Ref.
PAO1 Wild-type ATCC; BAA-47
PAO25 PAO1 leu arg (71)
PAN8 PAO25 lasB::kmR aprE::ΩHg (56)
PAN11 PAO25 xcpR-54 lasB::kmR (56)
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Table S2. qPCR primers
Name Forward primer / Reverse primer Melting temp (°C) Ref.
HUMAN
CHOP 5’ GCACCTCCCAGAGCCCTCACTCTCC 3’
5’ GTCTACTCCAAGCCTTCCCCCTGCG 3’
62 (69)
GADD34 5’ ATGTATGGTGAGCGAGAGGC 3’
5’ GCAGTGTCCTTATCAGAAGGC 3’
62 (72)
GRP78 5’ CGAGGAGGAGGACAAGAAGG 3’
5’ CACCTTGAACGGCAAGAACT 3’
62 (73)




Actb 5’ TCCTGGCCTCACTGTCCA 3’
5’ GTCCGCCTAGAAGCACTTGC 3’
59 (74)
Chop 5’ GGAGCTGGAAGCCTGGTATGA G 3’
5’ GCAGGGTCAAGAGTAGTGAAGG 3’
59 (57)
Gadd34 5’ CCCGAGATTCCTCTAAAAGC 3’
5’ CCAGACAGCAAGGAAATGG 3’
59 (75)
Sdha 5’ TTGCTACTGGGGGCTACGGGC 3’
5’ TGACCATGGCTGTGCCGTCC 3’
59 -
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Figure S1.  Conditioned medium of strain PAO1 causes disruption of the epithelial barrier function. 
A. Time- and dose-dependent decrease in epithelial resistance measured by ECIS®.  Primary bronchial 
epithelial cells were cultured on golden electrodes a described previously and epithelial resistance was 
measured every 5 minutes at 1000 Hz.  Values are displayed as a relative number of the resistance at time 
point 0 (n=3; mean ± SEM).  B. Trypan blue staining of primary bronchial epithelial cells incubated for 12 
hours with CM-PAO1.
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Figure S2. Exotoxin A does not elicit an ER stress response in 16HBE cells.  
A. Normalised expression levels of spliced XBP1, CHOP, GADD34 and GRP78 mRNA in 16HBE cells after 
stimulation with 0, 1 or 10 ng/ml P. aeruginosa exotoxin A (ETA) (n=3; mean ± SEM).  All values are 
normalised to the housekeeping genes RPL13A and ATP5B.  B.  Normalised expression levels of spliced 
XBP1, CHOP, GADD34 and GRP78 mRNA in 16HBE cells after stimulation with in 16HBE cells after 
stimulation with CM-PAO25, CM-PAN8 or CM-PAN8+Fe3+ (n=3; mean ± SEM).  All values are normalised to 
the housekeeping genes RPL13A and ATP5B.  C. AprA western blot of a standard curve of purified AprA. 
Undiluted CM-PAO25 is used to semi-quantify AprA content within.  * p<0.05, ** p<0.01, *** p<0.001 









































































































































































































































































•  P. aeruginosa induces the UPR and ISR
Figure S3. Conditioned medium of strain PAO1 and PAO25 are comparable in inducing ER stress.  A. 
Quantitation of pyocyanin in CM-PAO1 and CM-PAO25 (n=3; mean ± SEM).  B. Western blot for AprA levels 
present in CM-PAO1, -PAO25, -PAO25 cultured in the presence of iron (PAO25 + Fe3+), -PAN8 and -PAN11 
(representative of n=3).  C. Spliced XBP1, CHOP, GADD34 and GRP78 mRNA levels in 16HBE cells treated 
with CM-PAO1 or CM-PAO25 (n=3; mean ± SEM).  * p<0.05, ** p<0.01, *** p<0.001 versus untreated (-) 
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•  P. aeruginosa induces the UPR and ISR
Figure S4. CHOP can be regulated via the ER stress independent ISR.  
A. IL-8 release of 16HBE cells after treatment with CM-PAO1 in the presence of 30 µM 4µ8C, a selective 
inhibitor of the ER stress responsive kinase IRE1 (n=3; mean ± SEM).  B. Chop and Gadd34 mRNA induction 
in Chop+/+ or Chop-/- MEFs exposed to CM-PAO1 for 8, 16 or 24 hours or tunicamycin (Tm) for 6 hours as a 
positive control (n=3; mean ± SEM).  All values are normalised to the housekeeping genes Actb and Sdha. 
C. Splicing of XBP1 mRNA in wild-type MEFs after treatment as in B. (n=3; mean ± SEM).  All values are 
normalised to the housekeeping genes Actb and Sdha.  D-I. Chop mRNA normalised expression in Perk-/-, 
eIF2α AA, Atf4-/-, Pkr-/-, Gcn2-/- and Hri-/- mouse embryonic fibroblasts (MEFs) treated as in A.  (n=3; mean ± 
SEM).  All values are normalised to the housekeeping genes Actb and Sdha.  J. CHOP mRNA levels in HeLa 
cells upon exposure to CM-PAO1 after knock-down of HRI or GCN2 with siRNA  (n=3; mean ± SEM).  All 
values are normalised to the housekeeping genes RPL13A and ATP5B.  K. Gadd34 mRNA levels in wild-
type MEFs after repletion of the cell culture medium with iron (Fe3+) when treated with CM-PAO1.  The 
first lane (- Fe3+, - CM-PAO1) reflects medium control cells, without adding or depleting iron from the cell 
culture medium (n=3; mean ± SEM).  All values are normalised to the housekeeping genes Actb and Sdha. 
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Figure S5. HRI and GCN2 knock down in epithelial cells. 
HRI and GCN2 expression in HeLa cells after transfection with two different siRNA for each gene.  (n=3; 
mean ± SEM).  All values are normalised to the housekeeping genes RPL13A and ATP5B.  * p<0.05, ** 















Figure S6. Expression of GFP-tagged 
GADD34 in HeLa Tet-ON cells .
A. Response of HeLa cells incubated for 
24 hours with a range of doxycycline 
concentrations (n=3).  B. Time-
dependent induction of GFP-tagged 
GADD34 in HeLa cells treated with 0.5 













































































•  P. aeruginosa induces the UPR and ISR
Figure S7. Schematic overview.
Secreted virulence factors of P. aeruginosa induce both the UPR and the ISR.  UPR induction is dependent 
on the TAK1-p38 MAPK pathway, whereas the induction of the ISR is mediated via iron deficiency.  In 
human bronchial epithelial cells, the UPR causes XBP1 splicing, and the induction of GRP78 and CHOP 
(all in red).  Iron deficiency, most likely in part caused by sequestration of iron by secreted siderophores, 
leads to activation of GADD34 via the ER stress independent kinase HRI (in blue).  The common pathway 
is displayed in purple.  In our model, it seems unlikely that CHOP influences GADD34.  It is yet unknown 
whether cells distinguish between the phosphorylation of eIF2α by different kinases, and thereby 














- alkaline protease (AprA)
- others ?







Increased ERK signalling promotes inflammatory signalling in primary 
airway epithelial cells expressing Z α1-antitrypsin 
Emily F.A. van ‘t Wout1,2, Jennifer A. Dickens1, Annemarie van Schadewijk2, Imran Haq1, 
Hang Fai Kwok3, Adriana Ordóñez1, Gillian Murphy3, Jan Stolk2, David A. Lomas1,4* , Pieter S. 
Hiemstra2*, Stefan J. Marciniak1* 
1 Department of Medicine, University of Cambridge, Cambridge Institute for Medical Research, Wellcome Trust/   
  Medical Research Council Building, Cambridge, United Kingdom
2 Department of Pulmonology, Leiden University Medical Centre, Leiden, the Netherlands
3 Department of Oncology,  University of Cambridge, Proteases and Tumour Microenvironment Group, Cancer  
  Research UK Cambridge Research Institute, Cambridge, United Kingdom
4 Wolfson Institute for Biomedical Research, University College London, London, United Kingdom 
* Joint senior authors
Human Molecular Genetics 2014; 23:929-941
Chapter 5
110
Chapter 5  •
Abstract
 Overexpression of Z α1-antitrypsin is known to induce polymer 
formation, prime the cells for ER stress and initiate NF-κB signalling.  However, 
whether endogenous expression in primary bronchial epithelial cells has similar 
consequences remains unclear.  Moreover, the mechanism of NF-κB activation 
has not yet been elucidated.  Here we report excessive NF-κB signalling in resting 
primary bronchial epithelial cells from ZZ patients compared to wild-type (MM) 
controls, and this appears to be mediated by MEK, EGFR and ADAM17 activity. 
Moreover, we show that rather than being a response to protein polymers, NF-κB 
signalling in airway-derived cells represents a loss of anti-inflammatory signalling 
by M α1-antitrypsin.  Treatment of ZZ primary bronchial epithelial cells with purified 
plasma M α1-antitrypsin attenuates this inflammatory response, opening up new 
therapeutic options to modulate airway inflammation in the lung.
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Introduction
 Alpha1-antitrypsin is a 52-kDa serine protease inhibitor (or serpin), primarily 
produced by hepatocytes, but also secreted locally by lung epithelial cells and alveolar 
macrophages (1, 2).  Its known function is to inhibit a number of serine proteases, including 
neutrophil elastase and proteinase 3, thereby preventing excessive degradation of the 
extracellular matrix.  It has also been reported to exhibit anti-inflammatory properties, 
including the inhibition of TNFα gene expression (3), inhibition of a disintegrin and 
metalloprotease (ADAM)17 activity in neutrophils and endothelial cells (4, 5) and the 
regulation of CD14 expression and cytokine release in monocytes (6, 7). 
 The Z mutation (E342K) of α1-antitrypsin causes subtle misfolding of the protein 
that permits polymer formation and accumulation within the endoplasmic reticulum (ER) 
of hepatocytes or degradation by the proteasome leading to deficiency of the secreted 
protein (8, 9).  This causes hepatic cirrhosis through toxic gain-of-function within the liver, 
most likely due to the retention of polymers, and early-onset lung emphysema, due in 
large part to the loss of protease inhibition (10).  The discovery of polymers in broncho-
alveolar lavage fluid and pulmonary tissue (11, 12), the pro-inflammatory nature of such 
extracellular polymers (11, 13) and their identification many years after liver transplantation 
(14) led to the proposal that pulmonary pathology could be induced by polymer-induced 
toxic gain-of-function with inflammation as an additional mechanism (15).
 Secreted proteins are first folded within the ER where quality control systems 
ensure that only properly folded proteins exit the organelle (16).  Accumulation of unfolded 
or misfolded proteins within the ER induces “ER stress”, thereby activating intracellular 
signal transduction pathways, collectively called the unfolded protein response (UPR) 
(16).  This complex cellular response evolved to restore ER homeostasis by reducing 
the load of newly synthesised protein while increasing the complement of molecular 
chaperones, which enhance ER protein folding capacity, and increasing the efficiency of 
misfolded protein degradation (ERAD) (17, 18).  We have shown previously that mutant Z 
α1-antitrypsin is degraded predominantly by ERAD (19).  Remarkably, the accumulation of 
polymers of Z α1-antitrypsin within the ER of hepatocytes does not activate the UPR but 
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instead increases the cell’s sensitivity to ER-stress upon a ‘second hit’ due to impaired ER 
luminal protein mobility (20-22). 
 The transcription factor nuclear factor kappa B (NF-κB) regulates many genes 
involved in inflammation and cell death, including numerous cytokines and chemokines 
e.g. interleukin (IL)-8 (23).  Phosphorylation of NF-κB is classically mediated through the 
phosphorylation of inhibitor kappa-B alpha (IκBα); however, NF-κB can also be activated 
via mitogen-activated protein kinase (MAPK) signalling cascades (24, 25). 
 Epidermal growth factor (EGF) and related mitogens such as heparin binding-EGF 
(HB-EGF), amphiregulin (AREG) and transforming growth factor (TGF)α are synthesised 
as membrane-bound proteins that upon cleavage by metalloproteases (MPs), including 
ADAMs, bind to and activate the EGF receptor (EGFR) (reviewed in (26)).  Transactivation of 
the EGFR can also occur via activation of ADAMs by G-protein coupled receptor signalling 
(reviewed in (27)).  Within the lung, EGFR activation can induce epithelial cell proliferation 
by activating ERK1/2.  This is mediated by Ras activation of c-Raf, causing phosphorylation 
of the mitogen-activated protein/extracellular signal-regulated kinase kinase (MEK), 
which in turn phosphorylates ERK1/2 (28).
 Mutants of members of the serpin superfamily, including α1-antitrypsin, have 
been shown to activate NF-κB signalling, postulated to be a response to the formation of 
protein polymers within the ER (20, 21, 29). However, this appears to be independent of 
their ability to prime cells for ER stress (29).  Whether the local expression of Z α1-antitrypsin 
by airway epithelial cells in vivo leads to the formation of protein polymers and to the 
activation of the NF-κB pathway remains unclear.  We report here the detection of NF-κB 
activation in primary bronchial epithelial cells isolated from patients homozygous for the 
Z mutation (ZZ) and demonstrate this to be mediated by increased ADAM17-dependent 
EGFR-MEK-ERK signalling in the absence of either detectable polymer formation or ER 
stress response.  Instead, the activation of the EGFR in this setting represents a loss of M 
α1-antitrypsin phenotype.
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Results
Z α1-antitrypsin activates NF-κB in lung epithelial cells 
 It is well-recognised that overexpression of Z α1-antitrypsin activates the NF-
κB response leading to pro-inflammatory cytokine release (20, 21, 30).  We therefore 
asked whether expression of Z α1-antitrypsin regulated by its endogenous promoter in 
airway epithelial cells could also activate this pathway.  Primary bronchial epithelial cells 
were differentiated into mucin producing, ciliated epithelial cell layers (Figure 1A) and a 
multiplex ELISA (Meso Scale Discovery®) of apical washings (air exposed) and basal (liquid 
exposed) conditioned medium for IL-8, IL-6, TNFα, IL-1β, MCP-1 and IP-10 was performed 
(Figure 1B).  This revealed that resting ZZ differentiated primary bronchial epithelial 
cells secreted more IL-8 basally when compared to MM cells (p<0.01).  After combined 
stimulation with oncostatin M (OSM), TNFα and IL-1β (OSM-mix), ZZ differentiated 
primary bronchial epithelial cells showed significantly higher release of MCP-1 (p<0.01), 
IP-10 (p<0.05) and IL-1β (p<0.01) compared to MM controls.  The reduced secretion of IL-8 
most likely reflects the known inhibitory effect of OSM on IL-1β-induced IL-8 release (31). 
To determine whether this enhanced release of cytokines was mediated by increased NF-
κB signalling, submerged cultures of patient-derived ZZ primary bronchial epithelial cells 
were induced to express increased levels of α1-antitrypsin by treatment with OSM and 
NF-κB activity was assayed using a luciferase reporter system (Figure 1C) (29).  Low levels 
of basal NF-κB luciferase activity were detected in MM primary bronchial epithelial cells, 
whereas ZZ cells showed significantly higher activity at baseline (p<0.05 compared to 
MM; Figure 1C).  When α1-antitrypsin production was increased by treatment with OSM, 
the NF-κB activity in ZZ primary bronchial epithelial cells increased significantly (p<0.001) 
and the difference between MM and ZZ cells further increased (p<0.01).  Stimulation with 
TNFα, a cytokine known to induce NF-κB activation, showed the same difference between 
MM and ZZ cells (p<0.05).  The same effect was seen in Tet-On A549 cells overexpressing 
either M or Z α1-antitrypsin (Figure S1).  To test if the baseline difference in NF-κB activity 
was related to the transfection of the reporter constructs, we measured transcription 
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•  The ERK pathway in α1-antitrypsin deficiency
of the NF-κB-dependent chemokine IL-8, which confirmed basal levels of inflammatory 
signalling were higher in ZZ primary bronchial epithelial cells compared with controls 
(p<0.05; Figure 1D). 
Z α1-antitrypsin does not form detectable polymers nor causes ER stress in lung epithelial 
cells  
 NF-κB activation by mutant serpins has previously been associated with the 
accumulation of protein polymers within the ER (20-22, 29).  This accumulation has also 
been shown to exaggerate ER stress upon a second hit (20, 22).  To verify whether this 
mechanism was responsible for the enhanced NF-κB signalling in fully differentiated ZZ 
primary bronchial epithelial cells, we first measured total secreted and intracellular α1-
antitrypsin. Resting primary bronchial epithelial cells produced unquantifiable amounts 
of α1-antitrypsin, but after stimulation with OSM-mix for 48 hours, α1-antitrypsin was 
detectable in both the apical washes and basal supernatant (Figure 2A).  Similar results 
were obtained after exclusion of the current smokers, indicating that the differences 
Figure 1. Z α1-antitrypsin expression enhances NF-κB signalling in lung epithelial cells.  
A. Schematic diagram of culturing primary bronchial epithelial cells at an air (apical) - liquid (basal) 
interface.  Once differentiated, the epithelium is a pseudo-stratified cell layer composed of ciliated cells, 
goblet cells and basal cells.  B. Meso scale discovery® of apically and basally secreted cyto- and chemokines 
(IL-8, IL-6, TNFα, IL-1β, MCP-1 and IP-10).  Cells were treated ± oncostatin M (100ng/ml; OSM) + TNFα/IL-1β 
(both 20 ng/ml; OSM mix) for 48 hours before harvesting apical washes and basal medium (mean, n=6). 
C. NF-κB luciferase activity of undifferentiated MM and ZZ cells.  Submerged cells were cultured for 24 
hours, then transfected with luciferase reporters for 6 hours and left 16 hours ± OSM or TNFα (20 ng/ml) 
as indicated.  NF-κB reporter activity is corrected for Renilla (mean, n=3-4).  D. Basal IL8 mRNA expression 
levels of undifferentiated primary bronchial epithelial cells measured by qPCR (mean, n=4).  *p<0.05, 
**p<0.01, ***p<0.001 versus – with a two-way repeated-measurements ANOVA (Bonferroni post-hoc).
<<<
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in smoking status of the patients between MM and ZZ patients from which cells were 
obtained did not explain the differences in production of α1-antitrypsin (data not 
shown).  Using the 2C1 monoclonal antibody that specifically detects naturally occurring 
polymers of Z α1-antitrypsin (32), we found no evidence of polymer formation (Figure 2A). 
Accordingly, we could detect no differences in ER protein mobility (Figure S2), which we 
have previously shown occurs in cells containing ER luminal polymers of α1-antitrypsin 
(22).  To determine if the absence of polymer formation was a feature of lung epithelial 
cells, we generated stable transfected A549 lung carcinoma cell lines that conditionally 
expressed either M or Z α1-antitrypsin under the control of a Tet-On responsive promoter. 
As expected, M α1-antitrypsin-expressing A549 cells secreted five-times more α1-
antitrypsin than did Z α1-antitrypsin-expressing A549 cells (Figure 2B).  Again, we were 
unable to detect protein polymers in either the supernatant or cellular lysates (Figure 
2B).  Since polymer formation is dependent upon α1-antitrypsin concentration (8), we 
Figure 2. Polymer formation and an (exaggerated) ER stress response are not causing the 
augmented NF-κB response.  
A. Total α1-antitrypsin (AAT) and α1-antitrypsin polymer production of fully differentiated primary bronchial 
epithelial cells stimulated with OSM mix for 48 hours.  Note lack of polymer signal with the 2C1 antibody 
(mean, n=6).  B. Total α1-antitrypsin and α1-antitrypsin polymer production of the overexpressing Tet-On 
A549 cells after inducing for 48 hours with doxycycline (dox; mean ± SEM, n=3).  C. Total α1-antitrypsin 
levels produced by ZZ lung epithelial cells compared to ZZ liver homogenate (n=3 from one individual). 
D. Quantitative RT-PCR of fully differentiated primary bronchial epithelial cells treated ± OSM mix for 48 
hours.  Four hours before harvesting, cells were stimulated with tunicamycin (Tm; 1 µg/ml).  Spliced XBP1, 
CHOP and GADD34 mRNA levels are displayed normalised to the housekeeping genes RPL13A and ATP5B 
(mean, n=6).  E. Western blot for GRP94 and GRP78 using anti-KDEL antibody.  Cells were treated as in 
D, but stimulated for 16 hours with tunicamycin (mean, n=6). N.D. not detectable. *p<0.05, **p<0.01, 
***p<0.001 versus – or 0 with a two-way repeated-measurements ANOVA (Bonferroni post-hoc).
>>>
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compared the relative levels of α1-antitrypsin in tissue from an explanted cirrhotic ZZ 
liver (Figure 2C) with those in cultured airway epithelial cells.  This revealed a 100-fold 
higher level of α1-antitrypsin in hepatic tissue and significant polymer accumulation 
(Figure 2C).  While polymerisation of α1-antitrypsin in vitro is highly dependent upon 
protein concentration, the concentration-dependence of polymerisation within the 
crowded environment of the endoplasmic reticulum in vivo is not known.  Therefore, to 
determine the critical concentration for the polymerisation of Z α1-antitrypsin in living 
cells, we induced the expression of Z α1-antitrypsin in Tet-On stable CHO stable cells (22) 
and measured both total α1-antitrypsin and polymer levels (Figure S3A).  This revealed 
that levels of 300 ng α1-antitrypsin per mg total lysate protein are necessary before 
intracellular polymers can be detected in these cells (Figure S3A).  To test this finding in 
lung epithelial-derived cells, we induced expression of Z α1-antitrypsin in Tet-On A549 cells 
with doxycycline and augmented the protein level by inhibiting endoplasmic reticulum 
associated degradation (ERAD) with lactacystin, a selective proteasome inhibitor.  This 
increased the concentration of intracellular Z α1-antitrypsin above 300 ng α1-antitrypsin 
per mg total lysate, whereupon polymers were detected (Figure S3B).  It therefore seems 
likely that the low levels of α1-antitrypsin produced by airway epithelia are insufficient to 
generate detectable polymers.
 To define whether Z α1-antitrypsin expressed in epithelial cells alters the ER stress 
response, we induced expression of α1-antitrypsin in fully differentiated primary bronchial 
epithelial cells with OSM-mix in the presence or absence of the ER stress-inducing toxin 
tunicamycin.  We detected no differences in the basal or OSM-mix-stimulated levels of 
spliced XBP1, CHOP, and GADD34 mRNA between MM and ZZ primary bronchial epithelial 
cells (Figure 2D).  As expected, tunicamycin increased the level of these transcripts; 
however, there was not an exaggerated ER stress response in ZZ epithelial cells (Figure 
2D).  Similarly, we were unable to detect differences in ER stress by western blot for the 
KDEL-positive chaperones, GRP94 and GRP78, in ZZ and MM cells (Figure 2E). 
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Figure 3. Increased NF-κB response in ZZ primary bronchial epithelial cells is dependent on the 
ERK/MEK/EGFR pathway.  
A. Representative western blot of the activation of the MAP kinases ERK1/2, JNK and p38 MAPK of whole 
cell lysates from undifferentiated primary bronchial epithelial cells knocked-out for α1-antitrypsin (AAT) 
with siRNA.  Cells were cultured overnight, transfected for 24 hours and left 48 hours before harvesting. 
Neuroserpin (NS) siRNA served as a control.  Densitometry of four independent experiments in duplicate 
(mean, n=4).  B. ZZ primary bronchial epithelial cells treated for 24 hours with 1 mg/ml purified plasma 
M α1-antitrypsin normalised ERK1/2 levels.  Densitometry of four independent experiments in duplicate 
(mean, n=4).  C. ZZ primary bronchial epithelial cells treated with 10 µM U0126 (a specific MEK inhibitor) 
for 8 hours or 2 µg/ml anti-EGFR blocking antibody for 24 hours.  Densitometry of three independent 
experiments in duplicate (mean, n=3).  *p<0.05, **p<0.01, ***p<0.001 versus – or 0 with a two-way 
repeated-measurements ANOVA (Bonferroni post-hoc).
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Loss of M α1-antitrypsin leads to increased activation of ERK, which is dependent on MEK 
and EGFR
 In order to understand the mechanism of inflammatory signalling in ZZ epithelial 
cells, we next evaluated activation of the NF-κB pathway components IKKβ, IκBα and 
p65.  To evaluate MAPK signalling, we also measured JNK, p38 MAPK and ERK1/2.  This 
revealed a significant difference only in the activation of ERK (p<0.05; Figure 3A and S4). 
Interestingly, depletion of α1-antitrypsin by siRNA caused phosphorylation of ERK1/2 in 
MM primary bronchial epithelial cells, but did not alter the phosphorylation of ERK1/2 in 
ZZ cells (Figure 3A).  This effect was specific for ablation of α1-antitrypsin, since silencing 
a nonspecific serpin, neuroserpin (NS), did not increase phosphorylation of ERK1/2 in MM 
cells.  This suggested that it was the lack of M α1-antitrypsin, rather than the presence 
of Z α1-antitrypsin, that might be responsible for the phosphorylation of ERK1/2 in ZZ 
primary bronchial epithelial cells.  To test this, we treated ZZ primary bronchial epithelial 
cells with plasma purified M α1-antitrypsin and observed a suppression of ERK1/2 
phosphorylation (p<0.05; Figure 3B).  We wished to determine whether this loss of 
function phenotype reflected a lack of anti-inflammatory activity in Z α1-antitrypsin or 
if cells secreted insufficient Z α1-antitrypsin.  Since concentration of plasma purified Z α1-
antitrypsin to a degree required for this experiment would result in its polymerisation, 
we instead transiently transfected HeLa cells with either M or Z α1-antitrypsin or empty 
vector as control.  After transfection, the cells produced high levels of α1-antitrypsin, with 
ZZ cells producing approximately 20% of the amount that MM cells produced (444 ng/
mg α1-antitrypsin in the total lysate versus 1995 ng/mg α1-antitrypsin in the total lysate 
respectively; Figure S5A).  Although 14% (33 ng/mg total lysate) of the extracellular Z α1-
antitrypsin formed polymers (not shown), the protein was able to inhibit phosphorylation 
of ERK1/2 to a similar degree as M α1-antitrypsin (Figure S5B).  This result is consistent with 
a model in which ZZ primary bronchial epithelial cells secrete insufficient α1-antitrypsin to 
inhibit ERK1/2 phosphorylation, rather than Z α1-antitrypsin lacking the anti-inflammatory 
activity per se. 
 To determine the mechanism of ERK1/2 phosphorylation in ZZ primary bronchial 
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epithelial cells, we treated cells with U0126, a specific inhibitor of MEK, or an anti-EGFR 
blocking monoclonal antibody.  Both reagents abrogated the phosphorylation of ERK 
indicating that the EGFR-MEK signalling pathway was involved and was activated by 
the ligand-binding site of EGFR (Figure 3C).  Although under some circumstances the 
activation of ERK1/2 can lead to epithelial cell proliferation, we did not observe differences 
in the rate of MM and ZZ cell proliferation (Figure S6A).  Attempts to assess the effect of 
ERK1/2 inhibition in each cell type were hampered by toxicity, but it did not appear that 
modulation of ERK1/2 activation affected proliferation of MM or ZZ cells differentially. 
Treatment of ZZ cells with purified M α1-antitrypsin did not appear to affect the rate of 
proliferation (Figure S6B).
ZZ primary bronchial epithelial cells generate higher levels of ADAM17-dependent EGFR 
ligands
 We reasoned that this increased EGFR signalling might reflect increased cleavage 
of membrane-tethered ligands by MMPs and/or ADAMs.  Therefore, we incubated MM 
and ZZ primary bronchial epithelial cells with GM6001, a broad-spectrum MP-inhibitor, 
or TAPI-2, a broad-spectrum MP inhibitor with enhanced ADAM17 inhibitory activity. 
TAPI-2 completely blocked the phosphorylation of ERK1/2 in ZZ cells (p<0.001), while 
GM6001 failed to affect phosphorylation (Figure 4A).  Furthermore, only treatment with 
TAPI-2 reduced secretion of IL-8 from ZZ cells (p<0.01) (Figure 4B).  Since this suggested 
the involvement of ADAM17, we next tested the effect of a specific ADAM17 blocking 
antibody, D1(A12) (33).  At 200 nM, a concentration known to block the activity of ADAM17 
(34), we observed a substantial decrease in phosphorylation of ERK1/2 (p<0.05; Figure 
4C). 
 A previous report suggested that M α1-antitrypsin can directly inhibit ADAM17 
derived from neutrophils (4), and so we attempted to reproduce this observation.  We 
first performed an in vitro ADAM17 activity assay by incubating 1 nM ADAM17 with 0-30 
µM purified plasma M α1-antitrypsin, but were unable to detect any inhibition of ADAM17 
(Figure 4D).  When using 10 µM β-mercaptoethanol in PBS or PBS alone, two potent 
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ADAM17 inhibitors, we were able to inhibit its activity, confirming the functionality of 
our assay (Figure 4D).  Moreover, we were unable to detect the formation of a complex 
between ADAM17 and either form of α1-antitrypsin (Figure 4E).  Although it remains 
controversial as to whether cytoplasmic phosphorylation of ADAM17 plays an important 
regulatory role (35), we also tested for phosphorylation of ADAM17 in MM and ZZ cells 
grown with or without supplementary M α1-antitrypsin (Figure S7).  We detected no 
differences between these conditions.
 To explore this pathway further, we next measured whether ZZ primary bronchial 
epithelial cells generated more EGFR ligands than controls.  We detected significantly 
higher levels of mRNA encoding HB-EGF and TGFα in ZZ cells compared with MM controls 
(p<0.05 and p=0.05; Figure 5A).  When the EGFR was blocked using a monoclonal antibody 
to prevent ligand binding to its receptor, significantly more release of TGFα and AREG was 
Figure 4. M α1-antitrypsin protects primary bronchial epithelial cells against constituvely activated 
ERK1/2 in an ADAM17-dependent fashion.  
A. Western blot for phosphorylated ERK1/2 of whole cell lysates from primary bronchial epithelial 
cells treated with 25 µM GM6001 (MP inhibitor) or 25 µM TAPI-2 (MMP and ADAM17 inhibitor) for 24 
hours.  Densitometry of three independent experiments in duplicate (mean, n=3).  B. IL-8 secretion in 
supernatant of primary bronchial epithelial cells treated as in A (mean, n=3).  C. Treatment with D1(A12), 
a specific ADAM17 blocking antibody, inhibits phosphorylation of ERK1/2 in ZZ cells after 6 hours.  (–) 
represents a control IgG.  Densitometry of three independent experiments in duplicate (mean, n=3).  D. 
ADAM17 (1 nM) was incubated with 7.5 or 30 µM plasma M α1-antitrypsin.  ADAM17 activity was assayed 
against a fluorogenic substrate. β-mercaptoethanol (10 µM) in PBS was used as a positive control for 
inhibition.  (–) represents baseline ADAM17 activity against the fluorogenic substrate.  E. Silver stain of 
a Bis-Tris non-reducing PAGE revealed no binding of ADAM17 to plasma M α1-antitrypsin incubated in 
a 1:1 molar ratio for 1 hour at 37°C.  *p<0.05, **p<0.01, ***p<0.001 versus – with a two-way repeated-
measurements ANOVA (Bonferroni post-hoc).
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Figure 5. EGFR ligands are enriched in ZZ primary bronchial epithelial cells. 
A. Basal expression levels of the EGFR ligands HB-EGF, TGFα and amphiregulin (AREG) in undifferentiated 
primary bronchial epithelial cells, measured by qPCR.  EGF was not quantifiable (mean, n=4).  B. Increased 
TGFα and AREG in the cell supernatant of ZZ primary bronchial epithelial cells after blockade of the 
EGFR, quantified by ELISA.  HB-EGF was undetectable (mean, n=3).  C. Conditioned medium from ZZ 
primary bronchial epithelial cell culture given to MM primary bronchial epithelial cells and vice versa. 
Phosphorylation of ERK1/2 was measured 1 and 24 hours after media exchange. Densitometry of four 
independent experiments in duplicate (mean, n=4).  *p<0.05, **p<0.01, ***p<0.001 versus – with a two-
way repeated-measurements ANOVA (Bonferroni post-hoc).
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detected in ZZ cells compared with MM cells (p<0.05; Figure 5B).  Consistent with these 
observations, when we treated MM primary bronchial epithelial cells with conditioned 
medium derived from ZZ cultures, we observed a significant increase in phosphorylation 
of ERK1/2 after 1 hour (p<0.01), which returned to baseline after 24 hours (p<0.001; Figure 
5C). 
 Taken together, these data indicate that the increased NF-κB signalling in ZZ 
primary bronchial epithelial cells is caused by phosphorylation of ERK1/2. This is due 
Figure 6. ZZ primary bronchial epithelial cells show an enhanced inflammatory response dependent 
of the ERK/EGFR/ADAM17 pathway.  
Impaired expression of α1-antitrypsin in primary bronchial epithelial cells leads to increased 
phosphorylation of ERK1/2, which is dependent on MEK, EGFR and ADAM17.  M α1-antitrypsin modulates 
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to increased availability of ADAM17-dependent EGFR ligands leading to activation of 
the EGFR and signalling via MEK (Figure 6).  Surprisingly, we were unable to detect the 
formation of polymers of α1-antitrypsin in ZZ primary bronchial epithelial cells or A549 
lung adenocarcinoma cells overexpressing the protein, which may reflect the low levels 
of α1-antitrypsin expression of which these cells are capable.
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Discussion
 For many years, it was thought that an imbalance between protease and 
antiprotease activity was solely responsible for the accelerated onset of emphysema 
in patients homozygous for the Z allele of α1-antitrypsin (reviewed in (36)).  However, 
α1-antitrypsin has been found to possess additional roles to its antiprotease activity, 
including a range of anti-inflammatory properties (3-5), and the Z alleles can increase 
inflammatory NF-κB signalling when overexpressed pulmonary epithelial cells (20, 21, 
30).  The results of our current study using primary bronchial epithelial cells in which 
α1-antitrypsin is expressed under the control of its endogenous promoter, confirm and 
extend these findings.  We found that at the low levels of α1-antitrypsin expression that 
occur in these cells, clinically relevant polymer formation is unlikely to occur.  Sufficient 
α1-antitrypsin is generated by wild-type cells to suppress ERK1/2 and NF-κB signalling, 
but this anti-inflammatory effect appears to be lost in ZZ epithelia, suggesting a novel 
mechanism for airway pathology in α1-antitrypsin deficiency.  Surprisingly, while ADAM17 
is required to generate secreted EGFR ligands mediating inflammatory signals in these ZZ 
cells, we were unable to detect a direct inhibition of ADAM17 by M α1-antitrypsin. 
 Many heterologous overexpression systems have reported the presence of Z α1-
antitrypsin polymers both intracellular and in conditioned medium (20, 21).  Unexpectedly, 
but importantly, we were unable to detect 2C1-positive polymers in primary bronchial 
epithelial cultures.  Although the 2C1 monoclonal antibody is highly specific for polymers, 
it is formally possible that it is less sensitive than other anti-polymer antibodies, for 
example ATZ11.  However, in our hands both have similar avidity towards Z polymers, but 
the polyclonal antibody ATZ11 is less specific for polymers, detecting both Z monomers 
as well as Z polymers (32).  Even if very low levels of Z α1-antitrypsin polymer is made 
within bronchial epithelial cells, it is unlikely to affect cellular function as we were unable 
to detect impaired ER protein mobility nor altered ER stress responsiveness as we have 
done previously for polymer-expressing cells (22). 
 We were unable to identify all components required for ERK1/2 activation in 
ZZ primary bronchial epithelial cells.  It is likely that there exists a significant level of 
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redundancy in this system as we were able to detect multiple EGFR ligands to be increased 
in the conditioned medium of ZZ cultures.  In our system, α1-antitrypsin did not directly 
inhibit ADAM17 as has been reported for neutrophils (4).  Interestingly, it has recently been 
speculated that endocytosed α1-antitrypsin may modulate ADAM17 in endothelial cells 
(5).  If intracellular α1-antitrypsin can indeed modulate these pathways, multiple potential 
mechanisms may explain this effect.  ADAM-dependent transactivation of the EGFR by 
activation of G-protein coupled receptors can also occur (reviewed in (27)).  For example, 
IL-8 can induce EGFR phosphorylation in epithelial cells via its receptors CXCR1 and CXCR2 
(28, 37), while binding of α1-antitrypsin to IL-8 has been reported to prevent activation of 
CXCR1 (4).  Although there are contradictory reports concerning the expression of CXCR1 
and CXCR2 on bronchial epithelial cells (38, 39), we found that IL-8 release is increased 
in ZZ primary bronchial epithelial cells, which potentially might provide an autocrine 
inflammatory signal in the absence of sufficient α1-antitrypsin. Alternatively, CCL20 (also 
known as MIP-3α) and its receptor CCR6 have been shown to activate ADAM17 causing 
transactivation of EGFR (40, 41). 
 Taken together, our experiments have demonstrated that airway epithelial cells 
have anti-inflammatory activity due to the local synthesis of M α1-antitrypsin from its 
endogenous promoter and that this effect is lacking in ZZ homozygous epithelial cells 
because of a lack of α1-antitrypsin secretion.  This raises the possibility that α1-antitrypsin 
augmentation may have unanticipated effects within the airway.  It also raises the potential 
that targeted anti-EGFR therapy might have anti-inflammatory effects within the lung.
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Materials and methods
Reagents and antibodies
 OSM (100 ng/ml) was purchased from R&D systems (R&D systems, Minneapolis, 
MN, USA), and TNFα and IL-1β (both 10 ng/ml) from Peprotech (Peprotech, Rocky Hill, NJ, 
USA).  Tunicamycin (1 µg/ml) was bought from Sigma (Sigma-Aldrich, St.Louis, MO, USA), 
U0126 (10 nM) from Promega (Promega, Madison, WI, USA), monoclonal (Ab-3) anti-EGFR 
antibody (2 µg/ml), GM6001 (25 µM) and TAPI-2 (25 µM) all from Calbiochem (Calbiochem, 
Darmstadt, Germany) and D1(A12) (200 nM) (33).  Purified plasma M α1-antitrypsin (1 mg/
ml) was derived as described previously (42). All antibodies for immunoblotting were 
from Cell Signaling (Cell Signaling Technology, Danvers, MA, USA), except secondary 
HRP-labeled antibodies (Sigma) and GRP94 and GRP78 was detected using an anti-KDEL 
monoclonal antibody (StressGen).
Cell cultures
 Primary bronchial epithelial cells were cultured submerged in a 1:1 mixture of 
Dulbecco’s modified Eagle’s medium (DMEM) and bronchial epithelial growth medium 
(BEGM; Clonectics, San Diego, CA, USA) with BEGM SingleQuot supplements and growth 
factors (Clonetics), 1.5 µg/ml bovine serum albumin (BSA; Sigma-Aldrich), 1 mM HEPES 
(Invitrogen, Life Technologies, Breda, the Netherlands) and 100 U/ml penicillin and 100 
µg/ml streptomycin (Sigma), shortened as full medium, at 37°C, 5% CO2 (43).  Starvation 
medium consist of full medium except BSA and the SingleQuot supplements EGF and 
BPE.
 We carried out siRNA-mediated knockdown of α1-antitrypsin using a SMARTpool 
of ONTARGETplus α1-antitrypsin siRNA (Dharmacon, Lafayette, CO, USA) or SERPIN1 siRNA 
(Dharmacon) as a mock control.  In general, 10 nM siRNA and 1 µl RNAiMAX (Invitrogen) 
was used according to manufacturer’s descriptions and α1-antitrypsin expression, 
measured with qPCR and ELISA, was knocked down >90% after 72 hours by this method 
(Figure S8).
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 Primary bronchial epithelial cells were differentiated as described previously (44). 
Briefly, cells were cultured submerged until confluence on semi-permeable Transwell 
membranes (Corning Costar, Cambridge, MA, USA) in B/D medium with addition of retinoic 
acid (end-concentration 15 ng/ml; Sigma), and subsequently cultured air-exposed for 14 
days to allow mucociliary differentiation. 
 A549 cells were obtained from American Type Culture Collection (ATCC) and 
stably transfected with the pTetON vector (Clontech) to obtain Tet-On A549 cells.  ELISA 
confirmed that production of endogenous α1-antitrypsin protein was below the level of 
detection in these cells (data not shown).  These were stably transfected with pTRE2-hyg 
plasmid encoding M or Z α1-antitrypsin as described previously (42).  Cells were maintained 
in DMEM with 10% (v/v) Tetracycline-free Fetal Bovine Serum, 100 U/ml penicillin, 100 µg/
ml streptomycin, 400 µg/ml geneticin and 400 µg/ml hygromycin B (selective antibiotics 
from Invitrogen) at 37°C, 5% CO2. Expression of α1-antitrypsin was usually induced using 2 
µg/ml doxycycline (Sigma) for 48 hours.  HeLa cells were obtained from ATCC and transient 
transfected with pcDNA3.1 encoding M or Z α1-antitrypsin (or empty vector) as shown 
previously (19).  
Patient groups
 PiZZ α1-antitrypsin deficient patients were recruited in the Leiden University 
Medical Center (LUMC; Leiden, the Netherlands).  ZZ primary bronchial epithelial cells 
were acquired by bronchial biopsy, with approval from the Medical Ethical Committee of 
the LUMC.  Briefly, bronchial biopsies were washed with PBS, divided in 2mm pieces and 
placed into a fibronectin/collagen-coated 24-well plate.  Twice daily, the explants were 
fed with 20 µl B/D medium until they became adherent (maximum of three days).  Then, 
primary bronchial epithelial cells were expanded submerged with 500 µl B/D medium, 
replaced triweekly.  When confluent, cells were frozen down in liquid nitrogen until further 
use.  MM primary bronchial epithelial cells were obtained from tumour-free resected lung 
tissue as described previously (43) and matched to ZZ primary bronchial epithelial cells 
according to sex, GOLD-stage (0-III) and smoking status (non-, ex-, or current smoker) 
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(Table S1).  In each case, care was taken to ensure that cells were sourced only from the 2nd-
3rd branches of the bronchial tree in order that results from each were directly comparable.
Measurement of total α1-antitrypsin, polymerised α1-antitrypsin and cytokine release
 Total and polymerised α1-antitrypsin were measured in whole cell lysate 
(intracellular) and supernatant (secreted) by ELISA as described previously (32).  Cytokine 
release of fully differentiated cells was measured using a 4-plex Meso Scale Discovery 
(MSD) kit (IL-6, IL-8, TNFα and IL-1β) and singleplex kits (MCP-1 and IP-10; Meso Scale 
Discovery, Rockville, MD, USA).  EGFR-ligands were measured using commercial available 
ELISA’s following manufacturer’s protocol (R&D systems).  IL-8 release in supernatant of 
submerged primary bronchial epithelial cultures was quantified using an IL-8 ELISA kit 
(Sanquin, Amsterdam, the Netherlands). 
Protein mobility assay
 Submerged cultured primary bronchial epithelial cells were grown overnight 
on coated 35mm glass bottom petri dishes (MatTek Corporation, Ashland, MA, USA) and 
transiently transfected with an ER-GFP plasmid (45). Live cells were imaged on an LSM510 
confocal microscope (DuoScan; Carl Zeiss Inc., Thornwood, NY, USA) at 37°C as defined 
in (22). Briefly, ER-GFP was visualised with a x63/1.4NA oil objective at 488nm laser 
and fluorescence recovery after photobleaching (FRAP) experiments were performed. 
Fluorescence recovery curves were obtained by transforming fluorescence intensities into 
a percentage scale in which the pre-bleach time point represents 100% of fluorescence 
intensity.
Luciferase activity assays
 Transfection with luciferase-reporter plasmids was typically performed in 6-well 
plates with 1 µg of either p(5x)ATF6-luc (Firefly) or pELAM1-luc (Firefly) and 50 ng of pRL-
TK (Renilla) as a transfection efficacy control (29).  Cells were transfected for 6 hours with 
2 µl Lipofectamine LTX (Invitrogen) in serum- and antibiotic free OptiMEM according to 
132
Chapter 5  •
manufacturer’s instructions and lysed the next day using the recommended protocol of 
the Dual-Luciferase Reporter Assay (Promega). 
Western blotting
 Cells were lysed in 50 µl buffer H (10 mM HEPES, pH 7.9, 50 mM NaCl, 500 mM 
sucrose, 0.1 mM EDTA and 0.5%, (v/v) Triton X-100, 1 mM PMSF, 1X Complete™ protease 
inhibitor cocktail (Roche Applied Science, Mannheim, Germany) supplemented with 
phosphatase inhibitors (10 mM tetrasodium pyrophosphate, 17.5 mM β-glycerophosphate, 
and 100 mM NaF;  (46, 47)).  Samples were run on a 10% SDS-PAGE gel and transferred 
onto a nitrocellulose membrane. After blocking with PBS/0.05% Tween-20 (v/v)/5% skim-
milk (w/v), the membrane was incubated with the primary antibody (1:1000) in TBS/0.05% 
Tween-20 (v/v)/5% BSA (w/v) overnight at 4°C. The HRP-labeled antibody was incubated 
for 1 hour in blocking buffer and developed with ECL (ThermoScientific).
Quantitative RT-PCR
 Total RNA was isolated and normalised mRNA levels were calculated using 
RPL13A and ATP5B as housekeeping genes (48).  Primers used are described in Table S2.  IQ 
SYBRGreen supermix (Bio-rad , Herculus, CA, USA) was used for amplification of the cDNA.
ADAM17 activity and binding assay
 ADAM17 activity assay was performed as descried earlier (49).  In brief, 1 nM 
purified recombinant ADAM17 was incubated with or without 0-30 µM purified plasma 
M α1-antitrypsin and assayed for ADAM17 activity using the fluorogenic substrate 
MOCAc-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 (R&D systems).  Purified plasma M α1-
antitrypsin (0.5 µg) was incubated for 1 hour at 37°C in a 1:1 molar ratio with ADAM17, ran 
on a Native Page Bis Tris (3 – 12% w/v; Invitrogen) gel and visualised by Silver stain.  Both 
ADAM17 and purified plasma M α1-antitrypsin were incubated in  50mM Tris-HCl (pH 7.4), 
100mM NaCl, 10 mM CaCl. 
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Statistical analysis
 Results from primary bronchial epithelial cells are expressed as single patients 
(each dot is the average of one patient in duplicate).  Results from Tet-On A549 are shown 
as mean ± SEM.  Data were analysed using two-way repeated-measures analysis of 
variance (ANOVA) or Student t-test as appropriate.  Differences with p-values < 0.05 were 
considered to be statistically significant.
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Figure S1. Tet-On A549 cells overexpressing Z α1-antitrypsin show enhanced NF-κB signalling upon 
an inflammatory stimulus.  
Cells were treated as in Figure 1C, only cells were induced with doxycycline (dox) instead of OSM (mean 
± SEM, n=3).
Figure S2. Z α1-antitrypsin does not alter ER protein mobility.  
Primary bronchial epithelial cells were transiently transfected with ER-GFP and fluorescence recovery was 
measured by fluorescence recovery after photo-bleaching (FRAP).  Recovery is displayed relative to pre-
bleach fluorescence intensity (mean ± SEM, n=9-10).
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Figure S3. Critical concentration for polymer formation within cells.
A. Dose-response doxycycline on a CHO stable cell line overexpressing Z α1-antitrypsin under the control 
of a Tet-On responsive promotor.  Intracellular total and polymeric Z α1-antitrypsin levels are measured by 
ELISA.  B. Z α1-antitrypsin-expressing A549 cells induced with doxycycline and stimulated in the presence 
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Figure S4. Increased NF-κB response in ZZ primary bronchial epithelial cells is caused by increased 
phosphorylated ERK. 
A. Representative western blots of the activation of the NF-κB proteins IKKβ and NF-κB p65 and 
degradation of total IκBα of whole cell lysates from undifferentiated primary bronchial epithelial cells 
knocked-down for α1-antitrypsin by siRNA (see Figure 3A).  Densitometry was done on four independent 
experiments in duplicate (mean, n=3).  B. Densitometry of the Western blots shown in Figure 3A (mean, 
n=3-4).
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Figure S5. Overexpression of Z α1-antitrypsin downregulates ERK1/2 phosphorylation.  
A. Alpha1-antitrypsin (AAT) production after transfection of HeLa cells with pcDNA3.1 containing M or Z 
α1-antitrypsin (or empty vector as control).  B. Representative western blot of phospho ERK1/2 in HeLa 
cells after transfection with M or Z α1-antitrypsin.  High amounts of Z α1-antitrypsin are able to inhibit 
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Figure S6. Increased ERK1/2 phosphorylation in ZZ cells does not enhance proliferation. 
A. Cells were seeded at 3.104 cells/well and cultured for 48 hours as indicated.  Starvation medium is full 
medium except BSA and the SingleQuot supplements EGF and BPE to minimise the effects of exogenous 
growth factors.  FR180204, a specific ERK inhibitor did not change proliferation rates.  U0126, a specific 
MEK inhibitor, was toxic to both MM and ZZ cells.  B. ZZ cells were seeded at 3.104 cells/well and cultured 
for 48 hours in the presence of 1 mg/ml M α1-antitrypsin.
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Figure S8. Confirmation of α1-antitrypsin knock-down by siRNA in primary bronchial epithelial 
cells.
 A. SERPINA1 mRNA knock-down was >90% efficient (left panel) and after α1-antitrypsin up-regulation 
with OSM mix >98% efficient (right panel).  Neuroserpin (NS) siRNA served as a control (mean, n=3).  B. α1-
antitrypsin was undetectable in cell supernatant after knock-down of α1-antitrypsin, measured by ELISA 
(mean, n=3). 
Figure S7. ZZ cells do not display increased phosphorylation of ADAM17.  
ZZ primary bronchial epithelial cells were treated for 24 hours with 1 mg/ml purified plasma M α1-
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Table S1. Patient characteristics.
PiMM controls PiZZ patients
age (mean, range) 61 (51-83) 52 (43-57)
sex (M/F) 3/3 3/3
GOLD-stage (0/I/II/III) 2/2/1/1 3/1/1/1
smoking status (current/never/ex) 2/0/4 0/1/5
Table S2. qPCR primers.
Name Forward primer / Reverse primer Melting temp. (°C) Ref.
AREG 5’ GGTGGTGCTGTCGCTCTTG 3’
5’ AGGTGTCATTGAGGTCCAATCC 3’
62 -
CHOP 5’ GCACCTCCCAGAGCCCTCACTCTCC 3’
5’ GTCTACTCCAAGCCTTCCCCCTGCG 3’
62 (48)
EGF 5’ TGCAGAGGGATACGCCCTAA 3’
5’ CAAGAGTACAGCCATGATTCCAAA 3’
62 -
GADD34 5’ ATGTATGGTGAGCGAGAGGC 3’
5’ GCAGTGTCCTTATCAGAAGGC 3’
62 (50)
HB-EGF 5’ TGGACCTTTTGAGAGTCACTT TATCC 3’
5’ CGTGCTCCTCCTTGTTTGGT 3’
62 -
IL8 5’ CTGGACCCCAAGGAAAAC 3’
5’ TGGCAACCCTACAACAGAC 3’
60 -
SERPINA1 5’ AAGGCAAATGGGAGAGACCC 3’
5’ AAGAAGATGGCGGTGGCAT 3
60 (51)
TGFα 5’ AGGTCCGAAAACACTGTGAGT 3’
5’ AGCAAGCGGTTCTTCCCTTC 3’
62 -
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Abstract
 Alpha1-antitrypsin acts as an important neutrophil elastase inhibitor in the 
lung.  Although the hepatocyte is considered as the primary source of α1-antitrypsin, 
local production by monocytes, macrophages and epithelial cells may contribute 
to the formation of an anti-elastase screen.  Since monocytes can differentiate 
into a heterogeneous population of macrophages with subpopulations ranging 
from pro-inflammatory properties (mφ-1) to anti-inflammatory properties (mφ-2) 
and into dendritic cells (DC), we studied whether lipopolysaccharide (LPS), tumor 
necrosis factor alpha (TNFα) and oncostatin M enhance α1-antitrypsin production 
differentially in cultured mφ-1, mφ-2 and DC.  Monocytes from healthy blood donors 
were cultured for 7 days in the presence of GM-CSF, M-CSF, or GM-CSF and IL-4 to 
obtain mφ-1, mφ-2 and immature(i)DC, respectively.  Next, cells were stimulated 
with LPS, TNFα or oncostatin M and synthesis of α1-antitrypsin was assessed by 
quantitative RT-PCR, immunocytochemistry and ELISA.  Spontaneous release of 
α1-antitrypsin was higher in mφ-1 than in mφ-2 and iDC and only LPS significantly 
increased α1-antitrypsin production in mφ-1, mφ-2 and DC, whereas TNFα and 
oncostatin M did not affect α1-antitrypsin secretion.  The secretion levels of the 
related protease inhibitors α1-antichymotrypsin and secretory leucocyte proteinase 
inhibitor (SLPI) were below the limits of detection by ELISA.  In contrast to the protein 
data, analysis by quantitative RT-PCR showed that 24 hours LPS exposure caused a 
maximal 2.1-fold SERPINA1 mRNA increase in mφ-1, a 21-fold increase in mφ-2 and 
11-fold increase in DC.  These data suggest that cellular differentiation is a regulator 
of local α1-antitrypsin production.
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Introduction
 Alpha1-antitrypsin, a member of the serine protease inhibitor (SERPIN) superfamily, 
is not only a major inhibitor of the neutrophil-derived serine proteases neutrophil 
elastase, cathepsin G and proteinase 3, but also complexes with trypsin, chymotrypsin and 
thrombin.  In inflammatory lung disease, one of the most important inhibitory functions 
of α1-antitrypsin is the irreversible binding and inactivation of neutrophil elastase, thereby 
protecting lung tissue against the destructive effects of neutrophil elastase released by 
degranulating neutrophils during inflammation (1).  Alpha1-antitrypsin deficiency is the 
major identified genetic risk factor for chronic obstructive pulmonary disease (COPD) and 
is characterised by early-onset pulmonary emphysema, which is partially explained by 
a protease-antiprotease imbalance (reviewed by Stockley (2)).  In addition, many other 
airway diseases, including bronchiectasis, cystic fibrosis and certain phenotypes of asthma, 
are associated with neutrophilic inflammation and the number of neutrophils present in 
the lung is correlated to the disease severity (3-5).  Therefore, neutrophil elastase and α1-
antitrypsin are also implicated in the pathogenesis of these diseases. 
 Alpha1-antitrypsin is primarily synthesised in hepatocytes and its secretion is 
enhanced during an inflammatory response.  This increase is mainly mediated by pro-
inflammatory cytokines like interleukin (IL)-6, IL-1β and tumor necrosis factor alpha (TNFα) 
(6).  Members of the IL-6 family, including oncostatin M, have also been shown to induce 
α1-antitrypsin secretion (7). 
 While hepatocytes are considered as the primary source of α1-antitrypsin, human 
lung epithelial cells, monocytes and alveolar macrophages have also been shown to 
produce α1-antitrypsin (7-10).  Although these cells produce substantially lower amounts 
of α1-antitrypsin compared to hepatocytes, its production is also augmented by cytokines 
such as IL-6, oncostatin M, TNFα and IL-1β, and thereby these cells may contribute to 
the formation of an anti-elastase shield in the lung during inflammation.  In addition, 
monocytes showed an increase in α1-antitrypsin secretion after lipopolysaccharide (LPS) 
exposure, indicating the importance of the regulation of the anti-protease screen as a 
defense during infection, particularly in the microenvironment of lung inflammatory cells 
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(9, 11).
 Macrophages constitute a heterogeneous population with subpopulations 
displaying pro-inflammatory properties and those with repair-inducing and anti-
inflammatory properties (reviewed by Gordon and Taylor (12)).  Previous studies have 
already shown the heterogeneity of these different subsets in vivo (reviewed by Mosser 
and Edwards (13)).  In vitro studies has shown that macrophages can be polarized into 
type I (mφ-1) or type II (mφ-2) macrophages in the presence of granulocyte-macrophage 
colony-stimulating factor (GM-CSF) or macrophage colony-stimulating factor (M-CSF), 
respectively (14).  Pro-inflammatory mφ-1, or classically activated macrophages, are 
characterised by production of pro-inflammatory cytokines like IL-6, IL-12p40 and IL-
23p40 and promotion of T-helper 1 response (14).  In contrast, anti-inflammatory mφ-2, 
or so-called alternatively activated macrophages, are characterised by production of IL-10 
in the absence of pro-inflammatory cytokines, promotion of T regulatory responses and 
ingestion of early apoptotic cells (15, 16).  Alveolar macrophages have been shown to be 
immunosuppressive with poor antigen-presenting capacities (17, 18), and thus display 
characteristics of mφ-2.  However, recent studies have suggested a role for (chronic) 
inflammation causing phenotype switching of alveolar macrophages and monocyte-
derived macrophages in vivo and in vitro (19-21). 
 Monocytes and macrophages play a key role in the early defense in the lung 
and, more importantly, these cell types are involved in the pathogenesis of COPD (20). 
Furthermore, dendritic cells (DC), the third in vitro monocyte-derived cell type, may 
also contribute to the formation of the anti-elastase screen in the lung.  However, the 
regulation of α1-antitrypsin production by mφ-1, mφ-2 and DC has not yet been studied. 
Therefore, we hypothesised that LPS and pro-inflammatory cytokines like TNFα and 
oncostatin M can induce α1-antitrypsin production by mφ-1, mφ-2 and DC.  To this end, 
we used monocyte-derived mφ-1 and mφ-2 macrophages and dendritic cells, as well as 
alveolar macrophages to characterise the production of α1-antitrypsin.
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Results
Differentiation of mφ-1 and mφ-2
 Differentiation of human blood monocytes into pro- (mφ-1) and anti-
inflammatory (mφ-2) macrophages was assessed by morphological characteristics, by 
measuring  IL-12p40/IL-23p40 and IL-10 secretion and by evaluating cell surface markers. 
After 6 days, morphological distinct subsets were observed (Figure 1A).  After stimulation 
with LPS (100 ng/ml) for 24 hours, mφ-1 produced significantly more IL-12p40 than mφ-
2, whereas mφ-2 produced significantly more IL-10 than mφ-1 (Figure 1B).  In line with 
previous studies, mφ-2 expressed CD163 and high levels of CD14, whereas mφ-1 were 
CD14low and showed no detectable expression of CD163 (Figure 1C) (22, 23).  Both cell 
types were positive for the intracellular cell marker CD68, confirming that these cells were 
classical macrophages.
Mφ-1 produces more α1-antitrypsin than mφ-2
 To evaluate whether the production of α1-antitrypsin differed between mφ-1 and 
mφ-2, monocyte-derived macrophages were stimulated with LPS, TNFα or oncostatin M, 
known to be inducers of α1-antitrypsin expression in lung epithelial cells and monocytes 
(7-9).  Spontaneous release of α1-antitrypsin after 24 hours was higher in mφ-1 than mφ-2 
(204 ng/106 cells vs. 42 ng/106 cells; p < 0.001, Figure 2A).  LPS significantly enhanced α1-
antitrypsin secretion from both mφ-1 and mφ-2 and levels were significantly higher in 
mφ-1 than mφ-2 (323 ng/106 cells vs. 93 ng/106 cells; p = 0.003).  TNFα and oncostatin M 
did not affect α1-antitrypsin secretion (Figure 2A), whereas measurement of enhanced IL-8 
in the cell supernatant by ELISA confirmed the activation of the macrophages by these 
cytokines (data not shown).  Interestingly, after 24 hours LPS exposure, the normalised 
expression of SERPINA1 mRNA, the gene encoding α1-antitrypsin, was significantly lower 
in mφ-1 than mφ-2 (Figure 2B).  In line with the protein data, neither TNFα nor oncostatin 
M showed an effect at mRNA level.   
 To explain the differences in SERPINA1 mRNA levels and measured protein levels 
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•  α1-antitrypsin production in macrophage subsets
in the cell supernatant, cell-associated α1-antitrypsin of mφ-1 and mφ-2 was examined by 
immunocytochemistry.  Analysis showed that in mφ-1 compared to mφ-2, the staining 
intensity of cell-associated α1-antitrypsin was markedly higher, and that mφ-1 cells 
showed a more membrane-associated pattern (Figure 2C).  These findings suggest that the 
increased SERPINA1 mRNA after LPS stimulation observed in mφ-1, is directly translated 
and secreted as α1-antitrypsin protein.  However, the enhanced SERPINA1 mRNA in mφ-2 
after LPS exposure could not be detected to the same extent at protein level.  Levels of 
secreted α1-antichymotrypsin, another member of the serpin family, and SLPI were below 
the limits of detection of the ELISA.
Alpha1-antitrypsin is secreted in a time-dependent way
 To verify the apparent discrepancy between the effect of LPS exposure on 
SERPINA1 mRNA and protein levels (both cell-associated and secreted), we stimulated 
both mφ-1 and mφ-2 with 100 ng/ml LPS for 4, 24 and 48 hours.  In mφ-2, an LPS-induced 
increase in SERPINA1 mRNA was already detected by quantitative RT-PCR after 4 hours, 
Figure 1.  Differentiation of human monocytes into pro- (mφ-1) and anti-inflammatory (mφ-2) 
macrophages. 
Human monocytes were cultured for 6 days in the presence of GM-CSF or M-CSF to obtain mφ-1 and 
mφ-2, respectively.  A. After 6 days, mφ-1 (left) typically showed a ‘fried-egg’ morphology; mφ-2 (right) 
appeared as ‘spindle-like’ cells as visualised by phase contrast microscopy.  Images are representative of 
at least five independent donors.  B. After stimulation with LPS for 24 hours, IL-12p40/IL-23p40 and IL-
10 concentrations in cell supernatant were measured by ELISA (n=10; different donors).  C. Cell surface 
expression (closed histograms) of CD14, CD163 and CD68 on mφ-1 and mφ-2 was determined by flow 
cytometry.  Open histograms represent matched isotype controls.  Data are representative of at least 
three independent experiments using separate donors.  These results confirm appropriate differentiation 
towards mφ-1 and mφ-2 cells.
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•  α1-antitrypsin production in macrophage subsets
whereas a significant difference in SERPINA1 mRNA induction upon LPS exposure in mφ-1 
was only seen after 24 hours (Figure 3B).  The highest fold increase in SERPINA1 mRNA 
was seen after 48 hours in both mφ-1 and mφ-2 (4-fold vs. 62-fold increase compared to 
control-treated mφ-1 or mφ-2, respectively).  Although mφ-2 showed the highest fold 
increase at mRNA level and although the relative increase in secreted α1-antitrypsin after 
LPS exposure for 48 hour was higher in mφ-2 compared to mφ-1 (Figure 3A), the absolute 
levels of secreted α1-antitrypsin were still higher in mφ-1 than mφ-2 (Figure 3A), indicating 
that the different kinetics could only explain a part of the inconsistency in mRNA and 
protein levels.
 To further explore the discrepancy, cells were incubated with LPS in the presence 
or absence of MG132, a proteasome inhibitor which reduces the ubiquitin-proteasomal 
degradation.  After 24 h, MG132 did not influence the SERPINA1 mRNA nor the α1-antitrypsin 
secretion in both mφ-1 and mφ-2 (Figure 4A and 4B), indicating that differences in mRNA 
and protein could not be explained by an increased degradation by the proteasome.  To 
ensure that the increase of α1-antitrypsin secretion was dependent on de novo mRNA 
synthesis and/or de novo protein synthesis, cells were treated with actinomycin D or 
Figure 2.  Effects of LPS, tumor necrosis factor alpha (TNFα) and oncostatin M (OSM) on α1-
antitrypsin synthesis and secretion of mφ-1 and mφ-2. 
Mφ-1 (open bars) and mφ-2 (closed bars) were stimulated with LPS (100 ng/ml), TNFα (10 ng/ml) or 
oncostatin M (100 ng/ml) for 24 hours.  Cell supernatants were collected, total RNA was isolated and 
cytospin preparations were made.  A. Alpha1-antitrypsin (AAT) protein levels in cell supernatant measured 
by ELISA (*** p<0.001 versus control; n=5).  B. SERPINA1, ATP5B and ACTB mRNA concentrations were 
determined by quantitative RT-PCR (qPCR), with SERPINA1 normalised to ATP5B and ACTB as assessed 
using GeNorm software (*** p<0.001 versus control; n=6).  C. 1.105 cells of each sample were used for 
cytospin preparation.  Slides were stained with monoclonal antibody α1-antitrypsin to visualise cell-
associated/intracellular α1-antitrypsin.  Representative photomicrographs are shown.
<<<
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cycloheximide, respectively.   Actinomycin D fully inhibited the increase in both SERPINA1 
mRNA and α1-antitrypsin protein in LPS treated cells (data not shown).  Similarly, blocking 
the de novo protein synthesis by cycloheximide showed reduced secreted amounts of 
α1-antitrypsin by both mφ-1 and mφ-2, demonstrating that de novo mRNA synthesis and 
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Figure 3.  Kinetics of α1-antitrypsin expression and secretion. 
Mφ-1 (open bars) and mφ-2 (closed bars) were stimulated with 100 ng/ml LPS and both cell supernatant 
and RNA were harvested at different time points as indicated.  A. Alpha1-antitrypsin secretion in cell 
supernatants were measured by ELISA (* p<0.05, *** p<0.001 versus control at 24 hours; n=4) and B. 
SERPINA1 mRNA production was determined using quantitative RT-PCR.  All samples were normalised to 
ATP5B and ACTB (*** p<0.001 versus control at 24 hours; $ p<0.05 versus LPS-stimulated mφ-2 at 4 hours; 
n=4).
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DC produce α1-antitrypsin as an intermediate phenotype 
 To investigate whether all monocyte-derived cell-lineages are able to produce 
α1-antitrypsin, immature monocyte-derived dendritic cells (iDC) were stimulated with 
LPS for 24 hours.  Immature DC released 65 ng/106 cells α1-antitrypsin compared to 204 
ng/106 cells and 42 ng/106 cells for mφ-1 and mφ-2, respectively (Figure 5A).  Amounts 
of α1-antitrypsin secreted by mature LPS-exposed DC (mDC) were elevated (190 ng/10
6 
cells) compared to control treated iDC.  At mRNA level, mDC showed a 12-fold increase 
of SERPINA1 after 24 hours compared to control treated iDC (Figure 5B).  These results 
suggest an intermediate phenotype of DC concerning the production of α1-antitrypsin. 
Levels of ACT and SLPI were below the limits of detection.
 
Alpha1-antitrypsin production by alveolar macrophages
 Alveolar macrophages are known to be very heterogeneous.  To determine 
which in vitro subset of monocyte-derived macrophages best represents the production 
Figure 4.  Effects of the proteasome inhibitor MG132 on α1-antitrypsin (AAT) production of mφ-1 
and mφ-2.  
Mφ-1 (open bars) and mφ-2 (closed bars) were stimulated for 24 hours with 100 ng/ml LPS and/or MG132 
as indicated.  A. Alpha1-antitrypsin secretion in cell supernatants were measured by ELISA (*** p<0.001 
versus control, n.s. not significant; n=6) and B. SERPINA1 mRNA production was determined using qPCR 
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of α1-antitrypsin by alveolar macrophages, we stimulated alveolar macrophages for 24 
hours in the presence of LPS. Characterisation of these cells by measuring IL-12p40/IL-
23p40 and IL-10 secretion and evaluating cell surface markers showed that these alveolar 
macrophages produce high amounts of IL-10 in the complete absence of IL-12p40/IL-
23p40 (Figure 6A) and were CD163high using immunocytochemistry (data not shown), 
both typical features of mφ-2.  Alveolar macrophages produced 143 ng/106 cells of α1-
antitrypsin, which was not further increased by LPS stimulation (162 ng/106 cells).  These 
α1-antitrypsin levels are comparable to those produced by mφ-2 after LPS stimulation 
(Figure 6B) and were confirmed by quantifying the SERPINA1 mRNA levels (Figure 6B). 
Interestingly, cell-associated α1-antitrypsin was comparable with mφ-1 (Figure 6C), 
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Figure 5.  Effects of LPS on α1-antitrypsin production of dendritic cells (DC) compared to mφ-1 and 
mφ-2.  
Human monocytes were cultured for 6 days in the presence of GM-CSF, M-CSF or GM-CSF + IL-4 to allow 
appropriate differentiation of mφ-1 (open bars), mφ-2 (closed bars) and DC (diamond bars), respectively. 
After 6 days, cells were stimulated with 100 ng/ml LPS and cell supernatant and RNA were isolated.  A. 
Alpha1-antitrypsin (AAT) secretion in cell supernatants were measured by ELISA (*** p<0.001 versus 
control; n=4) and B. SERPINA1 mRNA production was determined using quantitative RT-PCR.  All samples 
were normalised to ATP5B and ACTB (* p<0.05, *** p<0.001 versus control; n=4).
159
•  α1-antitrypsin production in macrophage subsets
Discussion 
 In the present study, we demonstrated that differentiated monocyte-derived 
macrophages, monocyte-derived DC and alveolar macrophages produce α1-antitrypsin, 
although to different extent.  Only LPS could significantly induce SERPINA1 mRNA 
synthesis and α1-antitrypsin secretion in the monocyte-derived cell types, suggesting 
that in addition to its pro-inflammatory activities, LPS also contributes to the prevention 
of lung tissue destruction by proteases during inflammation via the up-regulation of α1-
antitrypsin.
 Many lung diseases, including α1-antitrypsin deficiency, cystic fibrosis and 
neutrophilic asthma, are characterised by a neutrophil-dominated inflammation, where 
a protease-antiprotease imbalance can result in lung injury.  It is interesting that both 
mφ-1 and mφ-2 did not increase α1-antitrypsin production following TNFα or oncostatin 
M treatment, whereas IL-8 secretion was increased by these cytokines.  Previous studies 
with human bronchial epithelial cells already showed that both TNFα and oncostatin M 
can increase α1-antitrypsin production by these cells (8, 10, 24), and that both LPS and 
TNFα could up-regulate α1-antitrypsin in monocytes (9).  In contrast, Perlmutter et al. (25) 
showed earlier the inability of monocytes to release α1-antitrypsin following exposure to 
TNFα.  Together with our results, these studies indicate the complexity of the regulation of 
the antiprotease shield by macrophages in the microenvironment of the lung.  In addition, 
to the best of our knowledge, we are the first to describe the capacity of DC to synthesise 
and secrete α1-antitrypsin.  The role of DC-produced α1-antitrypsin in the regulation of the 
protease-antiprotease imbalance should be further investigated. 
 Although α1-antitrypsin is the major antiprotease present in the lung, α1-
antichymotrypsin and SLPI can contribute to the protection of the alveolar tissue against 
neutrophil elastase, cathepsin G and proteinase-3.  In contrast to our expectation, we were 
unable to detect α1-antichymotrypsin or SLPI produced by mφ-1, mφ-2 or DC with ELISA, 
although it has been reported that alveolar macrophages produce α1-antichymotrypsin 
and SLPI in response to LPS (26, 27).  Moreover, a recent study showed that bone marrow 
derived DC from mice could produce SLPI in response to LPS (28).  This discrepancy may 
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•  α1-antitrypsin production in macrophage subsets
be explained by the different roles of DC in mice and human. 
 For decades, human alveolar macrophages have been known to express 
SERPINA1 mRNA (29) and to increase the SERPINA1 mRNA levels when exposed to LPS (30). 
However, to our knowledge this is the first time that α1-antitrypsin production is explored 
in alveolar macrophages, mφ-1 and mφ-2.  In contrast to our findings in mφ-1 and mφ-2, 
we did not find an increase in α1-antitrypsin induction by LPS in alveolar macrophages. 
This finding could be explained by the fact that we used alveolar macrophages obtained 
from subjects during the diagnostic work-up of sarcoidosis.  Wikén et al. (31) showed 
that there is no evidence of altered alveolar macrophages polarisation in patients with 
sarcoidosis, although others reported increased IP-10 and CCL-20 production by alveolar 
macrophages from sarcoidosis patients (32, 33).  The phenotype of alveolar macrophages 
appears to be influenced by the unique environment in the lung (34), and the plasticity of 
alveolar macrophages may have affected their ability to produce α1-antitrypsin.  At present, 
it is unclear whether the inability of LPS to increase α1-antitrypsin secretion in alveolar 
macrophages and the fact that these cells produce high amounts of both α1-antitrypsin 
Figure 6.  Effects of LPS on α1-antitrypsin production of alveolar macrophages (AM) compared to 
mφ-1 and mφ-2. 
Alveolar macrophages were obtained from 4 patients susceptible of sarcoidosis by bronchoalveolar 
lavage and cultured for 24 hours in the presence of LPS as indicated.  Mφ-1 and mφ-2 were obtained for 
blood monocytes of healthy blood donors.  A. Alpha1-antitrypsin (AAT) protein levels in cell supernatant 
of mφ-1 (open bars), mφ-2 (closed bars) and alveolar macrophages (checker board bars) were measured 
by ELISA (*** p<0.001 versus control; n=4).  B. SERPINA1, ATP5B and ACTB mRNA concentrations were 
determined by quantitative RT-PCR, with SERPINA1 normalised to ATP5B and ACTB as assessed using 
GeNorm software (*** p<0.001 versus control; n=4).  C. 1.105 cells of each sample were used for cytospin 
preparation.  Slides were stained with a monoclonal mouse antibody against α1-antitrypsin to visualise 
cell-associated/intracellular α1-antitrypsin.  Images are representative for at least two different donors. 
Photomicrographs of mφ-1 and mφ-2 are identical to those shown in Figure 2C, and shown for comparison.
<<<
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and IL-10 (which is in contrast to our findings in monocytes-derived macrophages), is 
related to differences between alveolar macrophages and in vitro generated monocytes-
derived macrophages or to a disease specific phenomenon.
 Functionally, mφ-1 and mφ-2 are distinct subsets concerning the cytokine 
production and T cell response, and evidently regarding the α1-antitrypsin production: 
mφ-1 release more α1-antitrypsin spontaneously and after stimulation with LPS than mφ-
2, whereas SERPINA1 mRNA levels are significantly higher in mφ-2 after LPS exposure. 
Recently, mφ-1 have been shown to degrade more rapidly IκBα and consequently more 
rapidly activate NF-κB pathway than mφ-2 following LPS treatment (21), providing a 
possible explanation for the observed differences in kinetics.  However, these differences 
could only partially explain the observed differences in α1-antitrypsin secretion. 
Experiments inhibiting the proteasome did not provide any insights regarding the 
discrepancies, excluding the possibility of enhanced intracellular degradation of α1-
antitrypsin. Blocking the de novo mRNA synthesis and de novo protein synthesis did not 
reveal an underlying mechanism concerning the transcriptional regulation and stability of 
SERPINA1 mRNA.  Therefore, we suggest a translational block for α1-antitrypsin in mφ-2 as 
a possible mechanism. 
 Several of our findings showed that mφ-2 in vitro resemble alveolar macrophages, 
which is supported by the data of other studies (17, 18).  However, alveolar macrophages 
constitute a heterogeneous population and have been shown to be able to switch their 
phenotype during (chronic) inflammation and smoking (19, 20, 35).  Our data indicate 
that α1-antitrypsin production of all monocyte-derived cell lineages may contribute to the 
restriction of neutrophil-mediated tissue injury. 
 In conclusion, this study provides evidence that both mφ-1 and mφ-2 are able to 
produce α1-antitrypsin, though in different amounts, which is partially explained by the 
high spontaneous release by the mφ-1.  Moreover, also the third monocyte-derived cell 
lineage, namely DC, is capable to release α1-antitrypsin and therefore may contribute to 
the anti-elastase screen in the lung. 
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Materials and methods
Isolation and culture of monocyte-derived cells
 Monocytes were isolated from buffy coats of healthy blood donors (Sanquin 
Blood Bank, Leiden, The Netherlands) using magnetic-labeled anti-CD14 beads (Myltenyi 
Biotec, Auburn, CA, USA) per manufacturer’s instructions.  Next, cells were cultured for 
6 days in medium (RPMI 1640, Invitrogen, Breda Life Technologies, The Netherlands) 
containing 10% fetal calf serum (FCS, Invitrogen), 2 mM L-glutamine, 100 U/ml penicillin 
and 100 µg/ml streptomycin (all Bio Whittaker, Walkersville, MD, USA) at 37°C in 5% CO2 
atmosphere in the presence of GM-CSF (5 ng/ml; Invitrogen) or M-CSF (50 ng/ml; R&D 
systems, Minneapolis, MN, USA) to obtain mφ-1 and mφ-2 macrophages, respectively (22). 
At day 6, cells were stimulated with LPS (100 ng/ml; LPS from Pseudomonas aeruginosa, 
Sigma-Aldrich, St. Louis, MO, USA), human TNFα (10 ng/ml; Peprotech, Rocky Hill, NJ, USA), 
oncostatin M (100 ng/ml; R&D Systems) and MG132 (10 nM; Sigma) for 4, 24 or 48 hours as 
indicated, at 37°C in 5% CO2.  Actinomycin D (1 µg/ml) and cycloheximide (10 µg/ml) were 
both purchased from Sigma.
 Immature DC were generated by culturing CD14-isolated monocytes for 6 days 
in the presence of 5 ng/ml GM-CSF and 10 ng/ml IL-4 (14).  Appropriate differentiation 
was ensured by determining the cell surface markers CD1a and CD83 and measuring the 
amounts of IL-12p40/IL-23p40 and IL-10 in the supernatant after LPS stimulation for 24 
hours. 
Isolation and culture of alveolar macrophages
 Alveolar macrophages were obtained from left-over material of a bronchoalveolar 
lavage (BAL) that was obtained as part of the diagnostic procedure for the diagnosis 
of sarcoidosis, and the patients were not on current treatment.  Culture of alveolar 
macrophages was performed as described previously (36).  Briefly, the collected BAL fluid 
was centrifuged, washed twice in PBS and finally cells were resuspended in RPMI culture 
medium with supplements as described above.  Cells were allowed to adhere by incubation 
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for 1 hour at 37°C in 5% CO2 atmosphere.  The non-adherent cells were removed by three 
washes with medium and the remaining cells were stimulated as indicated.  The adherent 
population of cells was > 95% pure macrophages, as assessed using CD68 flow cytometry.
Flow cytometry
 Cell surface markers were assessed by standard flow cytometry using a FACSCalibur 
cytometer (Becton and Dickinson, La Jolla, CA, USA) and CellQuest Pro software.  APC-
labeled anti-human CD14 and PE-labeled anti-human CD163 were purchased from BD 
Biosciences/Pharmingen (Temse, Belgium).  Anti-human CD68 (FITC-labeled; eBioscience, 
Vienna, Austria) was used for intracellular staining and appropriate IgG antibodies were 
used as isotype-control.  Cells were incubated with the antibodies for 30 minutes on ice 
in PBS containing 0.5% BSA (w/v) and 0.2% sodium-azide (w/v) (both from Sigma).  After 
fixation, intracellular staining was performed in PBS containing 1% saponine (Sigma) and 
5% FCS.
Immunocytochemistry
 Expression of α1-antitrypsin by mφ-1, mφ-2 and alveolar macrophages in 
cytospin preparations was demonstrated by immunocytochemistry.  Cells in cytospin 
preparations were fixed with 4% (w/v) formaldehyde for 30 minutes at room temperature. 
Next, cells were incubated with PBS/0.3% Triton X-100 for 30 minutes for permeabilisation 
and stained with mouse monoclonal IgG1 anti-α1-antitrypsin (1:500, Abcam, Cambridge, 
UK) or control mouse IgG1 as a negative control (DAKO, Glostrup, Denmark) at room 
temperature for 1 hour.  As a secondary antibody, the horseradish peroxidase conjugated 
anti-mouse Envision system (DAKO) was used, with NovaRED (Vector, Burlingame,CA) as 
the chromagen.  The sections were counterstained with Mayer’s haematoxylin (Klinipath, 
Duiven, The Netherlands).  
165
•  α1-antitrypsin production in macrophage subsets
Enzyme-linked immunosorbent assay (ELISA)
 Macrophage differentiation was verified by assessing the secretion of IL-12p40/
IL-23p40 (R&D systems; sensitivity: 62.5 pg/ml) and IL-10 (Sanquin, Amsterdam, The 
Netherlands; sensitivity: 4.096 pg/ml) by sandwich ELISA according to manufacturer’s 
description.  Specific ELISA’s for α1-antitrypsin and α1-antichymotrypsin were purchased 
from Kordia (Leiden, The Netherlands; sensitivity: 0.342 ng/ml) and Immunology 
Consultants Laboratory, Inc. (ICL, Newberg, OR, USA; sensitivity: 3.125 ng/ml), respectively. 
Levels of SLPI in the cell supernatant were quantified as described previously (37).  
Quantitative reverse-transcriptase polymerase chain reaction (RT-PCR)
 Total RNA was isolated using Qiagen RNeasy mini kit (Qiagen/Westburg, 
Leusden, The Netherlands) and cDNA was synthesised in equal amounts per experiment. 
Quantitative RT-PCR was performed using the following primer pair: SERPINA1 (gene 
encoding α1-antitrypsin) sense-primer 5’ AAGGCAAATGGGAGAGACCC 3’ and anti-sense 
5’ AAGAAGATGGCGGTGGCAT 3’.  Quantitative RT-PCR was performed on the iCycler PCR 
machine and MyiQ real-time PCR detection system using iQ SYBR Green Supermix (all from 
Bio-Rad, Hercules, USA) for 40 cycles at 60°C.  The levels of the reference genes ACTB and 
ATP5B were used for normalisation, and their stability was determined by using GeNorm 
software (PrimerDesign Ltd., Southampton, UK).
Statistical analysis
 Results were expressed as mean ± S.E.M. Mixed model analysis was performed 
to explore the overall effect.  If the mixed model analysis was significant, we performed 
the paired t-test or one-way ANOVA as indicated using SPSS Statistics 17.0.  Differences at 
p-values < 0.05 were considered as significant.
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Abstract
 Alpha1-antitrypsin deficiency is the most widely recognised genetic 
disorder causing COPD.  Mutant Z α1-antitrypsin expression has previous been 
linked to intracellular accumulation and polymerisation of this proteinase inhibitor. 
Subsequently, this has been described to underlie an exaggerated endoplasmic 
reticulum (ER) stress response and enhanced NF-κB signalling.  However, whether 
monocyte-derived macrophages display the same features remains unknown. 
Monocytes from homozygous PiZZ α1-antitrypsin deficiency patients and PiMM 
controls were cultured for 6 days in the presence of GM-CSF or M-CSF to obtain 
pro- and anti-inflammatory macrophages (mφ-1 and mφ-2, respectively).  We first 
show that in contrast to monocytes, pre-stressed mφ-1 and mφ-2 from healthy 
blood donors display an enhanced ER stress response upon a LPS trigger (spliced 
XBP1, CHOP, GADD34 and GRP78 mRNA).  However, this ER stress response did not 
differ between monocyte-derived macrophages and monocytes from ZZ patients 
compared to MM controls.  Furthermore, these ZZ cells also do not secrete higher 
cytokine levels, and α1-antitrypsin polymers were not detectable by ELISA.  These 
data suggest that monocyte-derived macrophages are not the local source of Z 
α1-antitrypsin polymers found in the lung and that the ER stress response and pro-
inflammatory cytokine release is not altered.
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Introduction
 Alpha1-antitrypsin is an important serine proteinase inhibitor (serpin) that 
protects lung tissue from the destructive effects of serine proteases such as neutrophil 
elastase, proteinase 3 and cathepsin G that are released by degranulating neutrophils. 
Moreover, α1-antitrypsin is thought to display anti-inflammatory activity including 
cytokine inhibition (1-3), inhibition of ERK1/2 (4) and regulation of CD14 expression (5). 
Although α1-antitrypsin is primarily synthesised in the liver, we and others have shown 
that it can also be produced locally by lung epithelial cells, alveolar macrophages and 
dendritic cells (4, 6-8). 
 The Z mutation (E342K) of α1-antitrypsin comprises more than 95% of the 
mutations leading to severe α1-antitrypsin deficiency.  Due to this mutation, the Z α1-
antitrypsin is not properly folded, which leads to the formation of polymers that accumulate 
as PAS positive inclusions within the endoplasmic reticulum (ER) of hepatocytes (9).  This 
toxic gain-of-function within the liver causes hepatic cirrhosis and the concomitant 
plasma deficiency causes a protease-antiprotease imbalance within the lung and hence 
early-onset lung emphysema (10).  Polymers of Z α1-antitrypsin were identified in lung 
lavage (11, 12) and shown to have pro-inflammatory properties that may exacerbate 
inflammation and lung damage (11, 13-15), particularly in the cigarette smoking Z α1-
antitrypsin homozygote.  In 2004, Mulgrew et al. (15) showed that Z α1-antitrypsin polymers 
could still be detected in lung lavage ten years after liver transplantation, suggesting local 
secretion and polymerisation of Z α1-antitrypsin within the lung.  However, even after a 
decade, the source of these polymers remains unclear.
 The ER is the site of secretory and membrane protein folding and its quality 
control systems ensure that only properly folded proteins exit the organelle for secretion 
or integration into the cell membrane.  Accumulation of unfolded or misfolded proteins 
in the ER induces “ER stress”, thereby activating intracellular signal transduction pathways 
collectively called the unfolded protein response (UPR) (reviewed by Marciniak and Ron 
(16)).  The aim of this complex cellular response is to maintain ER homeostasis initially by 
reducing the influx of newly synthesised proteins into the ER lumen and subsequently by 
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enhancing the protein-folding capacity of the ER.  Cells also increase expression of proteins 
of the ER associated degradation (ERAD) pathway to remove terminally misfolded proteins 
(17).  Furthermore, the UPR not only orchestrates ER homeostasis, it has also be shown 
to be involved in ER stress-induced NF-κB activation (18).  For example, X-box binding 
protein 1 (XBP1), a key modulator of the UPR, has been shown to control the production of 
interleukin (IL)-6 and interferon (IFN)-β in B cells and macrophages, respectively (19, 20).
 Misfolded monomeric Z α1-antitrypsin is predominantly degraded by ERAD whilst 
polymers are cleared by autophagy (21, 22).  Interestingly, this does not activate the UPR 
within cells overexpressing Z α1-antitrypsin (23-25).  However, it does prime cells to an 
exaggerated ER stress response upon a “second hit”, probably due to the impaired protein 
mobility within the ER caused by α1-antitrypsin polymers (25).  In addition to the enhanced 
sensitivity to ER stress, cells expressing Z α1-antitrypsin also display an augmented NF-κB 
response with subsequent increase in cytokine secretion (4, 23, 24, 26).  Upon a second 
hit, such as exposure to lipopolysaccharide (LPS) or tumour necrosis factor (TNF)α, this 
inflammatory response is further increased (4, 26).  
 Peripheral blood monocytes are the precursors for various subsets of lung 
macrophages, including alveolar macrophages, which are increased in chronic lung 
diseases such as COPD (27) and are associated with the pathogenesis and disease severity 
of this condition (28).  In the healthy lung, alveolar macrophages have been shown to be 
immunosuppressive with poor antigen-presenting capacities, but different macrophage 
phenotypes can develop when monocytes are exposed to different (micro-)environmental 
signals (reviewed in (29, 30)).  Based largely on in vitro studies into development of 
human monocytes-derived macrophages, distinct macrophage subpopulations have 
been identified.  For instance, human monocytes exposed to GM-CSF will activate the 
classical pathway of macrophage differentiation, resulting in pro-inflammatory mφ-1 
macrophages releasing pro-inflammatory cytokines and promoting a T-helper 1 response 
(31).  On the other side of the spectrum, the anti-inflammatory mφ-2 macrophages (also 
called alternatively activated macrophages), can be derived from human monocytes 
exposed to M-CSF, and are characterised by the production of IL-10, the induction of T 
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regulatory cells and the phagocytosis of apoptotic cells (32, 33).  However, recent studies 
have shown altered alveolar macrophage polarisation with an “intermediate phenotype” 
and impaired phagocytosis in COPD patients (reviewed in (34)).
 Carroll et al. (26) previously showed intracellular accumulation of α1-antitrypsin 
and subsequent activation of the UPR in monocytes from homozygous Z α1-antitrypsin 
deficiency patients.  Since we have shown previously differential α1-antitrypsin 
production by different macrophage subsets (8), we set out to test the hypothesis that 
mφ-1 macrophages are able to produce Z α1-antitrypsin polymers.  Furthermore, we 
hypothesised that this subset contributes to the enhanced inflammation due to the 
activation of the UPR, and due to an increased NF-κB activation. 
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Results 
Monocytes and monocyte-derived macrophages experiencing ER stress display an 
exaggerated response upon LPS
 Thapsigargin inhibits the sarcoendoplasmic reticulum calcium ATPase, thereby 
releasing the Ca2+ stores from the ER and inducing the UPR and activation of NF-κB (38, 
39).  To confirm that low-grade ER stress can lead to an exaggerated UPR upon a second hit 
in monocytes and monocytes-derived macrophages, we pre-treated these cells isolated 
from MM donors with thapsigargin for 1h, and subsequent stimulation with LPS for 4 or 
24 hours.  As expected, thapsigargin significantly increased CHOP, GADD34, GRP78 mRNA 
and the splicing of XBP1 mRNA in all cell types at both 4 hours and 24 hours (Figure 1A-
D).  This response was slower in monocytes compared to both mφ-1 and mφ-2, since the 
levels of CHOP and spliced XBP1 mRNA were significantly lower at 4 hours, and significantly 
higher at 24 hours (p<0.01; Figure 1A-B).  LPS induced considerably higher levels of all four 
UPR genes in mφ-1 and mφ-2 at either 4 hours (for spliced XBP1 and GRP78 mRNA) or 24 
hours (for CHOP and GADD34 mRNA).  
 Next, we verified whether this increased ER stress response was accompanied by 
an increase in NF-κB response.  Basal levels of IκB, cFos and IL8 mRNA were significantly 
higher in monocytes compared to both mφ-1 and mφ-2 (Figure 2A).  LPS significantly 
increased all three parameters in monocytes at 4 hours, but not in mφ-1 or mφ-2. 
Figure 1.  ER stress response upon LPS treatment in MM monocytes and MM monocyte-derived 
macrophages experiencing ER stress. 
A. Monocytes (mono), and macrophages type I (mφ-1) and type II (mφ-2) were pre-incubated with 
thapsigargin (Tg) for 1 hour followed by LPS treatment for 4 hours (left) or 24 hours (right) as indicated. 
The splicing of XBP1 mRNA was measured with quantitative RT-PCR, normalised to ATP5B and ACTB mRNA. 
B-D. Cells were treated as in A and CHOP, GADD34 and GRP78 mRNA was measured, respectively.  *p<0.05, 
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Remarkably, mφ-1 and mφ-2 experiencing ER stress did show enhanced IκB mRNA 
levels after 4 hours of LPS treatment (p<0.001), whereas in monocytes this level actually 
decreased (p<0.05; Figure 2A).  After 24 hours no differences were observed anymore.
 To conclude, these data demonstrate that monocyte-derived macrophages 
display an exaggerated ER stress response and NF-κB response upon a second hit when 
experiencing ER stress, a phenomenon not observed in monocytes.
Monocytes and monocyte-derived macrophages from ZZ patients lack the production of 
detectable polymers
 It has been known for a long time that monocytes (40) and (monocyte-derived) 
macrophages produce α1-antitrypsin (8, 41).  However, it remains unknown whether 
macrophages from Z α1-antitrypsin patients (ZZ cells) are a source of Z α1-antitrypsin 
polymers found in the lung and experience an exaggerated ER stress response.  Therefore, 
we first confirmed our previous findings (8) that pro-inflammatory mφ-1 macrophages 
secrete significantly more α1-antitrypsin compared to anti-inflammatory mφ-2 
macrophages in both MM and ZZ cells (p<0.001; Figure 3A).  As expected, the levels of 
α1-antitrypsin in the cell supernatant of MM cells were up to five times higher compared 
to the supernatant of ZZ cells.  This could only in part be explained by the intracellular 
retention of Z α1-antitrypsin (Figure 3B).  The production of α1-antitrypsin in both mφ-1 
and mφ-2 was increased after 24 hours LPS treatment (p<0.05 and p<0.01, respectively; 
Figure 2.  Inflammatory response upon LPS treatment in MM monocytes and MM monocyte-
derived macrophages experiencing ER stress.  
A. Cells were treated as in Figure 1 and IkB,  cFos and IL8 mRNA was measured.  B. Pre-incubated cells with 
thapsigargin (Tg; 1 hour) were subjected to 24 hours LPS treatment and IL-10, IL-12p40 and IL-8 cytokine 
release were measured in cell supernatant by ELISA.  *p<0.05, **p<0.01, ***p<0.001 versus untreated with 
a two-way repeated-measurements ANOVA (Bonferroni post-hoc).
<<<
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Figure 3A-B).  When we used the 2C1 monoclonal antibody to specifically detect naturally 
occurring α1-antitrypsin polymers, we were unable to detect Z α1-antitrypsin polymers 
in any cell type (Figure 3A-B), whereas liver homogenate from a cirrhotic ZZ liver 
revealed accumulation of Z polymers (data not shown).  To verify whether this was due 
to their differentiation, we evaluated the total α1-antitrypsin and polymer production of 
monocytes from the same donors.  Unstimulated monocytes released equal amounts of 
total α1-antitrypsin measured in the cell supernatant compared to mφ-2 (Figure 3A), and 
did not significantly up-regulate the total α1-antitrypsin production after LPS treatment. 
Interestingly, the intracellular α1-antitrypsin levels were significantly higher in both MM as 
ZZ monocytes compared to pro- or anti-inflammatory macrophages (Figure 3B).  However, 
the polymer levels were undetectable in both the cell supernatant and whole cell lysate of 
ZZ monocytes (Figure 3A-B).
 
No evidence for the activation of the unfolded protein response in ZZ monocytes and 
monocyte-derived macrophages
 It has been shown that the overexpression of Z α1-antitrypsin to levels that cause 
its polymerisation leads to an exaggerated ER stress response upon a second hit (24, 25), 
whereas the presence of monomeric Z α1-antitrypsin alone does not trigger the UPR in 
primary bronchial epithelial cells (4).  Carroll et al. (26) showed a slightly enhanced UPR 
in resting ZZ monocytes in the presence of intracellular accumulated Z α1-antitrypsin. 
However, the conformation of this retained Z α1-antitrypsin remained unclear.  Therefore, to 
examine whether our ZZ monocytes and ZZ monocyte-derived macrophages experience 
increased ER stress, we investigated the expression of several UPR target genes; CHOP, 
GADD34 and GRP78 and the splicing of XBP1 mRNA.  In resting cells, there was no evidence 
of an increased ER stress response in ZZ cells compared to MM cells (Figure 4A-B).  In 
addition, beside basal GADD34 mRNA levels, which were elevated in monocytes, there was 
no significant difference in the basal expression of most UPR genes between monocytes, 
mφ-1 and mφ-2, indicating that the differentiation of monocytes into macrophages does 
not alter the stress status (Figure 1A-D and Figure 4A-B).  Next, to investigate the influence 
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Figure 3. Alpha1-antitrypsin production by monocyte-derived macrophages from ZZ patients and 
MM controls.  
A. Total α1-antitrypsin (AAT) and α1-antitrypsin polymer production measured in cell supernatant of 
monocytes (mono), and macrophages type I (mφ-1) and type II (mφ-2) after 24 hours LPS treatment.  B. 
As in A.  Total α1-antitrypsin and α1-antitrypsin polymer levels in whole cell lysates.  *p<0.05, **p<0.01, 
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Figure 4. No exaggerated ER stress response in monocytes and monocyte-derived macrophages 
from ZZ patients compared to MM controls.  A. mRNA levels in macrophages type I (mφ-1) and type 
II (mφ-2) of the ER stress genes spliced XBP1, CHOP, GADD34 and GRP78 after 24 hours LPS treatment 
measured by quantitative RT-PCR.  B. Monocytes were treated and subjected to analysis as in A.  C. 
Representative western blot for GRP94 and GRP78 using anti-KDEL antibody.  Monocyte-derived 
macrophages were treated as in A.  Densitometry of n=4.  *p<0.05, **p<0.01, ***p<0.001 versus untreated 
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of an enhanced α1-antitrypsin production, these cells were stimulated with LPS.  After 
24 hours, mφ-2 from Z α1-antitrypsin patients showed a significant increase in GADD34 
mRNA (Figure 4A).  However, this difference could not be detected in monocytes (Figure 
4B).  In line with previous research (42, 43), LPS significantly increased CHOP and GADD34 
mRNA levels and the splicing of XBP1 mRNA.  
 When we assessed GRP78 protein levels by western blot, we were unable to 
detect its increase in mφ-2 from ZZ patients (Figure 4C).  In fact, these levels appeared to 
be lower in ZZ macrophages compared to MM macrophages (Figure 4C).   
Production of Z α1-antitrypsin in monocyte-derived macrophages does not alter NF-κB 
signalling
 We and others (4, 23, 44) have shown that the presence of monomeric Z α1-
antitrypsin is associated with an enhanced NF-κB response in epithelial cells, even in the 
absence of polymers and an exaggerated ER stress response.  However, so far the data 
for monocytes are inconsistent (26, 45) and data for macrophages are lacking.  Therefore, 
we first measured the release of IL-12p40, IL-10 and IL-8 with or without LPS treatment. 
As shown previously (31, 46), mφ-1 produced more IL-12p40 compared to mφ-2 after 24 
hours of LPS, whereas mφ-2 produced more IL-10 (Figure 5A).  There was no difference in 
their IL-8 release.  However, in contrast to our expectations, MM macrophages produced 
enhanced levels of all three cytokines compared with ZZ macrophages after 24 hours 
LPS (p<0.01; Figure 5A).  There were no significant differences observed for all cytokines 
between resting MM and ZZ cells.  
 To verify whether this difference in cytokine release was caused by an increased NF-
κB or ERK1/2 signalling, we measured IκB and cFos mRNA (Figure 5B) and phosphorylation 
of ERK1/2 (Figure 5C).  We were unable to detect any difference, either basally or after 24 
hours of LPS, in IκB and cFos mRNA or phosphorylation of ERK1/2 between MM and ZZ 
macrophages.  However, mφ-2 showed higher levels of ERK1/2 phosphorylation in resting 
cells compared to mφ-1 (Figure 5C).  
 Once again, to ensure that the differentiation of monocytes into macrophages 
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•  Function of macrophage subsets in α1-antitrypsin defeciency 
did not influence our results, we determined IκB and cFos mRNA and the release of 
IL-8 (Figure 5D).  IκB mRNA was higher in MM monocytes compared to ZZ monocytes. 
Although not significant, this was also observed for IL-8 in the cell supernatant (Figure 5D). 
These results indicate that the differentiation of monocytes into macrophages does not 
alter the behaviour of either MM or ZZ cells concerning the parameters measured.
 
Figure 5. No increased inflammatory response in monocytes and monocyte-derived macrophages 
from ZZ patients compared to MM controls.  A. IL-8, IL-10 and IL-12p40 release of macrophages type I 
(mφ-1) and type II (mφ-2) after 24 hours LPS treatment measured by ELISA.  B. mRNA levels of IkB and cFos 
in mφ-1 and mφ-2 treated as in A.  C. Representative western blot of the activation of the MAP kinases 
ERK1/2 of whole cell lysates from mφ-1 and mφ-2 treated as in A.  Densitometry of n=4.  D. IL-8, IL-10 and 
IL-12p40 release of monocytes treated as in A.  *p<0.05, **p<0.01, ***p<0.001 versus untreated with a 
two-way repeated-measurements ANOVA (Bonferroni post-hoc).
<<<
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Discussion
 After the discovery of Z α1-antitrypsin polymers in the lung lavage of a ZZ α1-
antitrypsin deficiency patient who underwent a liver transplantation ten years before (15), 
the search for the responsible cell type emerged.  We have shown recently that primary 
bronchial epithelial cells of ZZ α1-antitrypsin deficiency patients are unlikely to be the 
source of polymers (4).  In this study, polymers were also not detectable in both monocytes 
and monocyte-derived macrophages from ZZ patients.  Furthermore, we show that these 
cells do not show an exaggerated ER stress nor an increased NF-κB response to a second 
trigger such as LPS.  
  Interestingly, we have recently shown that resting ZZ α1-antitrypsin primary 
bronchial epithelial cells display increased NF-κB activation even in the absence of 
detectable polymers and without an exaggerated ER stress response (4).  This enhanced NF-
κB response in these cells was explained by the inability to produce significant amounts of 
Z α1-antitrypsin by these cells to inhibit ERK1/2 phosphorylation via the epidermal growth 
factor receptor (EGFR) (4).  Monocytes are reported to lack substantial EGFR expression 
(47), which may explain why we were unable to detect this increased NF-κB response in 
ZZ monocytes and monocyte-derived macrophages.  This is in line with Aldonyte et al. 
(45), who showed lower TNFα release by ZZ monocytes.  On the other hand, Carroll et al. 
(26) performed a similar study comparing monocytes isolated from peripheral blood from 
MM and ZZ individuals, where they did find a difference in the release of IL-6, IL-8 and IL-
10. We cannot exclude that differences in handling and isolation of monocytes between 
our study and that of Carroll et al. explains the different results.  The increase in cytokine 
release found by Carroll et al. was accompanied by the accumulation of Z α1-antitrypsin 
within the ER of unknown conformation, and an exaggerated ER stress response.  We also 
detected the intracellular retention of Z α1-antitrypsin (Figure 3A-B), since the ratio of α1-
antitrypsin in the whole cell lysate and the supernatant was higher in ZZ (up to 3.5 to 1) 
compared to MM cells (up to 1 to 1).  It needs to be noted that these ratios may not be 
accurate especially for ZZ cells, since the α1-antitrypsin levels measured were close to the 
limit of detection of the ELISA.  Although we obtained preliminary evidence for increased 
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retention of α1-antitrypsin in ZZ cells, this does not fully explain the difference in secreted 
α1-antitrypsin between MM and ZZ cells.  This conclusion is based on the observation that 
the total amount of α1-antitrypsin produced (sum of whole cell lysates and supernatant) is 
lower in ZZ than MM cells (data not shown).  It would be interesting to investigate whether 
the remaining difference between MM and ZZ cells can be explained by degradation of Z 
α1-antitrypsin via ERAD by treating these cells with a proteasome inhibitor.   
 Previously, we have determined the critical Z concentration at which Z α1-
antitrypsin is likely to form polymers, namely 300 ng/mg total lysate protein (4).  In this 
study, monocytes and monocyte-derived macrophages did not reach this concentration 
(maximum of 30 ng/mg total lysate protein by MM cells), which could explain why we 
were unable to detect 2C1-positive polymers intracellularly or in their cell supernatant.  It 
is noteworthy that this critical Z concentration has been established in different epithelial 
cell lines.  Currently, we are unable to exclude the possibility that this concentration might 
be lower in mononuclear cell lineages.
 To our knowledge, this is the first study directly comparing monocytes and 
monocyte-derived macrophages of ZZ patients and MM controls in response to ER stress 
and a secondary trigger like LPS.  In our opinion, it is important that we have compared 
these subsets, since it not only excludes the possibility that our findings in the monocyte-
derived macrophages could have been explained by alterations in their behaviour 
whilst differentiating, it also reveals unknown differences between these subsets in the 
expression of inflammatory markers like cFos and IL8 mRNA and secretion of IL-8, IL-10 
and IL-12p40.  The cellular mechanisms behind these differences and their biological 
significance are important issues to be addressed, but beyond the scope of this study.
 Although monocyte-derived macrophages are in general a good model to study 
macrophage behaviour, we and others have shown previously that these cellular subsets 
in vitro might not always represents alveolar macrophages in vivo (8, 48).  Therefore, 
theoretically it is still possible that alveolar macrophages are a source of polymers within 
the lung in vivo, although the levels secreted by MM alveolar macrophages are comparable 
with monocytes and monocyte-derived macrophages in vitro (8, 41).  However, it needs 
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to be noted that marked differences exist in the characteristics of alveolar macrophages 
between patients with and without COPD (reviewed in (34)).  For example, alveolar 
macrophages from COPD patients have been shown to be unable to efficiently ingest 
microorganisms and apoptotic cells. Interestingly, this inability of COPD cells is already 
present in monocyte-derived macrophages obtained from peripheral blood of COPD 
patients.  This not only validates the use of these cells in vitro, it also illustrates the 
complexity of defining the ultimate alveolar macrophage phenotype.  Future studies 
with alveolar macrophages obtained from broncho-alveolar lavage of Z α1-antitrypsin 
deficiency patients will help to better understand the role of macrophages in Z α1-
antitrypsin deficiency in vivo.
 Taken together, this study extends our understanding of the current view of Z 
α1-antitrypsin polymerisation, exaggerated ER stress response and NF-κB signalling by 
all cell types expressing Z α1-antitrypsin.  However, more research needs to be done to 
completely understand the underlying mechanisms for these phenomena.  
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Material and methods
Subjects
 The ZZ α1-antitrypsin deficiency patients were stable without any sign of an 
exacerbation.   Patient characteristics of these patients can be found in Table 1.  Control 
MM subjects were asymptomatic without evidence of any disease or a (family) history 
of respiratory disease and/or allergy.  They were aged-matched to the ZZ patients, non-
smokers and all had a MM genotype as confirmed by reverse transcription polymerase 
chain reaction (RT-PCR; (35)).  Individuals gave written informed consent to take part in 
this study, as approved by the Medical Ethical Committee of Leiden University Medical 
Centre, Leiden, the Netherlands.
Table 1. Patient characteristics
PiZZ patients (n=7)
age (mean, range) 52 (43-57)
sex (M/F) 3/3
FEV1 (mean, range in %) 50 (33-84)
FEV1/FVC (mean, range in %) 38 (28-65)
Smoking status (current/ex/never) 0/1/5
Cell culture
 Monocytes were isolated from fresh blood and differentiated into  mφ-1 or mφ-2 
as described previously (8) or used directly as monocytes. Monocytes and monocyte-
derived macrophages were pre-incubated with 100 nM thapsigargin (Sigma-Aldrich, St. 
Louis, MO, USA) for 1 hour and stimulated with 100 ng/ml Pseudomonas aeruginosa LPS 
(Sigma) for 4 or 24 hours as indicated.  
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ELISA
 Total and polymerised α1-antitrypsin were measured in cell supernatant by ELISA 
as described previously (36).  Intracellular levels were determined using whole cell lysate. 
Limit of detection for polymers was 3.0 ng/mg total lysate.  Interleukin (IL)-8, IL-10 and 
IL12p40 was measured as described previously (4, 8).
Western blot analysis
 Western blot analysis was performed as described previously (4).  Briefly, 
samples were separated on a 10% w/v acrylamide SDS-PAGE gel.  Proteins were detected 
with specific primary antibodies to phospho-ERK1/2, total ERK1/2, and GAPDH (all Cell 
Signaling Technology, Beverly, MA, USA).  GRP78 and GRP94 were visualised by using a 
monoclonal antibody against the KDEL-sequence (Enzo Life Sciences, Raamsdonksveer, 
the Netherlands).  Although monocytes were seeded in the same density as monocyte-
derived macrophages, the protein content of monocytes was too low to perform western 
blot analysis.  
Quantitative real-time polymerase chain reaction (RT-PCR)
 RNA was isolated using Maxwell RNA extraction (Promega, Madison, WI, 
USA) according to manufacturer’s instructions.  Quantitative RT-PCR was performed as 
described (37) with the primer pairs as described in Table 2.  
 
Statistical analysis
 Results are expressed as individual donors (each dot is one donor), unless 
otherwise stated.  Data were analysed using GraphPad Prism 6.0 software (GraphPad 
Software, San Diego, CA, USA) and compared with two-way repeated measurements 
analysis of variance (ANOVA) and Bonferroni post-hoc analysis.  Differences were 
considered statistically significant with p-values < 0.05.
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Table 2. qPCR primers
Name Forward primer/ Reverse primer Melting temp. (°C) Ref.
CHOP 5’ GCACCTCCCAGAGCCCTCACTCTCC 3’
5’ GTCTACTCCAAGCCTTCCCCCTGCG 3’
62 (37)
GADD34 5’ ATGTATGGTGAGCGAGAGGC 3’
5’ GCAGTGTCCTTATCAGAAGGC 3’
62 (51)
IL8 5’ CTGGACCCCAAGGAAAAC 3’
5’ TGGCAACCCTACAACAGA C 3’
60 -
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 Summary and general discussion
Main findings
 Stress responses have been shown to play a central role in health and disease 
in the lung.  For instance, acute activation of the integrated stress response (ISR; chapter 
2, Figure 1) upon viral infection reduces viral replication and enhances appropriate 
cytokine release including that of interferons.  On the other hand, chronic activation 
of the integrated stress response, for example by cigarette smoke exposure, may lead 
to enhanced cell death (reviewed in chapter 2).  Until last year, the importance of both 
the ISR as well as the unfolded protein response (UPR; chapter 1, Figure 2) in bacterial 
infection received little attention.  We examined how virulence factors of Pseudomonas 
aeruginosa elicit both stress responses in bronchial epithelial cells (chapter 4).  The 
induction of endoplasmic reticulum (ER) stress, which was mediated via the TAK1-p38 
MAPK pathway, was caused by secreted virulence factors of P. aeruginosa.  Pyocyanin 
and alkaline protease were the main contributors to the observed effect.  To evaluate the 
ER stress response and subsequent UPR, we made use of our newly developed primers 
presented in chapter 3.  In this way, we were able to monitor the splicing of XBP1 mRNA in 
a reliable and quantitative way.  The induction of GADD34 was caused by the ability of the 
Pseudomonas supernatant to sequester iron leading to iron deficiency for the epithelial 
cells in vitro, which was mediated exclusively by the eIF2α kinase HRI and the ISR.  This 
induction of GADD34 expression appeared to be cytoprotective for bronchial epithelial 
cells exposed to conditioned medium of P. aeruginosa.  
 Whereas the study of the ISR remained a relatively small field, research in the 
role of the ER stress response and UPR in the pathophysiology of lung diseases expanded 
massively in the past five years.  In particular conformational diseases, such as Alzheimer’s 
and Parkinson’s diseases, amyloidosis and Z α1-antitrypsin deficiency, gained much 
attention due to the structural (conformational) change of a mutant protein leading to 
intracellular polymerisation and eventually disease (1).  A subclass of conformational 
diseases that result from a point mutation in a protein member of the serpin superfamily 
199
•  General discussion
of serine proteinase inhibitors, like Z α1-antitrypsin deficiency, are also referred to as 
serpinopathies.  Central questions in the study of serpinopathies are whether protein 
polymerisation causes ER stress and related cell death (toxic gain of function); how these 
serpins are related to increased inflammation found in cells expressing mutants (loss of 
function); and how ER stress and inflammation contribute to the pathophysiology of 
the associated diseases.  In case of Z α1-antitrypsin deficiency, much of the answers to 
these questions were derived from liver samples or overexpressing models.  These studies 
showed that overexpression of Z α1-antitrypsin leads to accumulation and polymerisation 
inside the ER, but does not elicit the UPR (2).  Remarkably, polymers do prime cells to 
generate an exaggerated ER stress response upon a so-called second hit (3, 4).  Furthermore, 
polymer formation activates caspases-4 (and -12) and enhances the NF-κB response (2). 
After the discovery of polymers in bronchoalveolar lavage fluid and lung tissue (5, 6), even 
10 years after liver transplantation (7), it was hypothesised that these polymers and the 
accompanying cellular consequences would contribute massively to the pathophysiology 
of the lung disease.  And so the search for the responsible cell type emerged.  Therefore, 
we investigated whether two of the major sources of α1-antitrypsin in the lung, bronchial 
epithelial cells (chapter 5) and macrophages (chapter 7), were the cells responsible for the 
production of these polymers.  In chapter 5 we determined the “critical Z α1-antitrypsin 
concentration”; the minimal concentration of α1-antitrypsin producted by a cell in order to 
be able to form polymers.  We showed that both primary bronchial epithelial cells (chapter 
5) and monocyte-derived-macrophages (chapter 7) are able to secrete detectable 
amounts of α1-antitrypsin, however, they do not reach the concentration threshold to 
form polymers.  Furthermore, monomeric Z α1-antitrypsin does not elicit an exaggerated 
ER stress response upon a second hit in these cells.  Importantly, even in the absence of 
these polymers, primary bronchial epithelial cells do exhibit an enhanced NF-κB response, 
dependent of the EGF receptor.  This might also explain the absence of this exaggerated 
response in monocyte-derived macrophages (chapter 7).  Since macrophages constitute a 
heterogeneous population, we studied the two extremes of a continuum of macrophage 
phenotypes, the pro- (mφ-1) and anti-inflammatory (mφ-2) macrophages, and examined 
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differences in its α1 -antitrypsin production (chapter 6 and 7). 
 Based on my main findings, this discussion is subdivided into three main topics. 
First, I will describe macrophage heterogeneity in COPD and its possible implications 
for α1-antitrypsin deficiency.  Then, I will discuss my experiences with measuring the ER 
stress response, thereafter I address potential therapeutic options for ER stress associated 
diseases and α1-antitrypsin deficiency.
Macrophage heterogeneity
 Macrophage diversity enables these cells to possess a wide variety of functions 
in the innate immune response, such as phagocytosis, the production of effector 
molecules and antigen presentation to T cells (8).  However, the broad range of different 
macrophage phenotypes is not only explained by their anatomical site, but is also a result 
of the local environment within one anatomical compartment (8, 9).  Furthermore, once 
differentiated into a subset, a macrophage is still able to adapt to changing conditions, 
altering its functions, which is termed macrophage plasticity.  Although monocytes can be 
differentiated into distinct macrophage subtypes in vitro, the plasticity and dependence 
on the local milieu are features that make it difficult to mimic in vivo monocyte-into-
macrophage differentiation (9).  Therefore, results derived from two polarised subtypes 
in vitro, the mφ-1 and mφ-2, might not always represent the phenotype of e.g. alveolar 
macrophages in vivo.  This was demonstrated in chapter 6, where mφ-1 macrophages 
produce approximately 4-fold more α1-antitrypsin compared to the mφ-2 macrophages in 
vitro, and both increase production after LPS treatment.  However, alveolar macrophages, 
which display more a mφ-2 phenotype according to their IL-10 production and complete 
lack of IL-12p40 secretion (chapter 6 and (10)), produce intermediate amounts of α1-
antitrypsin in vitro, which is unresponsive to LPS stimulation.  However, it needs to be 
noted that marked differences exist in the characteristics of alveolar macrophages 
between patients with and without COPD (11), illustrating the complexity of defining the 
ultimate alveolar macrophage phenotype.
 Nevertheless, access to locally differentiated alveolar macrophages can be 
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limited, for instance when it is unethical or too dangerous to perform bronchoscopy. 
Interestingly, some altered characteristics found in alveolar macrophages can also be 
detected in monocyte-derived macrophages and even in monocytes.  Prieto et al. (12) 
showed that circulating monocytes of COPD patients exhibit decreased phagocytic 
capacity to Escherichia coli, and a similar defect was seen in alveolar macrophages (13). 
More recently, different studies showed the same phagocytic impairment of the more 
relevant pathogen Haemophilus influenzae by both monocyte-derived macrophages as 
alveolar macrophages of patients with COPD (13-15).  The same impairment was found 
in the ability to phagocyte apoptotic cells (16, 17); however, the phagocytosis of latex 
beads did not seem to be altered (15, 17).  Often smoking has been proposed to be 
the underlying cause, since healthy controls are better able to phagocytose apoptotic 
cells compared to smokers and the same holds for ex-smokers with COPD compared to 
smoking COPD patients (16).  Furthermore, macrophages isolated from induced sputum 
of smoking COPD patients were shown to have predominantly a mφ-1 phenotype (18), 
whereas in healthy lungs it would resemble a mφ-2 macrophage and thus would contain 
an increased ability to phagocytose compared to mφ-1.  In line, smoking cessation in 
COPD has been associated with a phenotype shift back towards the mφ-2 phenotype 
(19).  On the other hand, the same reduced phagocytic capacity in monocytes and 
monocyte-derived macrophages of COPD patients suggests an inherent defect rather 
than a consequence of local differentiation or environmental exposure of macrophages in 
the lung. 
 Since α1-antitrypsin is known to exhibit also anti-inflammatory properties ((20-22) 
and chapter 5), a genetic defect could provide additional insights in altered macrophage 
functions in chronic lung diseases.  Indeed, α1-antitrypsin deficiency is associated with 
rapidly growing mycobacterial infections, and monocyte-derived macrophages treated 
with α1-antitrypsin appeared to be less prone to infection with Mycobacterium abscessus 
(23).  However, whether this is due to a reduced phagocytic capacity needs to be 
investigated.  Furthermore, to my knowledge, it is not known whether the phenotype-
shift of alveolar macrophages found in COPD is also found in α1-antitrypsin deficiency. 
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Interestingly, it has been shown that in vitro and in vivo treatment with azithromycin 
improves phagocytic function in alveolar macrophages from COPD patients.  Therefore, it 
would be highly relevant to explore the effect of such treatment on alveolar macrophage 
function in α1-antitrypsin deficiency, and to study the clinical benefit of such treatment. 
 
Monitoring ER stress
 The ER stress field developed rapidly with many investigators becoming interested 
in the UPR.  Therefore, many experimental methods have been described to study the 
UPR.  However, some of them are very laborious and others extremely difficult because of 
the lack of (proper) antibodies or low endogenous expression of certain proteins.  Here, I 
will discuss my experience with different tools to measure and interpret the activation of 
each arm of the UPR.
 PERK is an eIF2α kinase mediating the activation of one of the three branches 
of the UPR, and is known to have a poor endogenous expression in cells, which makes 
detection of its phosphorylation (as well as that of IRE1α) hard to measure.  Moreover, PERK 
becomes highly phosphorylated upon activation, so its mobility is altered on SDS-PAGE 
resulting in an activation-dependent mobility shift (24).  When specific questions require 
the detection of PERK activation, it is important to perform immunoprecipitation of PERK 
from cell lysates before immunoblotting (24).  However, this method is very difficult and 
both time- and material-consuming.  Once PERK is studied in the context of the ISR, and 
the involvement of this kinase in the activation of the ISR, then the use of knock-out MEFs 
or silencing RNA interference (RNAi) is advised.  Alternatively, one can use downstream 
markers to evaluate the activation status of this pathway in general.  There are good 
antibodies available to detect the phosphorylation of eIF2α (see Chapter 4), however, it 
is recommended to treat the cells with care and to replenish the media with pre-warmed 
(37°C) media one hour before treatment.  Moreover, stimulation should be started when 
the cells are only 50% confluent and the use of an acute stressor as a positive control, such 
as thapsigargin, is advised to detect a notable change.  For the detection of the nuclear 
proteins ATF4 and CHOP (25, 26), large quantities of nuclear extracts are needed, and 
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therefore, in my opinion, too expensive to use in primary cell cultures.  Additionally, until 
recently, no appropriate antibodies were available for GADD34.  Instead, CHOP, as well as 
GADD34, can be measured quantitatively at mRNA levels by quantitative RT-PCR (qPCR). 
Taken together, in most cases, phosphorylation of eIF2α, together with CHOP and GADD34 
mRNA levels are sufficient to verify the activation of this pathway. However, detection of 
these downstream mediators does not allow the identification of PERK or another kinase 
as being responsible for eIF2α phosphorylation.  
 Like PERK, phophorylation of IRE1 (the starting point for activation of another 
branch of the UPR) is difficult to measure, but fortunately detection of its most important 
downstream target, the splicing of XBP1 mRNA, is more straight forward.  Until 2006, the 
splicing of XBP1 mRNA was mainly assessed by detection of PCR fragments following RT-
PCR and gel electrophoresis (27).  By this method, it was not only difficult to quantify 
the spliced XBP1, it was also very laborious and challenging to obtain a conclusive result. 
In 2006, Hirota et al. (28) introduced a new method by which the spliced form could be 
quantified by cleavage of the RT-PCR product of double stranded (unspliced) XBP1 with 
the restriction enzyme PstI.  This method requires the addition of the restriction enzyme 
after 2-4 cycles of annealing-elongating during the qPCR, and is therefore complex 
and prone to errors.  In our search for reliable and simple methods to screen for the 
involvement of the UPR, we developed a specific primer for the quantitative detection 
of spliced XBP1 by qPCR (Chapter 3).  Spliced XBP1 is highly transcriptionally active and 
regulates the transcription of UPR target genes via direct binding to the UPR element 
(UPRE) and ER stress response element (ERSE) when in complex with NF-Y (27).  ATF6 is the 
sensor of the third branch of the UPR, and this transcription factor binds to and acts via 
the ERSE as well (29). Therefore, separation of the UPR target genes belonging to spliced 
XBP1 specifically is difficult.  Using Xbp1-/- and Atf6-/- MEFs treated with tunicamycin, Lee et 
al. (30) identified ERdj4, a heat shock protein 40 family member that interacts with ERAD 
(31) and chaperone p581PK as specific downstream targets of spliced XBP1.  
 Interestingly, the same group did not identify a specific marker for ATF6.  However, 
both Kaufman’s lab (32) and Mori’s lab (33, 34) performed transcriptional profile analysis 
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and microarray analyses on ATF6α-/- MEFs.  Both groups, independently, pointed towards 
Derlin-3, a functional component of the ERAD, as a sole downstream target.  It is worth 
mentioning that in both screens p581PK was significantly reduced in ATF6α-/- treated with 
tunicamycin, which suggests that p581PK may not be specific for detection of spliced XBP1. 
Due to this shared binding site, namely the ERSE, the opposite might be true, with so-
called ATF6 specific genes also being responsive to spliced XBP1.  For instance, bronchial 
epithelial cells transfected with the commonly used specific ATF6 luciferase reporter 
plasmid (p5xATF6-luc), showed a 15-fold increase in luciferase activity when treated with 
tunicamycin for 6 hours.  Remarkably, in my hands, this increase was totally abolished 
when the cells were co-stimulated with 4µ8C (35), a specific IRE1 inhibitor (unpublished 
data).
 A rather general, but important indicator of ER stress is the detection of the 
KDEL sequence (Lys-Asp-Glu-Leu).  This sequence keeps soluble ER resident proteins, 
such as Glucose Regulated Proteins 78 and 94 (GRP78; also referred to as BiP and GRP94, 
respectively) and Protein Disulphide Isomerase (PDI) retained inside the ER.  Especially 
the chaperone GRP78 is a key regulator in ER stress, since the activation of the UPR is 
dependent on its release from the three ER stress transducers.  Activation of the three 
branches of the UPR eventually lead to the induction of UPR target genes, amongst which 
GRP78.  Therefore, GRP78 up regulation is indicative for an ER undergoing stress. 
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Therapeutic approaches
ER stress mediated diseases
 As reviewed in Chapter 2, there is increasing evidence of the involvement of the 
ISR in various chronic lung diseases and lung cancer, which has mainly been associated 
with an increased PERK activity.  Chronic ER stress is in most cases detrimental for the cell, 
leading to cell death and worsening of the disease, whereas in cancer, increased PERK 
signalling favours tumour progression and cancer cell survival (36, 37).  For that reason, 
the inhibition of the PERK-arm is currently receiving much attention and significant 
advances in therapeutical approaches to block this kinase have been made over the last 
years.  However, ER stress-mediated cell death is not only induced via PERK, but can also 
be triggered via the IRE1α-JNK signalling cascade.  Therefore, inhibition of this arm might 
be relevant as well.  In 2012, the laboratorium of David Ron (35) used high-throughput 
screening to identify the aforementioned 4µ8C as a potent inhibitor of IRE1.  Interestingly, 
this compound not only inhibits the ER stress kinase IRE1α, but is also predicted to be 
able to inhibit the second isoform, IRE1β (38, 39).  The expression of this second IRE1 
was initially reported to be restricted to the epithelial cells in the gastrointestinal tract 
(40).  It has long been suggested that this kinase regulates ER homeostasis of goblet cells 
via an interaction with mucin production.  Furthermore, it was assumed that this kinase 
might also be expressed in lung goblet cells to regulate mucin expression.  However, no 
real evidence existed until very recently, when Tsuru et al. (39) showed that IRE1β-/- mice 
showed increased mucin 2 (MUC2) mRNA stability and accumulation of MUC2 protein in 
the ER of intestinal goblet cells.  Four months later, Martino et al. (41) presented the same 
findings for airway goblet cells.  In line with this finding, I found that fully differentiated 
primary bronchial epithelial cells treated with 4µ8C showed reduced expression MUC5AC 
and MUC2 mRNA and decreased secretion of mucin 5AC (unpublished data).  Therefore, it 
is a potential therapeutic target for patients with ER stress-associated lung diseases and 
mucus overproduction, like COPD and cystic fibrosis.  
 Also during chronic infections, ER stress and activation of the UPR are important 
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causes of cell death.  For P. aeruginosa, spliced XBP1 has recently been shown to be crucial 
in N-(3-oxo-dodecanoyl) homoserine lactone (C12)-mediated apoptosis (42).  Blocking 
IRE1 might be relevant to counteract this effect.  In contrast, in chapter 4, we have shown 
that GADD34 serves a cytoprotective role in human bronchial epithelial cells and mouse 
fibroblasts upon exposure to secreted virulence factors of P. aeruginosa.  Inhibition 
of GADD34 would in this case be detrimental.  We have not investigated the presence 
and contribution of C12 in our conditioned medium from P. aeruginosa to the observed 
effects, which should be done in the future as this might be relevant to further reduce 
the cytotoxicity of P. aeruginosa in bronchial epithelial cells.  Another approach to treat P. 
aeruginosa infection that needs to be considered is the inhibition of individual virulence 
factors to reduce the interference with the physiological ISR and ER stress response of 
the host.  However, we were unable to ascribe the observed effect to a single virulence 
factor, making this approach more complex.  Future studies will give us more insights in 
the contribution of each virulence factor, possibly opening up new therapeutic targets.
 Although the development of many ER stress inhibitors, such as the PERK inhibitor 
(43) and the IRE1α inhibitor 4µ8C (35), are still in the early stages, it has demonstrated the 
importance of the right balance in ISR activation, and further development of inhibitors 
might lead to therapeutic options in the different lung diseases.  Recently, encouraging 
results were obtained using a PERK inhibitor that inhibited neurodegeneration in prion-
infected mice (44).  However, one should bear in mind that only the stressed cells need 
targeting, since a physiological and functional ISR is crucial to maintain healthy tissue.
Alpha1-antitrypsin deficiency
 The discovery of the association between mutants of α1-antitrypsin and early-
onset lung emphysema made the protease-antiprotease imbalance hypothesis the 
dominant model for the development of the disease.  However, restoring this imbalance 
with intravenous α1-antitrypsin augmentation therapy did not cure the disease nor had its 
expected effects on disease progression (45).  For this reason, α1-antitrypsin augmentation 
therapy remains unsupported for the treatment of α1-antitrypsin deficiency in several 
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countries, amongst which the Netherlands and the United Kingdom.
Treating the defect
 The group of David Lomas at the University of Cambridge (now relocated to 
University College London) made major contributions in the development of novel 
strategies to treat α1-antitrypsin deficiency.  They showed that small molecules that block 
surface cavities of α1-antitrypsin could inhibit polymerisation in vitro and in vivo (46). 
However, this treatment also inactivated α1-antitrypsin as a neutrophil elastase inhibitor 
(46).  Moreover, the effective concentrations were expected to be too toxic to use in 
patients.  Due to the enormous potential of this approach as a treatment, future research 
must certainly provide us new small molecules that are less toxic.  
 The polymers found in the lung are thought to arise from local production, as 
they have been reported to be still present in bronchoalveolar lavage fluid ten years after 
liver transplantation (7).  Since we showed in chapter 5 and 7 that both cultured primary 
bronchial epithelial cells and monocyte-derived macrophages from ZZ patients do not 
produce these polymers, the origin of these polymers is still unknown.  The main question 
to be answered, in my opinion, is whether only one specific type of cells is responsible 
for the polymer formation or whether α1-antitrypsin secreted locally by various cells is 
retained in the interstitium and epithelial lining fluid, and that at these sites the critical 
Z α1-antitrypsin concentrations is reached that is required for extracellular polymer 
formation.  Another explanation could be that the extracellular milieu favours polymer 
formation, and thus lower secreted concentrations might allow polymerisation.  Once we 
know the answer, we might be able to use the small molecules also as a potential lung 
therapy. 
 A second approach for developing a curative treatment for α1-antitrypsin 
deficiency is the use of genetic corrections and induced pluripotent stem cells (iPS). 
Rashid et al. (47) presented the derivation of iPS from fibroblasts of skin biopsies of α1-
antitrypsin deficiency patients.  Genetic correction of the point mutation underlying 
the Z mutation (E342K) restored α1-antitrypsin production and its proper activity in iPS-
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derived liver-like cells (48).  The challenge remains to differentiate these corrected liver 
cells to fully mature hepatocytes and to restore the mutations that resulted from the iPS 
development.  Another approach was used by the Birmingham group, who showed that 
α1-antitrypsin secretion from monocytes carrying the Z mutation can be corrected with 
small DNA fragments encoding M α1-antitrypsin (49).  Whether this approach can form 
the basis for development of new treatments for α1-antitrypsin deficiency is unclear at 
present.   
Blocking the MEK-EGFR pathway 
 Based on the studies described in this thesis (chapter 5 and 7), we could argue 
that bronchial epithelial cells are the main contributors to the local inflammation in the 
lungs of α1-antitrypsin deficiency patients.  Even in the absence of polymers, they exhibit 
an increased inflammatory response as demonstrated by increased ERK1/2 signalling 
and subsequent cytokine release.  Interestingly, we were able to reduce these effects by 
treating the cells with extracellular M α1-antitrypsin.  This might implicate that inhaled 
α1-antitrypsin augmentation therapy could diminish local inflammation through an effect 
on for example neutrophil influx and survival, and local macrophage differentiation.  In 
my opinion, the primary outcome of a first clinical proof-of-concept study using inhaled 
α1-antitrypsin should therefore be the measurement of inflammatory markers, such as 
IL-8, in bronchoalveolar lavage and/or sputum.  Subsequent more long-term studies 
would be needed to explore the effect on lung function (including FEV1, VC, CO diffusion 
and single-breath nitrogen test) and alveolar pathology as assessed by densitometric 
CT scans.  Secondary outcomes could comprise bacterial colonisation and exacerbation 
rates.  However, I would like to stress that these read-outs are very complex and not 
solely dependent on increased inflammation, and therefore possibly not conclusive. 
Furthermore, the increased ERK1/2 phosphorylation was dependent on the ‘classical’ 
MEK-EGFR pathway, which is shared with non-small cell lung carcinoma and certain breast 
cancers (50, 51).  Major therapeutic advances have already been made in the cancer field, 
and the use of existing MEK inhibitors, EGFR monoclonal antibodies or tyrosine kinase 
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inhibitors should also be considered as a treatment for α1-antitrypsin deficiency related 
emphysema.  Further research has to be done to confirm these therapeutic options as 
actual treatment in α1-antitrypsin deficiency.  However, it needs to be noted that a safety 
and efficacy trial with an EGFR inhibitor in COPD patients did not show convincing 
evidence for an effect on mucin stores and furthermore was associated with adverse 
effects (52). 
Future directions
 This thesis started with the initial question about the role of polymers and its 
relation to ER stress in the development of Z α1-antitrypsin deficiency related emphysema. 
When the years progressed, it became evident that polymers might not be produced 
locally by lung cells and that monomeric Z α1-antitrypsin does not prime cells for an 
exaggerated ER stress response upon a second hit.  In contrast, we can conclude that there 
is a prominent role for ER stress in other lung related diseases and bacterial infections.  Two 
important questions have been raised by these studies, but still remain to be answered in 
full:
1) Stress responses during bacterial infection:
•	 What is the role of the each virulence factor in the induction of ER stress and the ER 
stress-independent ISR by P. aeruginosa and can we use that for future treatment? 
•	 Are these mechanisms specific for virulence factors of P. aeruginosa, or are they 
applicable to other (Gram negative) respiratory pathogens as well?
2) Alpha1-antitrypsin deficiency:
•	 Is there local production of Z α1-antitrypsin polymers in the lung? 
•	 Would aerosolised α1-antitrypsin be suitable as a therapy to reduce lung inflammation? 
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Chronic obstructive pulmonary disease (chronisch obstructieve longziekte; 
afgekort COPD), een verzamelnaam voor longemfyseem en chronische bronchitis, is 
een irreversibele chronische longziekte die voornamelijk wordt veroorzaakt door roken 
en mogelijk ook door luchtvervuiling.  Door het roken worden de longblaasjes definitief 
afgebroken (longemfyseem) en raken de luchtwegen ontstoken waarbij vaak slijm wordt 
gevormd (chronische bronchitis).  Behalve roken kunnen ook erfelijke afwijkingen lijden 
tot de ontwikkeling van longemfyseem.  De bekendste en meest belangrijke genetische 
risicofactor is een tekort aan α1-antitrypsine (α1-antitrypsine deficiëntie), waarbij mensen 
door een mutatie een erfelijk tekort hebben aan het eiwit α1-antitrypsine.  In de gezonde 
long is α1-antitrypsine een remmer van eiwit-afbrekende enzymen die vrijkomen bij 
ontsteking (proteasen), en draagt op die manier bij aan het beschermen van de long 
tegen weefselschade die kan ontstaan tijdens een ontstekingsproces.  Alfa1-antitrypsine 
wordt vooral in de lever aangemaakt en bereikt de long via de bloedbaan, maar wordt 
ook lokaal in de long door macrofagen en epitheelcellen geproduceerd.  De concentratie 
α1-antitrypsine in de long echter wordt in hoge mate bepaald door productie in de lever. 
Bij pasgeborenen kan een mutatie in α1-antitrypsine leiden tot ernstige leverontstekingen 
(hepatitis) en geelzucht, en bij volwassenen, en met name rokers, tot een zeer sterk 
verhoogde kans op de ontwikkeling van longemfyseem vanaf het 35e levensjaar.  
De productie van eiwitten in een cel begint in de nucleus (kern) met het aflezen 
van DNA: de transcriptie.  Het ontstane messenger-RNA (mRNA) verplaatst naar het 
cytoplasma, waar het door de ribosomen vertaald wordt naar een aminozuurketting 
(polypeptide): de translatie.  Dit polypeptide wordt in het endoplasmatisch reticulum 
(ER) gevouwen in zijn tertiaire structuur: de posttranslationele modificatie.  Alleen correct 
gevouwen eiwitten zijn biologisch actief en worden uitgescheiden door het ER.  Dus 
naast het vouwen van eiwitten, vervult het ER ook een functie in de kwaliteitscontrole 
van gevormde eiwitten.  Het vouwen van eiwitten kan door verschillende zaken verstoord 
worden, met als gevolg een ophoping van verkeerd gevouwen eiwitten in het ER, wat 
ER stress oplevert.  De complexe fysiologische cellulaire reactie van het ER heeft als doel 
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de homeostase in een cel te herstellen door enerzijds het aanbod van nieuw te vouwen 
eiwitten te reduceren (translationele repressie) en anderzijds de capaciteit van het vouwen 
te verhogen.  Bij langdurige ER stress geeft deze respons aanleiding tot een verhoogde 
ontstekingsreactie en geprogrammeerde celdood.  Naast ER stress kunnen drie andere 
oorzaken een translationele repressie geven, te weten ijzergebrek, virus infecties en 
aminozuurtekorten; dit wordt gezamenlijk de Integrated Stress Reponse (ISR) genoemd.   
Veruit de meest voorkomende mutatie die leidt tot α1-antitrypsine deficiëntie is 
de zogenaamde Z mutatie.  Bij deze mutatie wordt het Z α1-antitrypsine nog wel gemaakt 
in de lever, maar kan het eiwit zich niet goed vouwen in het ER.  Dit leidt niet alleen tot 
ophoping van het Z α1-antitrypsine in het ER, maar ook tot samenklontering van de 
opgehoopte eiwitten (polymeren) en een beperkte uitscheiding in de bloedbaan.  Door 
het ontstane tekort aan α1-antitrypsine wordt de long lokaal onvoldoende beschermd 
tegen de proteasen die vrijkomen bij de door o.a. roken ontstane ontsteking; daarnaast 
dragen de polymeren van Z α1-antitrypsine lokaal in de long ook zelf bij aan de ontsteking 
doordat ze ontstekingscellen aantrekken (chemotaxie).
Het proces van polymeervorming en de vraag of deze polymeren ook ER 
stress veroorzaken is uitgebreid onderzocht in levercellen.  Interessant hierbij is dat er 
in deze cellen geen ER stress optreedt, ondanks de ophoping van fout-gevouwen Z α1-
antitrypsine in het ER.  Echter, de cellen die polymeren bevatten zijn wel extra gevoelig 
voor ER stress veroorzaakt door processen van buitenaf, met als gevolg dat deze cellen 
meer ontstekingsmediatoren uitscheiden en sneller dood gaan.  In de afgelopen jaren 
rees de vraag of dit proces zich niet alleen in levercellen maar ook lokaal in de macrofagen 
en epitheelcellen van de long afspeelt, waardoor deze cellen ook zelf zouden kunnen 
bijdragen aan het ontstekingsproces in de long.  Die vraag staat in dit proefschrift centraal. 




In hoofdstuk 1 wordt een algemene inleiding over COPD en α1-antitrypsine 
deficiëntie, de ER stress respons en cellulaire signaalverwerking bij ontstekingsprocessen 
gegeven.  De ER stress respons is een complexe respons, die overlap heeft met andere 
stress responsen, zoals de eerder genoemde Integrated Stress Response (ISR).  In de 
laatste jaren is steeds meer bekend geworden over de rol van de ISR in het ontstaan en 
het beloop van verschillende soorten longziekten, waaronder α1-antitrypsine deficiëntie. 
In hoofdstuk 2 wordt deze kennis in detail besproken.   
In hoofdstuk 3 wordt een nieuwe techniek beschreven voor het nauwkeurig en 
kwantitatief meten van een centrale pijler in de ER stress respons, namelijk de splitsing 
van het mRNA dat de informatie bevat voor het X-box binding protein-1 (XBP-1).  Deze 
techniek wordt vervolgens ook gebruikt in het onderzoek dat staat beschreven in 
hoofdstuk 4, 5 en 7.  
Behalve intrinsieke factoren, zoals gen mutaties, kunnen ook extrinsieke factoren 
leiden tot de ophoping van eiwitten in het ER.  Het is bijvoorbeeld bekend dat virussen 
voor een overmatige eiwitproductie in een cel zorgen, zodat niet alle eiwitten verwerkt 
kunnen worden en deze ophopen in het ER en ER stress geven.  Tot voor kort was niet 
bekend of bacteriën eenzelfde fenomeen konden veroorzaken.  In hoofdstuk 4 staat 
onderzoek centraal naar de ER stress respons en de ISR in luchtwegepitheelcellen die 
werden blootgesteld aan virulentie factoren van de bacterie Pseudomonas aeruginosa. 
Hieruit bleek dat de inductie van de ISR, en dan met name productie van GADD34 via de 
ijzer gereguleerde receptor HRI, cruciaal was voor de overleving van in het laboratorium 
gekweekte luchtwegepitheelcellen.
De gevolgen van Z α1-antitrypsine en de polymeren in levercellen is uitgebreid 
bestudeerd en het is al langere tijd bekend dat deze polymeren ook aanwezig zijn in 
de longen, en in één patiënt zelfs tien jaar na een levertransplantatie.  Lokale productie 
van deze polymeren en de cellulaire consequenties voor deze cellen zouden in grote 
mate kunnen bijdragen aan de ontwikkeling van longemfyseem, en mogelijk ook in het 
onderhouden van de ziekte.  In hoofdstuk 5 en 7 werden longepitheelcellen en macrofagen, 
de twee grootste bronnen van lokale α1-antitrypsine productie in de long, onderzocht 
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op het produceren van polymeren.  In hoofdstuk 5 werd de “kritieke Z α1-antitrypsine 
concentratie” (de drempel) vastgesteld waarbij cellen overgaan tot het produceren van 
de polymeren.  Uit deze drempelconcentratie bleek dat zowel luchtwegepitheelcellen 
(hoofdstuk 5) als macrofagen (hoofdstuk 7) niet voldoende Z α1-antitrypsine produceren 
om polymeervorming mogelijk te maken.  Uit beide hoofdstukken bleek ook dat bij 
de afwezigheid van deze polymeren geen overgevoeligheid bestaat voor ER stress. 
Aan de andere kant produceren de longepitheelcellen van Z α1-antitrypsine deficiënte 
patiënten wel overmatig veel ontstekingsmediatoren (hoofdstuk 5), en dragen daarmee 
dus bij aan de verhoogde ontstekingsreactie in de long (hyperinflammatie).  Macrofagen 
vertonen deze “hyperinflammatoire” respons niet (hoofdstuk 7), waarschijnlijk omdat 
deze cellen de EGF receptor (de receptor verantwoordelijk voor de ontstekingsreactie 
in de epitheelcellen) nauwelijks tot expressie brengen.  Daarnaast werden in hoofdstuk 
6 en 7 verschillen in α1-antitrypsine productie door verschillende soorten macrofagen 
onderzocht.  Daarin werd gevonden dat bij zowel gezonde mensen als bij α1-antitrypsine 
deficiënte patiënten de ontstekingsbevorderende macrofagen veel meer α1-antitrypsine 
maken dan de ontstekingsremmende macrofagen.
Deze resultaten geven ons meer inzicht in het ziekteproces bij patiënten met type 
ZZ α1-antitrypsine deficiëntie met longemfyseem.  Naar aanleiding van de uitkomsten van 
hoofdstuk 5 zou bijvoorbeeld een therapie met EGF receptor blokkers of geïnhaleerd α1-
antitrypsine tot de mogelijkheden behoren om zo de ontstekingsreactie lokaal in de long 
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